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iiiForeword
Foreword
HIV/AIDS, sexually transmitted diseases, and tuberculosis,
as well as a range of other health problems disproportion-
ately found among inmates and ex-offenders, pose serious
challenges for corrections administrators, health service
providers, and public health officials. These problems also
present opportunities to intervene with effective prevention
and treatment, thereby benefiting inmates and those close to
them as well as the larger community.
To meet these challenges corrections and public health
agencies must work closely together with community-based
organizations.
The findings presented in this 1996–1997 Update report
suggest that there have been substantial improvements in
many aspects of the policy response to HIV/AIDS, STDs, and
TB in correctional facilities. Much work is still needed in
comprehensive prevention programs, discharge planning,
community linkages, and continuity of treatment. The study
also shows increasing collaboration among correctional,
public health, and community-based agencies, but far more
is needed.
The three agencies that have sponsored and conducted the
research presented in this Update—the National Institute
of Justice (NIJ), the Centers for Disease Control and Preven-
tion (CDC), and the Bureau of Justice Statistics (BJS)—are
committed to collaboration in research on HIV/AIDS, STDs,
and TB in correctional facilities and to collection and
dissemination of information that will foster comprehensive
and cooperative responses in policy and practice. This
Update, for the first time, combines in one volume the latest
statistics on the extent of HIV infection and AIDS among
inmates from BJS surveys with the findings on policy and
practice from the ongoing series of national surveys spon-
sored by NIJ and CDC.
We hope that the expanding collaboration in research and
dissemination represented by this report presages further
increases in operational collaborations for the development
and implementation of model HIV/AIDS, STD, and TB
prevention and treatment programs in correctional settings.
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Director
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Director
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Executive Summary
At midyear 1998, more than 1.8 million people were in
prisons and jails in the United States, and 6 million were
under some form of criminal justice supervision. Inmates
have disproportionately high rates of infectious disease,
substance abuse, high-risk sexual activity, and other health
problems. Thousands of former correctional inmates return
to the community each month.   Because prisoners are part
of the community and because correctional health and
public health are increasingly intertwined, health care and
disease prevention in correctional facilities should be based
on the collaborative efforts of correctional, public health,
and community-based health care and social service organi-
zations.
This 1996–1997 Update reports on the extent of HIV/AIDS,
STDs, and TB among correctional inmates and on the
policies and practices being implemented to prevent and
control these diseases in correctional settings. In this report,
statistics on the prevalence of HIV infection and AIDS in
correctional populations are derived primarily from surveys
conducted by the Bureau of Justice Statistics (BJS) in 1996
and 1997. Findings regarding policies and practices and
legal and legislative issues are based primarily on the ninth
national survey of HIV/AIDS, STDs, and TB in correctional
facilities, sponsored by the National Institute of Justice (NIJ)
and the Centers for Disease Control and Prevention (CDC)
and conducted between December 1996 and August 1997.
Findings on HIV-testing policies presented in chapter 5 of
this report are from BJS’ 1996 National Prisoner Statistics
and the 1997 NIJ/CDC survey.  Statistics on other policies
are based primarily on the NIJ/CDC ninth national survey
and associated site visits. Although the report focuses on
adult correctional systems, several examples of HIV preven-
tion programs in chapter 3 were drawn from site visits to
juvenile facilities. Key findings presented in this report are
summarized below.
HIV/AIDS: Burden of Disease
Among Inmates
• The overall prevalence of HIV infection and AIDS
among inmates has been quite stable since 1991, but
some systems have experienced declines in HIV
seroprevalence.
• There have been some declines in AIDS deaths among
inmates since 1995.
• Nevertheless, HIV infection and AIDS continue to be
far more prevalent among inmates than in the total U.S.
population.
• The Northeast region has the largest number and per-
centage of inmates with HIV infection and AIDS.
• The prevalence of HIV and AIDS is higher among
Hispanic and black inmates than among white inmates.
• The prevalence of HIV and AIDS is higher among
female inmates than among male ones.
Sexually Transmitted Diseases and
Hepatitis: Burden of Disease Among
Inmates
• Available data on STDs and hepatitis B and C among
inmates are very incomplete, reflecting the relative
rarity of routine screening for these conditions in cor-
rectional facilities.
• However, behavioral profiles and anecdotal evidence
suggest that inmates are disproportionately affected by
STDs and hepatitis.
HIV and STD Education and
Behavioral Interventions
• HIV and STD education programs are becoming more
widespread in correctional facilities.
• However, few correctional systems have implemented
comprehensive and intensive HIV prevention programs
in all of their facilities.
• Peer-based education and prevention programs offer
important advantages, such as cost-effectiveness, cred-
ibility, flexibility, and benefits to peers themselves.
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• Although few HIV/STD prevention programs in cor-
rectional settings have been rigorously evaluated, anec-
dotal evidence suggests that programs can be successful
in reaching this extremely high-risk population with
practical risk-reduction messages.
HIV Transmission and Risk Factors,
Precautionary and Preventive
Measures
• High-risk behaviors for HIV transmission—sex, drug
use, sharing of injection materials, and tattooing—
occur in correctional facilities.
• HIV transmission among correctional inmates has been
shown to occur.
• Comprehensive and intensive education and preven-
tion programs represent the best response to these facts,
although the precise content of such programs is contro-
versial.
• Rape and coerced sexual activity also occur in correc-
tional facilities but require a different response, one
based on inmate classification, housing, and supervi-
sion.
• The implementation of “universal precautions” repre-
sents the heart of a correctional infection-control pro-
gram and the first line of defense against the occupa-
tional transmission of HIV.
• Condom distribution and other harm-reduction strate-
gies have not been widely adopted in American correc-
tional systems.
• Experience with harm reduction in correctional facili-
ties in Europe and elsewhere  may warrant the attention
of U.S. correctional administrators.
Counseling and Testing,
Confidentiality, and Disclosure
• Most correctional systems provide HIV antibody test-
ing, although testing policies differ widely.
• Seventeen State correctional systems and the Federal
Bureau of Prisons had policies for mandatory HIV-
antibody testing of inmates at intake and/or release.
• Few correctional systems have mandatory or routine
pregnancy testing of female inmates.
• Ongoing assessment of HIV-antibody and pregnancy-
testing policies is warranted in light of changing com-
munity standards for treatment of HIV/AIDS.
• Very few correctional systems have policies for notifi-
cation of correctional officers regarding inmates’ HIV
status.
• Few correctional systems routinely screen inmates for
STDs.
Housing and Correctional
Management
• Only a small number of correctional systems segregate
inmates with HIV disease, and the number of systems
with segregation policies has declined sharply since the
late 1980s.
• Some correctional systems still limit the work assign-
ments for which inmates with HIV are eligible.
• Few correctional systems permit conjugal visits for any
inmates, and even fewer allow such visits for inmates
with HIV.
• Policies for the early or compassionate release of in-
mates with terminal illness, including end-stage AIDS,
are quite common, but relatively few inmates are actu-
ally being released under such policies.
Medical Treatment and a
Continuum of Care
• Protease inhibitors and combination therapies have
brought dramatic  improvements in the medical condi-
tion and survival of people with HIV, at least over the
relatively short term that has been available for study to
date.
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• The new therapeutic combinations pose challenges for
patient adherence, and failure to adhere consistently to
the regimens may have serious public health conse-
quences if drug-resistant strains are transmitted to oth-
ers.
• New drugs and reduced dosing currently under study
offer hope of more “patient-friendly regimens.”
• Clinicians must work closely with patients to make the
best therapeutic decisions.
• A continuum of services including early identification,
timely and effective treatment, case management, dis-
charge planning, and community linkages will make for
optimal clinical and psychosocial outcomes for inmates
with HIV disease.
• Continuity of care and bridging to community services
also contribute to positive patient outcomes.
• Existing program models have not been rigorously
evaluated but probably warrant replication based on
anecdotal evidence.
Tuberculosis (TB)
• In recent years the incidence of TB has declined both in
the overall U.S. population and among correctional
inmates, although it remains much higher among in-
mates.
• Most State/Federal prison systems appear to be follow-
ing CDC guidelines regarding TB screening, isolation
and treatment, and preventive therapy, whereas adher-
ence is lower among city/county jail systems.
• Better collection and reporting of screening data would
help to document the burden of TB infection and
disease among inmates.
• Improvements are also needed in the use of directly
observed therapy, as well as in postrelease adherence to
treatment for TB disease and TB infection.
Legal and Legislative Issues
• The U.S. Supreme Court has ruled that HIV and HIV-
related discrimination are covered under the Americans
With Disabilities Act.
• There were few other major legal developments affect-
ing HIV/AIDS in correctional facilities during the pe-
riod covered by this Update report, although courts
generally continued to uphold correctional systems’
policy responses to HIV/AIDS.
• Some State legislatures have attempted to expand the
requirements for HIV antibody testing of inmates and
disclosure of inmates’ HIV status, but these efforts
generally have been unsuccessful.
1Introduction
Introduction
In 1996 the Joint United Nations Programme on HIV/AIDS
(UNAIDS) cogently summarized the importance of health
care and disease prevention in correctional facilities:  “Pris-
oners are the community.  They come from the community,
they return to it. Protection of prisoners is protection of our
communities.”1  In the United States, the case is made
particularly compelling by the following facts:  the continu-
ing surge in incarceration, with more than 1.8 million people
in prisons and jails and 6 million under some form of criminal
justice supervision at midyear 1998; the continuing dispro-
portionate rates of infectious disease, substance abuse, high-
risk sexual activity, and other health problems among cor-
rectional inmates; and the return of thousands of former
correctional inmates to the community each month.  The
1996 UNAIDS statement also declared that “failure to pro-
vide [prisoners] the basic measures, such as information,
education, and the means of [HIV] prevention available on
the outside, violates [their] rights to health, security of
person, and equality before the law.”  Because prisoners are
part of the community and because correctional health and
public health are increasingly intertwined, health care and
disease prevention in correctional facilities should be based
on the collaborative efforts of correctional, public health,
and community-based health care and social service organi-
zations.  A public health model of correctional health care
is needed.  Such an approach is particularly urgent given the
recent dramatic advances in antiretroviral therapy and the
attendant importance of continuity of treatment, adherence
to regimens, and minimizing the potential for development
of drug resistance.
HIV/AIDS in the U.S. Population
As context for the main contents of this Update, it is impor-
tant to understand the overall trends and patterns of HIV
disease in the U.S. population.
Between 1995 and 1996, the HIV/AIDS epidemic in the
United States appeared to be lessening in intensity, at least
in some sectors of the population.  However, the face of the
epidemic continued to change, with increasing concentra-
tion among the poor and people of color, the populations
from which the majority of inmates are drawn.
Table 1, adapted from CDC’s Morbidity and Mortality
Weekly Report, reveals the dramatic changes in the epidemic
that occurred between 1995 and 1996. Calendar year 1996
was the first year in which the incidence of AIDS-opportu-
nistic illnesses (AIDS-OIs) actually declined in the United
States.2  AIDS-OIs is a measure designed to adjust for the
1993 change in the AIDS case definition, thus permitting
valid comparisons in incidence over that time.  It is calcu-
lated from the sum of cases reported with an AIDS-OI and
cases with estimated dates of diagnosis of an AIDS-OI that
were reported based only on the immunologic criteria added
in the 1993 revised case definition.  (In this report, the AIDS-
OI measure is used only with regard to the total U.S. popu-
lation and not with regard to the situation in correctional
facilities.)
Although the incidence of AIDS-OIs continues to be high—
an estimated 56,730 cases were reported in 1996—
incidence declined in all geographic regions of the country,
all 5-year age groups, and many other sectors of the popula-
tion (table 1).  Incidence declined between 1995 and 1996
among men (by 8 percent),  non-Hispanic whites (by 13
percent), men who have sex with men (by 11 percent), and
injection drug users (by 5 percent).  Moreover, although
HIV/AIDS remains a leading cause of death among Ameri-
cans between 25 and 44 years of age, AIDS deaths actually
declined for the first time between 1995 and 1996.  The
decline was substantial—23 percent.  It was largest in the last
three quarters of 1996 and affected all geographic regions,
racial and ethnic groups, and exposure categories.
These temporal declines in AIDS-OI incidence are attribut-
able to reductions in rates of new infection—due in turn to
prevention efforts—a slowing in progression from infection
to active disease,  and AIDS-OI diagnosis.  Reductions in the
number of deaths are based on increased survival with AIDS-
OIs, in turn the result of newly available antiretroviral
therapies and prophylaxis for OIs.3  Increased survival and
the relatively stable incidence of new HIV infections, how-
ever, have resulted in an increased prevalence of AIDS in the
population:  from 1995 to 1996 the number of people living
with AIDS in the United States increased by 11 percent, from
211,000 to 235,000. This increasing AIDS prevalence indi-
cates the need for more resources and services to treat and
care for those who are ill.
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Table 1.    Estimated incidence of AIDS-Opportunistic Illnesses (AIDS-Ols) and AIDS-
related deaths, 1995–96—United Statesa
     AIDS-OIsb Deathsb
% Change  % Change
   1995   1996       From    1995    1996      From
Characteristics      n     n 1995 to 1996      n     n 1995 to 1996
Sex
  Men 49,360 45,240     -8 42,000 31,440 -25
  Women 11,260 11,490   2  8,140   7,340 -10
Race/Ethnicityc
  White, non-Hispanic 24,370 21,130   -13 21,700 14,670   -32
  Black, non-Hispanic 24,090 24,030    0 18,840 16,460   -13
  Hispanic  11,410 10,800     -5 9,010 7,220   -20
Exposure Category
  MSMd 28,640 25,530   -11 24,880 17,310   -30
  MSM–IDUe 3,580   3,030   -15 3,310 2,490   -25
  Male–IDU 12,880 12,140     -6 10,790   8,970   -17
  Female–IDU 4,950 4,750    -4 3,830   3,440   -10
Heterosexual Contact
  Male 3,420   3,790    11 2,300   2,120      -8
  Female   5,900   6,320   7 3,980 3,640     -8
  Totalf 60,620 56,730 -6 50,140 38,780    -23
aEstimates are presented rounded to the nearest 10 because they do not represent exact counts of persons with AIDS-Ols but are estimates
that are approximately ± 3% of the true value.
bFigures are for people ≥ 13 years old.
cNumbers for races other than black and white were too small for meaningful analysis.  Persons of Hispanic origin may be of any race.
dMen who have sex with men.
eInjection-drug user.
fIncludes persons aged 13 years with hemophilia/coagulation disorders, transfusion recipients, or persons with other or no risks
reported.
Source: Centers for Disease Control and Prevention, “Update: Trends in AIDS Incidence—United States, 1996.”  Morbidity and Mortality
Weekly Report 46 (September 19, 1997): 863.
The incidence of AIDS-OIs did not decline among all seg-
ments of the U.S. population between 1995 and 1996.  It
remained stable among non-Hispanic blacks, and actually
increased  among  women (by 2 percent) and persons who
were infected through heterosexual contact (by 8 percent).
In the United States, heterosexually transmitted HIV infec-
tion results primarily from sexual relations with drug users.
An examination of trends in the proportional distribution of
new AIDS-OI cases across racial/ethnic groups, genders, and
exposure categories reinforces the conclusions that the
epidemic is becoming increasingly concentrated among
people of color and that women are increasingly affected.
Between 1992 and 1996, the proportion of new cases of AIDS
that occurred among non-Hispanic whites declined from 48
3Introduction
percent to 38 percent, whereas it remained stable among
Hispanics (18 percent to 19 percent), and increased from 33
percent to 41 percent among non-Hispanic blacks.  Indeed,
for the first time in 1996, the number of new cases of AIDS
among blacks exceeded the number among whites.  The
proportion of new AIDS cases among women also increased
from 14 percent in 1992 to 20 percent in 1996.4
The 1996–1997 Update:
Contents and Sources
This Update reports on the extent of HIV/AIDS, STDs, and
TB among correctional inmates and on the policies and
practices being implemented to prevent and control these
diseases in correctional settings.  Statistics on the prevalence
of HIV infection and AIDS in correctional populations
presented in this report are primarily from the Bureau of
Justice Statistics  (BJS) 1997 Survey of State and Federal
Correctional Facilities, 1996 National Prisoner Statistics,
and 1996 Survey of Inmates in Local Jails.  Statistics on the
prevalence of STDs and TB among correctional inmates
come primarily from the ninth national survey of HIV/AIDS,
STDs, and TB in correctional facilities, sponsored by the
National Institute of Justice (NIJ) and the Centers for Disease
Control and Prevention conducted between December 1996
and August 1997 and the CDC’s TB surveillance system.
Findings on HIV-testing policies presented in chapter 5 of
this report are from BJS’ 1996 National Prisoner Statistics
and the 1997 NIJ/CDC survey.  Statistics and discussion in
all other chapters on policies and practices, as well as the
chapter on legal and legislative issues, are based primarily
on the NIJ/CDC ninth national survey.
As in all of the previous national surveys in this series,
responses were received from all 50 State departments of
correction and the Federal Bureau of Prisons.  The sample
selection for the city/county jail systems was modified in
1996–97 to target the 50 largest city/county jail systems by
average daily  inmate population.  Responses were received
from 41 of these, or 82 percent. Again in 1996–97, a valida-
tion survey was conducted.  An abbreviated version of the
questionnaire was sent to 50 individual facilities in 15 State
correctional systems and the Federal Bureau of Prisons.  The
objective of the validation study was to compare responses
on key policy issues from individual facilities and the
central offices of their departments of corrections.
The survey was supplemented by site visits to the States of
California and Louisiana and to New York City and San
Francisco to observe HIV prevention programs and dis-
charge planning/transitional programs. Site visits were also
conducted to observe HIV/STD prevention programs in the
juvenile systems of Massachusetts and Los Angeles County,
California.
Although the report focuses on adult correctional systems,
several examples of HIV prevention programs in chapter 3
were drawn from site visits to juvenile facilities.
How widespread are comprehensive and collaborative ap-
proaches to correctional and community health services?  In
general, the results of the 1997 NIJ/CDC survey suggest that
HIV/AIDS education and prevention programs are on the
increase in prisons and jails but, as was also demonstrated by
the previous survey and by an extensive review of the
literature, still fail to take full advantage of this important
public health opportunity.5  A separate report based on the
1997 survey shows that public health-corrections collabo-
rations are increasingly common but still rarely rise to the
level of a comprehensive public health model.6
Endnotes
1. “HIV/AIDS in Prisons,” Statement by the Joint United
Nations Programme on HIV/AIDS (UNAIDS), April 1996.
2. Centers for Disease Control and Prevention, “Update:
Trends in AIDS Incidence—United States, 1996,” Mor-
bidity and Mortality Weekly Report 46 (September 19,
1997): 861–867.
3. F.J. Palella, Jr., et al., “Declining Morbidity and Mortal-
ity Among Patients With Advanced HIV Infection,” New
England Journal of Medicine 338 (March 26, 1998):
853–860.
4. Centers for Disease Control and Prevention, “Update:
Trends in AIDS Incidence, Deaths, and Prevalence—
United States, 1996.” Morbidity and Mortality Weekly
Report 46 (February 28, 1997): 165–173.
5. T.M. Hammett and R. Widom, “HIV/AIDS Education
and Prevention Programs for Adults in Prisons and Jails
and Juveniles in Confinement Facilities—United States,
1994,” Morbidity and Mortality Weekly Report 45 (April
4 1996–1997 Update:  HIV/AIDS, STDs, and TB in Correctional Facilities
5, 1996): 268–271; T.M. Hammett, R. Widom, and S.
Kerr, “HIV Prevention in Prisons and Juvenile Facilities:
A Missed ‘Public Health Opportunity,’ ” oral abstract
We.D.351, presented at the 11th International Confer-
ence on AIDS, Vancouver, Canada, July 10, 1996; and
T.M. Hammett, J.L. Gaiter, and C. Crawford, “Reaching
Seriously At-Risk Populations: Health Interventions in
Criminal Justice Settings,” Health Education and Be-
havior 25 (February 1998): 99–120.
6. T.M. Hammett,  Public Health/Corrections Collabora-
tions: Prevention and Treatment of HIV/AIDS, STDs,
and TB, Research in Brief, Washington, DC: U.S. De-
partment of Justice, National Institute of Justice, 1998
(NCJ 169590).
At year-end 1996, 2.3 percent of all State and Federal
prison inmates were known to be infected with the human
immunodeficiency virus (HIV).  A total of 24,881 prison
inmates were HIV positive (947 Federal and 23,934 State).
HIV-positive inmates made up 1.0 percent of Federal
prison inmates and 2.4 percent of State prison inmates.  Of
those known to be HIV positive in all U.S. prisons, 5,874
were confirmed AIDS cases, while the remaining 17,656
either showed symptoms of HIV infection or were
asymptomatic.
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In 1996, there were a total of 907 AIDS-related deaths in
State prisons, down from 1,010 in 1995. For every 100,000
State prison inmates in 1996, 90 died of AIDS-related
causes.  Between 1991 and 1996, about 1 in 3 State prison
inmate deaths were attributed to AIDS-related causes.
Data based on personal interviews from the 1997 Survey
of Inmates in State Correctional Facilities show that 75
percent of State inmates were ever tested for HIV.  Of
those who were ever tested  and reported results, 2.2
percent were HIV positive&2.2 percent of males and 3.4
percent of females.  As reported level of involvement in
prior drug use increased, so did the percent of
HIV-positive inmates&2.3 percent of those who said they
had ever used drugs, 2.7 percent of those who used drugs
in the month before the current offense, 4.6 percent of
those who injected drugs, and 7.7 percent of those who
ever shared a needle were HIV positive.
Data on HIV/AIDS in jails have been collected in the 1993
Census of Jails and the 1996 Survey of Inmates in Local
Jails.  According to the 1993 Census of Jails, 1.8 percent
of local jail inmates were known to be HIV positive.  The
larger the size of the jail jurisdiction, the greater the
percentage of inmates with HIV/AIDS.  
Based on personal interviews conducted from October
1995 through March 1996 in the Survey of Inmates in
Local Jails, almost 6 in 10 inmates reported ever being
tested for HIV.  Of those who were tested and reported
results, 2.2 percent reported being HIV positive.  Among
female inmates, 2.4 percent said they were HIV positive;
among male inmates, 2.1 percent.  An estimated 2.3
percent of tested jail inmates who said they had ever used
drugs were HIV positive, as were 2.9 percent who used
drugs in the month before arrest, 4.0 percent who  used a  
needle  to inject  drugs,  and  6.3 percent who ever shared
needles. 
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At year-end 1996, 24,881 inmates in State and Federal
prisons were known to be infected with the human
immunodeficiency virus (HIV), up from 24,256 at year-
end 1995 (table 2).  In State prisons, 23,934 inmates were
known to be HIV positive, and in Federal prisons, 947
inmates were HIV positive.  Although the number of HIV
cases increased after 1991, the percent of the total custody
population with HIV remained relatively stable.  Between
1991 and 1996 the number of HIV-positive inmates grew
at about the same rate as the overall prison population
(both increased by about 42 percent).
HIV-positive inmates comprised 2.3 percent of the State
prison population in 1991 and 2.4 percent in 1996.  In
Federal prisons, HIV-positive inmates comprised 1.0
percent in 1996, unchanged from 1991.
Source: BJS, National Prisoner Statistics.
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HIV-infected inmates were concentrated in a small number
of States.  New York and Florida housed the largest
number of  HIV-positive inmates (9,500 and 2,152,
respectively).  In 1996, these two States housed nearly half
of all HIV-infected inmates in State prisons. 
More than half of the State prison inmates known to be
HIV positive were found in the Northeast.  Within the
Northeast, 7.5 percent of the prison population were HIV
positive, followed by 2.0 percent in the South, 1.1 percent
in the Midwest, and 0.8 percent in the West.  New York
had the highest percentage of inmates known to be HIV
positive (13.6 percent), followed by Connecticut (4.6
percent), and Rhode Island (3.9 percent).  These three
States had the highest percentage of HIV-positive inmates
after 1994.
Of the 48 States that reported information on the number
of HIV-positive inmates in 1996, each reported having at
least one.  Eight States (Alaska, Maine, Montana, North
Dakota, South Dakota, Vermont, West Virginia, and
Wyoming) reported 10 or fewer cases of HIV-positive
inmates in their prisons.  Eleven States reported that fewer
than 0.5 percent of their inmate population were HIV
positive.  Between 1995 and 1996 the largest growth of
HIV-positive inmates was reported in Virginia&383 in
1996, up from 134 in 1995.  Other notable increases
during 1996 were reported in Michigan (up 149) and
Maryland (up 108).
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--Not reported.
aThe custody population includes only those inmates housed in a jurisdiction's facilities.
bTotals exclude those inmates in jurisdictions that did not report data on HIV/AIDS. 
Counts may differ from previous reports.  Percentages for all years are based
on year-end custody counts. 
Source: BJS, National Prisoner Statistics.
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Table 2.  Inmates in custody of State or Federal prison authorities and 
known to be positive for the human immunodeficiency virus, 1994-96
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 Note: Totals and percentages exclude inmates in jurisdictions that did not report data on type 
 of HIV/AIDS infection.  The custody population includes only inmates housed at the end of 1996.
 **Not calculated for 10 or fewer cases.
 --Not reported.
,Less than .05%.
  aGeorgia, Louisiana, and Missouri reported the total of HIV-positive cases but not the type of HIV. 
  bIncludes all inmates who had tested positive for the HIV antibody but had no HIV-related symptoms.  
  cIncludes inmates with symptoms of HIV infection but without a confirmed AIDS diagnosis.
 Source: BJS, National Prisoner Statistics.
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Table 3.  Inmates in custody of State or Federal prison authorities,  by type of HIV infection 
or confirmed AIDS, year-end 1996
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At the end of 1996, 5,874 inmates in U.S. prisons had
confirmed AIDS: 5,521 were State inmates and 353 were
Federal inmates (table 3).  Of the remaining HIV-positive
inmates, 1,959 showed symptoms of AIDS (symptomatic),
while 15,697 were HIV positive but showed no symptoms
of AIDS (asymptomatic).
Confirmed AIDS cases made up 0.5 percent of all inmates
in State and Federal prisons.  Of those inmates known to
be HIV positive, nearly a quarter had confirmed AIDS.
During 1996 the number of confirmed AIDS cases
increased by 748.  Overall, after 1991 the number of
confirmed AIDS cases increased by 4,165&an average
annual increase of 28.3 percent.  The number of inmates
with lesser or no symptoms of HIV infection actually
decreased in 1996, and the number was below the numbers
reported  in every year from 1992 to 1995.  
The States with the largest number of confirmed AIDS
cases were New York (1,208), Florida (873), Texas (499),
and California (429).  Combined, these States made up 55
percent of all confirmed AIDS cases in State prisons.
Eighteen States reported having fewer than 10 confirmed
AIDS cases in their prisons.
The highest percentage of the State prison population
having confirmed AIDS was in New York (1.7 percent),
followed by Connecticut (1.6 percent), Massachusetts (1.5
percent), Florida (1.4 percent), and Maryland (1.3
percent).  In 17 States confirmed AIDS cases comprised
0.1 percent or fewer of State inmates.
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At the end of 1996, the rate of confirmed AIDS in State
and Federal prisons was six times higher than in the total
U.S. population.  About 54 in 10,000 prison inmates had
confirmed AIDS, compared to 9 in 10,000 persons in the
U.S. population.  
 
In every year from 1991 to 1996, the rate of confirmed
AIDS was higher among prison inmates than in the general
population.  In 1992 the rate of AIDS was 11 times higher
for prisoners than the general population.  In 1993, follow-
ing a revision of the HIV classification system and an
expansion of the case definition for AIDS, the rate of
confirmed AIDS increased 1ë times among prisoners and
doubled in the general population.  After the adoption of
these new measures, the incidence of AIDS grew
somewhat faster in the general population.   At year-end
1996 the rate of confirmed AIDS was six times higher in
prisons than in the general population.
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Note:  Care should be exercised when comparing the
number of reported cases over time.  In January 1993 the
Centers for Disease Control and Prevention revised the
HIV classification system and expanded the surveillance
case definition for AIDS to include specific CD4+
T-lymphocyte criteria and three additional clinical condi-
tions&pulmonary tuberculosis, recurrent pneumonia, and
invasive cervical cancer.  This expansion resulted in a
substantial increase in the number of reported AIDS
cases during 1993.  See Methodology, pp. 17-19.
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Note:  The percent of the general population with confirmed
AIDS in each year may be overestimated due to delays in
death reports.  Care should be exercised when comparing
percents over time, because of changes in the case definition
for AIDS.  See Methodology, pp. 17-19.
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At year-end 1996 there were 21,799 male inmates
and 2,135 female inmates known to be HIV positive
(table 4).  Overall, 2.3 percent of male inmates and
3.5 percent of all female inmates were known to be
HIV positive.  The rate of HIV infection in females
was higher than male infection rates in all regions
except the West and in most States.
Between 1995 and 1996 the number of infected
female inmates decreased 2.2 percent from 2,182 to
2,135; the number of infected male inmates
increased 5.4 percent from 20,690 in 1995 to 21,799
in 1996.  Overall, among State prisoners, the number
of males infected with HIV increased 35 percent,
and  the  number  of  females  infected increased   84
      percent between 1991 and 1996.
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--Not reported.
Source: BJS, National Prisoner Statistics.
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Table 4.  State prison inmates known to be positive  for the  
human immunodeficiency virus, by sex, year-end 1996
*In 1991 North Carolina, South Dakota, and the District 
of Columbia did not report data by gender.  In 1995 Delaware,
Indiana, South Carolina, and the District of Columbia did not report
data by gender.
Source: BJS, National Prisoner Statistics.
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States in the Northeast reported the largest number of
HIV-positive male and female inmates (10,985 and 1,105,
respectively).  In eight States, more than 5 percent of all
female inmates were known to be HIV positive.  In two
States over 10 percent of all female inmates were known to
be HIV positive&New York (20.5 percent) and Rhode
Island (11.7 percent).  New York (13.2 percent) was the
only State in which more than 10 percent of all male
inmates were HIV positive.  
Among all States, New York reported the largest number of
male and female HIV-positive inmates (8,736 and 764,
respectively).  The second largest number of  HIV-positive
male inmates were in Florida (1,929), followed by Texas
(1,645).  The second largest number of HIV-positive female
inmates were in Texas (231), followed by Florida (223).
Seven States reported no female HIV-positive inmates, and
every State reported at least one male HIV-positive inmate. 
#+&5/4GNCVGF &GCVJU KP 5VCVG 2TKUQPU
The number of State inmates who died of Pneumocystis
carinii pneumonia, Kaposi’s sarcoma, or other AIDS-
related diseases decreased from 1,010 in 1995 to 907 in
1996 (table 5).  These AIDS deaths accounted for 29
percent of all deaths among State prisoners, down from 34
percent in 1995. Beginning in 1991 AIDS-related causes
were the second leading cause of death in State prisons,
behind natural causes other than AIDS.   
In 1996, for every 100,000 inmates, 90 died from AIDS-
related causes.  Between 1991 and 1995, the number of
AIDS-related deaths in State prisons increased 94 percent;
however, in 1996 the number decreased 10 percent from
1995.  With the introduction of protease inhibitors and
combination antiretroviral therapies, there was appreciable
improvement in the effectiveness of HIV/AIDS care.
The rate of death because of AIDS is about three times
higher in the prison population than in the total U.S.
population age 15%54.  Between 1991 and 1996, about 1 in
every 3 prisoner deaths were attributable to AIDS-related
causes, compared to about 1 in 10 deaths in the general
population.
AIDS-related deaths accounted for more than half of all
inmate deaths in Connecticut (65 percent), New York (55
percent), New Jersey (52 percent), and Florida (50
percent) (table 6).  Seventeen States reported having no
AIDS-related deaths, and five States reported one AIDS-
related  death.
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-- Not available.
* See Methodology, p. 18, for source of data.
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Note:  In 1994 some States did not report complete data on cause of death.  To calculate the rate of death, the 
number of inmates under State jurisdiction on June 30 of each year was used as an approximation of the average 
population exposed to the risk of death during the year.  Inmates in States that did not report data on inmate deaths 
were excluded in 1994.   All States reported data on inmate deaths in 1995 and 1996.
Source: BJS, National Prisoner Statistics.
161662020427244Other/unspecified
665986768By another person
445656330Execution
443548433Accident
151541616017155Suicide
909071001,010104955AIDS
1701,7151561,5691521,393
Natural causes other
  than AIDS
3083,0953113,1333142,878 Total
Rate of  death per
100,000 inmates
  
 Number
Rate of  death per
100,000 inmates Number
Rate of  death per
100,000 inmates
   
 NumberCause of death
199619951994
Table 5.  Number of inmate deaths in State prisons, by cause, 1994%96
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--Not reported.
**Not calculated for 10 or fewer deaths. 
 aBased on the number of inmates under State jurisdiction on June 30, 1996. 
 bNational and regional totals exclude inmates in jurisdictions that did not report
 data on cause of death.
Source: BJS, National Prisoner Statistics.
**006128Wyoming
27.379928933Washington
**3112147Utah
8.027233325Oregon
**00974New Mexico
22.9107846735Nevada
**002645Montana
**311933Idaho
**001124Hawaii
00020522Colorado
19.43749192253California
00029261Arizona
**00933Alaska 
15.1%3370220463West
**002466West Virginia
36.91143130884Virginia
32.496122297377Texas
13.354840260Tennessee
35.51392739076South Carolina
6.123437566Oklahoma
35.1972627674North Carolina
15.640525732Mississippi
33.3751622448Maryland
23.3812034686Louisiana
3.38125130Kentucky
42.114148334114Georgia
50.2200124398247Florida
------27729District of Columbia
00043020Delaware
8.722225323Arkansas
14.6651344389Alabama
30.6%1094473271,461South
28.638413214Wisconsin
**002204South Dakota
17.14620269117Ohio
**0000North Dakota
**002868Nebraska
00019537Missouri
**21121010Minnesota
------302125Michigan
10.029228920Kansas
**0017610Iowa
5.113224839Indiana
33.3853225496Illinois
12.7%4161252480Midwest
**0000Vermont
**3212237Rhode Island
25.811133429128Pennsylvania
55.2266182482330New York
52.128974554142New Jersey
**00972New Hampshire
23.361726230Massachusetts
**002063Maine
65.32133232749Connecticut
47.6%208329437691Northeast
29.3%909073083,095Total
As a percent of 
all deathsb
Rate per 100,000
inmatesaTotal
Rate per 100,000
inmatesaTotalJurisdiction
AIDS-related deaths
Deaths from all causes 
in State prisons
Table 6.  AIDS-related deaths of sentenced prisoners under State jurisdiction, 1996
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Data on HIV prevalence rates are reported in the National
Prisoners Statistics series (NPS) by prison officials.  The
quality of the information reported varied by the testing
policies that a particular State implemented.  Testing
policies ranged from testing all inmates to testing only
upon inmate request. Although 19 States tested either all
inmates in custody or a random selection, and 27 test
targeted groups (high-risk individuals or upon indication
or incidence), 5 tested solely upon inmate request.  Official
data represent the minimum number of individuals known
to be HIV positive within a prison facility.
Blinded or “unlinked” studies have been conducted as
another means of determining the HIV prevalence in State
prisons.  These studies are blinded in that the identity of
the inmate is not linked to the result of the HIV test.  An
inmate’s blood that has been drawn during a routine physi-
cal examination upon entering a facility is tested for HIV.
The sample is sent to a lab with no information regarding
the inmate.  
Blinded studies may not accurately account for the preva-
lence rate of HIV in prisons. Often these studies are
conducted in only a few facilities, and are snapshots,
examined over one period solely on admission cohorts.
Because of this, blinded studies are limited in that they
may not be generalized to the overall prison population.
Discrepancies are apparent between HIV prevalence rates
reported in official records and those produced from
blinded studies.  
Data from a blinded study conducted in Massachusetts in
1995 suggest that 6.8 percent of incoming inmates are HIV
positive, while official data from 1995 indicate 3.9 percent
of all inmates in custody were HIV positive.  Similarly,
data from blinded studies conducted in Maryland (1991),
California (1994), Illinois (1991), and New Jersey (1991)
suggest that official data underestimate the HIV prevalence
rate.  
Official data from New York in 1994 and 1995, however,
revealed higher HIV prevalence rates than data from a
1994-1995 blinded study.  The blinded study showed that
10 percent of all incoming inmates were HIV positive,
while official data showed that of all inmates in custody,
12.4 percent in 1994 and 13.9 percent in 1995 were HIV
positive.  Similarly, National Prisoner Statistics (NPS) data
from Arkansas (1992) and Washington (1991) suggest a
higher prevalence rate among inmates than data from
blinded studies (0.9 percent compared to 0.6 percent, and
0.5 percent compared to 0.2 percent).
*+81#+&5 4GRQTVGF KP 2GTUQPCN
+PVGTXKGYU
Additional information on the prevalence of HIV/AIDS
may also be obtained through personal interviews of
prisoners.  Though some inmates may be reluctant to
report that they are HIV positive and others may not know,
surveys provide a means to track HIV infection among
demographic and “high-risk” groups not identified in
official records or blinded studies.
The 1997 Surveys of State and Federal Correctional Facili-
ties asked inmates if they had ever been tested, if they had
been tested since admission, and whether they were HIV
positive.  Similar questions were asked in the 1996 Survey
of Inmates in Local Jails.  (See Methodology for further
detail.)
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Note:  Categories are mutually exclusive;  therefore total adds to 51.
Delaware did not report data on testing policies.
See chapter 5 for more detailed data on testing policies.
Source: BJS, National Prisoner Statistics.
7+POCVG TGSWGUV QPN[
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KPFKECVKQP QH PGGF 49
54CPFQO
38*KPEQOKPI QT KP EWUVQF[+
#NN KPOCVGU
0WODGT QH LWTKUFKEVKQPU6GUVKPI RQNKE[
aData from Illinois, New Jersey, Arkansas, and Washington came from
the 1994 Update: HIV/AIDS and STDs in Correctional Facilities.  Data
for Massachusetts, Maryland, California, and New York came from other
sources.  (See Methodology, p. 19, for further detail.)
bThe New York blinded study covered both 1994 and 1995.  The NPS
rate for New York represents an average of the reporting years.
cNo women were tested in the blinded study.
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In 1997, 17,674 (1.7 percent) State prison inmates and 428
(0.5 percent) Federal prison inmates were known to be
HIV positive (table 7).  Of those inmates who reported
being tested since admission to State prison, or to Federal
prison, 2.6 percent and 0.7 percent, respectively, reported
being HIV positive.
Among State prisoners, female inmates (3.4 percent) were
more likely than male inmates (2.2 percent) to be HIV
positive (table 8).  Black non-Hispanic inmates (2.8
percent) were twice as likely as white non-Hispanic
inmates (1.4 percent) to report being HIV positive.  
Among male inmates, blacks (2.7 percent) were nearly
twice as likely as whites to be HIV positive.  The rates of 
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Note: Data are from the 1996 Survey of Inmates in Local Jails
and the 1997 Surveys of Inmates in State and Federal 
Correctional Facilities.
0.72.63.9HIV positive
69.7%59.1%17.7%Tested since admission
0.62.22.2HIV positive
79.6%74.6%57.2%Ever tested
0.5%1.7%1.2%HIV positive
All inmates
   Federal 
   prisons
   State 
   prisons
   Local 
   jailsCharacteristic
Percent of inmates
Table 7.  Inmates ever tested or tested since 
admission for the human immunodeficiency 
virus and test results
Note: Data are from the 1996 Survey of Inmates in Local Jails and the 1997 Surveys of Inmates
in State and Federal Correctional Facilities.  
0.537,2372.4254,9752.3122,597High school or more
0.616,3891.4231,7141.345,431GED
0.8%17,2262.7%302,4372.3%121,589Less than high school
Education
0.829,0452.4453,6642.1169,270Never married
03,8842.945,4352.125,929Separated
0.416,3312.0161,4683.048,695Widowed/divorced
0.5%21,5451.7%128,8341.4%45,890Married
Marital status
1.216,8842.792,1683.021,45545 or older
0.422,2283.1232,8353.870,77635%44
0.526,2622.3310,1612.1116,53225%34
0.1%5,5280.5%154,1810.7%81,22817%24
Age
01,5734.28,3821.34,774Female
0.716,8922.4115,3443.540,985Male
0.718,4662.5123,7253.245,759Hispanic
1.31,7913.927,1353.214,806Female
0.826,3872.7357,7362.5110,453Male
0.828,1782.8384,8702.6125,259Black non-Hispanic
0.31,5632.318,2322.111,278Female
0.319,5651.4239,6871.398,745Male
0.3%21,1281.4%257,9191.4%110,023White non-Hispanic
Race/Hispanic origin
0.65,1793.455,8002.431,972Female
0.6%65,7232.2%734,3272.1%258,019Male
Sex
0.6%70,902 2.2%790,1282.2%289,991All inmates
Percent 
HIV positiveNumber
Percent 
HIV positiveNumber
Percent 
HIV positiveNumberCharacteristic
Federal prisonsState prisonsLocal jails
Inmates ever tested 
Table 8.  Inmates ever tested for the human immunodeficiency virus and results, 
by selected characteristics
HIV infection among female inmates were not signifi-
cantly different among whites (2.3 percent), blacks (3.9
percent), and Hispanics (4.2 percent).
In Federal prisons 0.6 percent of males and of females
reported HIV infection.  Non-Hispanic white inmates
reported the lowest HIV-positive rates (0.3 percent). In
both State and Federal prisons, inmates age 17 to 24
reported the lowest rate of being HIV positive (0.5 percent
and 0.1 percent, respectively).  In State prisons, inmates
age 35 to 44 reported the highest HIV-positive rate (3.1
percent).  Those State inmates in each age category over
24 were more likely to be HIV positive than those who
were 24 or younger.  In Federal prisons, inmates age 45 or
older reported the highest rate of HIV infection (1.2
percent).
 
*+8/2QUKVKXG 2TKUQP +POCVGU.
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Those inmates being held on a drug offense in State
prisons reported the highest HIV positive rate (2.9 percent)
(table 9).  Of property offenders, 2.4 percent reported
being HIV positive.  Violent and public-order offenders
reported slightly lower rates (1.9 percent each).  Among
Federal prison inmates, 1.0 percent of violent offenders,
property offenders, and public-order offenders reported
being HIV positive as did 0.4 percent of drug offenders.
The percentage of State and Federal prison inmates report-
ing that they were HIV positive varied by level of prior
drug use.  By type of drug use practice, the following
percentages of State prison inmates reported being HIV
positive:  never using drugs, 1.7 percent HIV positive; ever
used drugs, 2.3 percent; used drugs in the month before
their current offense, 2.7 percent; used a needle to inject
drugs, 4.6 percent; and shared a needle, 7.7 percent HIV
positive.  Like State inmates, Federal inmates who used a
needle and shared a needle had a higher rate of HIV infec-
tion than those inmates who reported ever using drugs or
using drugs in the month before their current offense (1.3
percent and 2.1 percent compared to 0.7 percent and 0.3
percent).  Unlike State inmates, Federal inmates using
drugs in the month prior to their current offense reported a
lower rate of HIV infection (0.3 percent) than inmates who
reported ever using drugs (0.7 percent).
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Note: Data are from the 1996 Survey of Inmates in Local Jails and the 1997 Surveys of Inmates
in State and Federal Correctional Facilities. 
2.14,0227.774,3936.325,476      Ever shared a
         needle
1.39,4434.6168,4464.061,862
   Used needle to
       inject drugs
0.332,1132.7460,6852.9106,907
   In the month before
   offense
0.751,8472.3665,9772.3247,233Ever 
0.3%18,9171.7%123,0491.6%42,242Never 
Prior drug use
1.010,0291.977,0491.764,820Public-order
0.443,8152.9164,2563.365,780Drug
1.04,6602.4178,6012.279,936Property
1.0%10,6811.9%360,3701.5%72,846Violent
Current offense
Percent 
HIV positiveNumber
Percent 
HIV positiveNumber
Percent 
HIV positiveNumberCharacteristic
Federal prisonsState prisonsLocal jails
Inmates ever tested 
Table 9.  Inmates ever tested for the human immunodeficiency virus and results, 
by offense and prior drug use
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At midyear 1993, when the last national census of local
jails was conducted, 1.8 percent of the inmates were
known to be HIV positive.  Among jails reporting data, a
total of 6,711 inmates were HIV positive, and 1,888 had
confirmed AIDS.
  
The infection rate was highest in the
largest jail jurisdictions.  Almost 3 percent of the inmates
in the Nation's largest jurisdictions were reported HIV
positive.  Among the remaining jurisdictions, the larger the
size, the greater the percentage of inmates with HIV/AIDS.
In jurisdictions with 500 or more inmates, 1.6 percent of the
inmates were infected; in jurisdictions with 250 to 499
inmates, 1.2 percent; and in jurisdictions holding fewer than
250 inmates, 1 percent or less.
*+8 6GUV 4GUWNVU HQT .QECN ,CKN
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Detailed data, based on interviews of a national sample of
inmates in local jails, are available from the 1996 Survey
of Inmates in Local Jails.  Conducted between October
1995 and March 1996, the survey provides national
estimates of the number of jail inmates tested for
HIV/AIDS and the percent HIV positive.
In 1996, 6,289 local jail inmates (1.2 percent of all
inmates) were known to be HIV positive (table 7).  An
estimated 57 percent of all respondents in the survey said
they had ever been tested for HIV.  Of those who had been
tested for HIV, 2.2 percent said they were HIV positive.
Since admission, about 18 percent of inmates had been
tested for HIV, and 3.9 percent reported HIV positive
results.  
Among jail inmates, 2.1 percent of males and 2.4 percent
of females said they were HIV positive (table 8).  An
estimated 2.6 percent of black inmates, compared to 1.4
percent of white inmates, said they tested HIV positive.
Among male inmates, blacks (2.5 percent) were nearly
twice as likely as whites (1.3 percent) to report being HIV
positive.  Hispanic males had the highest HIV-positive rate
(3.5 percent).  Among female inmates, although the
percentage who reported they were HIV positive was
higher among blacks (3.2 percent) than whites (2.1
percent) and Hispanics (1.3 percent,) the differences were
not statistically significant.
Inmates age 24 or younger had the lowest HIV-positive
rates (0.7 percent), while those 35 to 44 had the highest
rates (3.8 percent).  Inmates 25%34 and 45 or older fell in
the middle (2.1 percent and 3.0 percent, respectively).
Inmates who had completed high school were as likely as
those who had not completed high school to say they
tested HIV positive (2.3 percent).  
2GTEGPV *+8 2QUKVKXG COQPI ,CKN
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Among jail inmates who said they had been tested for
HIV/AIDS, those held for drug offenses were the most
likely to be HIV positive (3.3 percent) (table 9).  Drug
offenders were twice as likely as violent offenders (1.5
percent) to report that they tested positive for HIV.
Property and public-order offenders reported somewhat
lower rates&2.2 percent and 1.7 percent, respectively.
The percent of jail inmates reporting that they were HIV
positive varied by level of prior drug use.  An estimated
2.3 percent of inmates who had ever used drugs, 2.9
percent of inmates who used drugs in the month before
their current offense, 4.0 percent of inmates who said they
had used needles to inject drugs, and 6.3 percent of those
who had shared a needle with someone else reported being
HIV positive.
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aBased on the average daily population between July 1, 1992,
and June 30, 1993.
bExcludes inmates in facilities that did not report data.
Source:  HIV in Prisons and Jails, 1993.
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National Prisoner Statistics
The National Prisoner Statistics series (NPS) includes an
annual year-end count of prisoners by jurisdiction, sex,
race, Hispanic origin, and admissions and releases during
the year.  The series consists of yearly reports to the
Bureau of Justice Statistics from the departments of
corrections of the 50 States and the District of Columbia
and from the Federal Bureau of Prisons.
Since 1991 respondents have been asked to indicate their
policies for testing for HIV and to provide the number of
HIV-infected inmates in their custody on the last day of the
calendar year.
Surveys of Inmates in State and Federal Correctional
Facilities, 1997
The 1997 Surveys of Inmates in State and Federal Correc-
tional Facilities were conducted for the Bureau of Justice
Statistics by the U.S. Bureau of the Census.  The Federal
Bureau of Prisons  co-sponsored the Survey of Inmates in
Federal Correctional Facilities.  Personal interviews were
conducted from June 1997 through October 1997.  Infor-
mation was collected about individual characteristics of
prison inmates, current and prior offenses and sentences,
criminal histories, characteristics of the
 
current offense,
family background, prior drug and alcohol use and treat-
ment, and conditions of confinement.  
The sample for the Federal inmates survey was selected
from a universe of 135 Federal prisons holding sentenced
inmates.  For State inmates the sample came from 1,453
State prisons counted in the 1995 Census of State Correc-
tional Facilities performed on June 30, 1995, with prisons
opening between the census and June 30, 1996, added.
The overall response rate in the State survey was 92.5
percent.  Similar surveys of State prison inmates were
conducted in 1974, 1979, 1986, and 1991.  The first
survey of Federal inmates was done in 1991.
Census of Jails, 1993
The 1993 Census of Jails included all locally administered
confinement facilities (3,287) that held inmates beyond
arraignment and were staffed by municipal or county
employees.  The census also included 17 jails that were
privately operated under contract for local governments.
Excluded from the census were temporary holding facili-
ties, such as drunk tanks and police lockups,
 
that do not
hold persons after being formally charged in court (usually
with in 72 hours of arrest).  Also excluded
 
were
 
State-
operated facilities in Alaska, Connecticut, Delaware,
Hawaii, Rhode Island, and Vermont, which have combined
jail-prison systems.
Survey of Inmates in Local Jails, 1996
The 1996 Survey of Inmates in Local Jails was conducted
for BJS by the U.S. Bureau of the Census.  Through
personal interviews conducted from October 1995 through
March 1996, data were collected on individual characteris-
tics of jail inmates, current offenses, sentences and time
served, criminal histories, jail activities, conditions and
programs, prior drug and alcohol use and treatment, and
health care services provided while in jail.  The sample for
the 1996 survey was selected from a universe of 3,328 jails
that were enumerated from the 1993 Census of Jails.  The
total nonresponse was 13.7 percent.  Similar surveys of jail
inmates were conducted in 1972, 1978, 1983, and 1989.  
Accuracy of the Survey Estimates
The accuracy of the estimates from the 1996 Survey of
Inmates in Local Jails and the 1997 Surveys of Inmates in
State and Federal Correctional Facilities depends on two
types of error:  sampling and nonsampling.  Sampling error
is variation that may occur by chance because a sample
rather than a complete enumeration of the population was
conducted.  Nonsampling error can be attributed to many
sources, such as nonresponse, differences in the interpreta-
tion of questions among inmates, recall difficulties, and
processing errors.  In any survey the full extent of the
nonsampling error is never known.
The sampling error, as measured by an estimated standard
error, varies by the size of the estimate and the size of the
base population.  Estimates for the percentage of inmates
ever tested for HIV and the percentage who tested HIV
positive have been calculated (see table 10).  These
standard errors may be used to construct confidence inter-
vals around percentages.  For example, the 95-percent
confidence interval around the percentage of males in local
jails who were HIV positive is approximately 2.1 percent
plus or minus 1.96 times 0.33 percent (or 1.5 percent to
2.7 percent).
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These standard errors may also be used to test the statisti-
cal significance of the difference between two sample
estimates by pooling the standard errors of the estimates
(that is, by taking the square root of the sum of the squared
standard errors for each sample estimate).  All compari-
sons discussed in this report were statistically significant at
the 95-percent confidence level.
AIDS in the U.S. Resident Population
The number of persons with confirmed AIDS in the U.S.
general population (age 13 and over) was derived from the
Centers for Disease Control and Prevention (CDC),
HIV/AIDS Surveillance Report, year-end editions
1991%1996.  For each year the number of active AIDS
cases in the United States was calculated by subtracting the
number of cumulative AIDS deaths for people age 15 and
older at year-end from the cumulative number of total
AIDS cases for people age 13 and older at year-end as
listed in the HIV/AIDS Surveillance Report.
The data for the U.S. general population, excluding
persons under age 13, from 1991 to 1996 were taken from
the U.S. Population Estimates, by Age, Sex, Race, and
Hispanic Origin: 1990 to 1995, PPL-41, and the update for
1996.
The rate of confirmed AIDS cases in the U.S. resident
population was calculated by dividing the annual totals for
individuals with AIDS by the population estimates for the
U.S. resident population of individuals 13 and older.
The classification system for HIV infection and the case
definition for AIDS were expanded in 1993.  This expan-
sion improved estimates of the number and the characteris-
tics of persons with HIV disease, but complicated interpre-
tation of AIDS trends.  The increase in reported AIDS
cases in 1993 was largely the consequence of the added
surveillance criteria.  (See CDC, Morbidity and Mortality
Weekly Report, Vol. 43, No. 45, November 18,1994.)
AIDS-Related Deaths in the United States
The number of AIDS-related deaths for persons age 15%54
was derived from the CDC, HIV/AIDS Surveillance
Report, year-end editions.  Deaths in the U.S. population
for persons age 15%54 were taken from the CDC, Monthly
Vital Statistics Report, Vol. 42, No. 2(S); Vol. 43, No. 12;
Vol. 43, No. 6(S); Vol. 45, No. 3(S); and Vol. 45, No.
11(S).
AIDS-related deaths as a percentage of all deaths in the
U.S. population were calculated by dividing the national
estimate of AIDS deaths of  persons age 15%54 by the
national mortality estimates of persons age 15%54 in a
given year.  
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1.411.091.71      Shared a needle
0.730.570.85    Used needle to inject drugs
0.190.270.58    Used month before offense
0.230.210.33  Ever used
%0.25%0.41%0.62  Never used
Prior drug use
0.620.550.66  Public-order
0.190.460.79  Drug
0.910.400.52  Property
%0.60%0.25%0.49  Violent
Current Offense
0.230.340.49  High school graduate or more
0.380.270.46  GED
%0.42%0.33%0.47  Less than high school
Education
0.330.250.38  Never married
0.000.880.97  Separated
0.310.390.88  Widowed/divorced
%0.30%0.40%0.58  Married
Marital Status
0.520.601.13  45 or older
0.260.400.85  35%44
0.270.300.42  25%34
%0.27%0.20%0.30  Under 24
Age
0.001.670.76    Female
0.560.611.09    Male
0.520.580.98  Hispanic
1.150.720.74    Female
0.510.380.53    Male
0.480.370.47  Black non-Hispanic
0.630.800.68    Female
0.330.310.41    Male
%0.31%0.29%0.38  White non-Hispanic
Race/Hispanic origin
0.350.440.44  Female
%0.19%0.20%0.33  Male
Sex
Federal
prisons
State 
prisons
Local 
jailsCharacteristics
Table 10.  Standard error estimates for the 1996 Survey 
of Inmates in Local Jails and the 1997 Surveys of State 
and Federal Correctional Facilities
HIV Prevalence Rates from Blinded Studies 
Data from blinded studies on HIV prevalence rates in
Massachusetts, Maryland, California, and New York were
gathered from several sources:
B. Werner et al., “Drop in HIV Seroprevalence among
Men and Women Entering Massachusetts Prisons,”
Abstract No. 115, presented at the Third Conference on
Retroviruses and Opportunistic Infections, Washington,
D.C.,  January 28%February 1, 1996.
C. Behrendt et al., “Voluntary Testing for HIV in a Prison
Population with a High Prevalence of HIV.” American
Journal of Epidemiology, 139 (1994) pp. 918-26.
J. Ruiz and J. Mikanda, Seroprevalence of HIV, Hepatitis
B, Hepatitis C, and Risk Behaviors among Inmates Enter-
ing the California Correctional System (Sacramento:  
California Department of Health Services, Office of AIDS,
HIV/AIDS Epidemiology Branch, March 1996). 
J. Mikl et al., “Trends in HIV Infection Rates among New
York State Prison Inmates, 1987%1997,” Poster abstract
Number 23516, presented at the 12th World Congress on
AIDS, Geneva, June 30, 1997.
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Chapter 2
Sexually Transmitted Diseases
and Hepatitis:
Burden of Disease Among Inmates
Theodore M. Hammett and Patricia Harmon—Abt Associates Inc.
STDs Among Inmates
According to the 1997 NIJ/CDC survey, 88 percent of State/
Federal prison systems and 41 percent of city/county jail
systems have policies for mandatory or routine syphilis
screening of incoming inmates (table 11).  However, 64
percent of State/Federal systems and 29 percent of city/
county systems with mandatory or routine syphilis screen-
ing did not report or were unable to report the results of such
screening on the survey.  Of those systems that did report,
most had syphilis positivity rates of less than 5 percent (table
11), but these are very incomplete data.  Even fewer correc-
tional systems have mandatory or routine screening for
gonorrhea or chlamydia, and the few systems reporting
results had positivity rates of less than 5 percent for incoming
inmates (tables 12–13).  Indeed, the most striking point
about these survey findings is the rarity of screening and the
paucity of screening data.  Since gonorrhea is likely to be
symptomatic among men, however, it is probable that most
cases will be detected without mass screening programs.
Key Findings
• Available data on STDs and hepatitis B and C among inmates are very incomplete, reflecting the relative rarity
of routine screening for these conditions in correctional facilities.
• However, behavioral profiles and anecdotal evidence suggest that inmates are disproportionately affected by
STDs and hepatitis.
Table 11.  Results of mandatory and routine
inmate syphilis screening, 1997
  State/Federal    City/County
% Positive Prison Systems Prison Systems
  n   % n %
<5 13  25 5 12
5–9.99 1 2 4 10
10–20 2 4 3 7
>20 0 — 0 —
Did not report 29 57 5 12
No mandatory or
   routine screening 6 12 24 59
   Total 51 100 41 100
Source:  NIJ/CDC survey.
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Most available behavioral profiles of correctional inmates
suggest that they are at high risk for, and disproportionately
infected with, STDs.  Anecdotal reports confirm this—for
example, 24 percent of all of Chicago’s incident syphilis
cases in 1996 were diagnosed in Cook County Jail, and 13
percent of Florida’s syphilis morbidity was identified in
correctional facilities (site visit interviews, Chicago and
Florida, March–April 1997).  Better estimates of the burden
of STD morbidity among inmates may help support in-
creased resources for STD prevention and treatment pro-
grams in correctional facilities.
Hepatitis Among Inmates
Hepatitis B vaccine is increasingly available to correctional
inmates and staff, and thus this infection, which is transmit-
ted by the same routes as HIV, can and should be brought
under better control in correctional facilities.  The Occupa-
tional Safety and Health Administration (OSHA) requires
that correctional staff who have direct contact with inmates
be offered hepatitis B vaccination.
By contrast, there is not yet a vaccine or proven effective
treatment for hepatitis C, and this disease is an increasingly
serious problem, particularly among injection-drug users
(IDUs) and persons infected with HIV.1   In a 1994 blinded
study, 41 percent of incoming California inmates (39 per-
cent of men and 55 percent of women) were antibody
positive for hepatitis C virus (HCV).  In the same study, 61
percent of HIV-seropositive men and 85 percent of HIV-
seropositive women were also HCV positive.2  A study of
female entrants to the Connecticut prison system found
adjusted odds ratios for HCV infection of 10 and 7, respec-
tively, among HIV-positive women and IDU women.  More
than 70 percent of IDU women in the study were HCV
positive, and 36 percent of sexual partners of IDUs were HCV
positive.3  A voluntary study of 192 inmates at a medium-
security facility in Springhill, Nova Scotia, found that 28
percent were HCV positive, but the rates were sharply higher
among IDUs (52 percent) than among non-IDUs (3 percent).4
A pilot study of 108 incoming male and female inmates at
the Hampden County, Massachusetts, Correctional Center
(Springfield area) in 1998 found that 22 percent were in-
fected with HCV.5
Conclusion
Although available data are very incomplete, it appears that
rates of STDs and hepatitis B and C are higher among inmates
than in the overall population. Hepatitis C positivity rates
are particularly high among HIV-positive inmates and those
with histories of injection-drug use. More widespread imple-
mentation of hepatitis B immunization and screening for
hepatitis C in correctional facilities seem warranted.
Endnotes
1. Centers for Disease Control and Prevention, “The Epide-
miology of Viral Hepatitis in the United States,” Morbid-
ity and Mortality Weekly Report 43 (1994): 437–455.
Table 12.  Results of mandatory and routine
gonorrhea screening, 1997
  State/Federal    City/County
% Positive Prison Systems Prison Systems
  n   % n %
<5 3  6 2 5
≥5 0 — 0 —
Did not report 11 22 1 2
No mandatory or
   routine screening 37 73 38 93
   Total 51         101* 41 100
*Due to rounding.
Source: NIJ/CDC survey.
Table 13.  Results of mandatory and routine
chlamydia screening, 1997
  State/Federal    City/County
% Positive Prison Systems Prison Systems
  n   % n %
<5 5  4 1 2
≥5 0 — 0 —
Did not report 5 16 1 2
No mandatory or
   routine screening 41 80 39 95
   Total 51 100 41 99*
*Due to rounding.
Source: NIJ/CDC survey.
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2. J.D. Ruiz and J. Mikanda, Seroprevalence of HIV, Hepa-
titis B, Hepatitis C and Risk Behaviors Among Inmates
Entering the California Correctional System, Sacra-
mento: California Department of Health Services, Office
of AIDS, HIV/AIDS Epidemiology Branch (March 1996):
1, 9, 12.
3. K.P. Fennie et al., “Hepatitis C Virus Seroprevalence and
Seroincidence in a Cohort of HIV+ and HIV- Female
Inmates,” poster abstract no. Tu.C.2655, presented at the
11th International Conference on AIDS, Vancouver,
July 9, 1996.
4. L.Y. Lior et al., “A Look Behind Closed Doors: Injection
and Sexual Risk Behaviour and HIV, HBV and HCV
Inside a Canadian Prison,” poster abstract no. 23528,
presented at the 12th World AIDS Conference, Geneva,
June 30, 1998.
5. Thomas Conklin, Hampden County Correctional Cen-
ter, unpublished data.
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Chapter 3
HIV and STD Education and
Behavioral Interventions
Theodore M. Hammett and Patricia Harmon—Abt Associates Inc.
Key Findings
• HIV and STD prevention programs are becoming more widespread in correctional facilities.
• However, few correctional systems have implemented comprehensive and intensive HIV prevention
programs in all of their facilities.
• Peer-based education and prevention programs offer important advantages, including cost-
effectiveness, credibility, flexibility, and benefits to peers themselves.
• Although few HIV/STD prevention programs in correctional settings have been rigorously evaluated,
anecdotal evidence suggests that they can be successful in reaching this extremely high-risk population
with practical risk-reduction messages.
Periods of incarceration offer important opportunities to
provide HIV and STD education and behavioral interven-
tion programs for populations that are at extremely high risk.
Taking advantage of these opportunities, moreover, stands
to benefit not only inmates themselves but also the health of
the communities to which the vast majority of inmates
return.  A wide range of HIV and STD prevention programs
have been offered in correctional facilities, but most have
been and continue to be basic education rather than more
intensive behavioral interventions.  In any case, very few
education and prevention programs in correctional facilities
have been subjected to a rigorous evaluation that includes
conducting interviews with former inmates in the community.1
Data from the 1997 NIJ/CDC survey presented in this
chapter show that HIV/STD education and prevention pro-
grams are becoming more widespread in correctional facili-
ties. Nevertheless, the important public health opportunity
to provide comprehensive HIV prevention programs for
correctional inmates has by no means been fully utilized.
Types of HIV/STD Education and
Prevention Programs Provided
Table 14 summarizes the types of HIV/STD education and
prevention programs that correctional systems provided to
inmates in at least one of their facilities, according to the
1992, 1994, and 1997 NIJ/CDC surveys.  This shows that the
percentage of State and Federal systems offering instructor-
led education rebounded to 94 percent in 1997 after drop-
ping to 75 percent in 1994.  The percentage of city/county
systems providing instructor-led education also increased in
1997 to 73 percent.
Peer-led programs are in place in an increasing percentage
of State/Federal systems, but still in fewer than half.  Only 7
percent of city/county jail systems have peer programs, in
part because inmates’ short jail stays make it more difficult
to institute such programs.
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In the 1997 NIJ/CDC survey, the category “multisession
prevention counseling” was added to gauge the extent to
which correctional systems are moving beyond simple edu-
cation and toward more intensive programs designed to help
inmates make and sustain the difficult behavioral changes
needed to reduce their risks of acquiring or transmitting HIV
and STDs. Almost 60 percent of State/Federal systems and
41 percent of city/county jail systems reported offering such
programs.  Pre- and posttest HIV counseling is offered in
virtually all prison and jail systems, almost all systems
provide written materials on HIV and STDs, and large
majorities of systems employ audiovisuals.
The above figures reflect only the percentages of systems
that reported providing these types of education and preven-
tion programs in at least one of their facilities.  The percent-
ages of facilities (as opposed to systems) that provide the
same types of education and prevention programs (table 15)
are, in most cases, substantially lower.  For example, less
than two-thirds of facilities provide instructor-led educa-
tion, about one-third provide multisession prevention coun-
seling, and only 13 percent of State/Federal prisons and 3
percent of city/county jails offer peer-led programs.  Pre-
and posttest counseling was offered in the vast majority of
facilities.
The validation study, in which reported policies in indi-
vidual facilities were compared with those reported by
systems’ central offices, revealed a fairly general agreement
regarding education and prevention programs but a few
discrepancies as well (table 16). In particular, in systems that
reported providing multisession prevention counseling in
all of their facilities, only 59 percent of the facilities actually
offered such programs.
Table 14.  HIV/STD education and prevention programs for inmates, 1992–97
  Percentage of State/Federal     Percentage of City/County
    Prison Systems Providing        Jail Systems Providing
      in at Least One Facility        in at Least One Facility
  1992   1994   1997   1992   1994   1997
Programs (n = 51) (n = 51) (n = 51) (n = 31) (n = 29) (n = 41)
Instructor-led education 86 75 94 58 62 73
Peer-led programs 33 35 41 10 7 7
Pre-/posttest counseling N/A N/A 96 N/A N/A 93
Multisession prevention counseling N/A N/A 59 N/A N/A 41
Audiovisual materials 96 88 84 90 66 78
Written materials 96 94 96 71 72 90
Source:  NIJ/CDC surveys.
Table 15.  HIV/STD education and
prevention programs in adult correctional
facilities, 1995–97
Percentage of     Percentage of
 State/Federal       City/County
                       Facilities Providing Facilities Providing
    1994      1997     1997
Programs (n = 1,207)  (n = 1,486)  (n = 152)
Instructor-led
  education 48 61 66
Peer-led
  programs 7 13 3
Pre-/posttest
  counseling N/A 86 84
Multisession
  prevention
  counseling N/A 31 33
Source:  NIJ/CDC surveys.
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The Importance of Comprehensive
HIV/STD Education and Prevention
Programs
Comprehensive HIV/STD education and prevention pro-
grams should be provided for correctional inmates, given
the prevalence of high-risk behaviors among them, the
opportunity for interventions afforded during periods of
incarceration, and the potential public health benefits of
such programs.  Given the existing knowledge of prevention
and of the particular circumstances and needs of the correc-
tional setting,  a comprehensive program may reasonably be
said to include instructor-led education, peer-led programs,
pre- and posttest counseling, and multisession prevention
counseling.  The results of the 1997 NIJ/CDC survey reveal
that only 10 percent of State/Federal prison systems and 5
percent of city/county jail systems offer comprehensive
programs meeting this definition in all of their facilities.
Clearly, then, there remains much room for improvement in
the depth and coverage of HIV/STD education and preven-
tion programs in correctional facilities.  A promising ap-
proach in this realm  is occurring in Massachusetts, where
the Department of Public Health is funding comprehensive
HIV/AIDS programs in the State’s county jails.  To be
eligible for this funding, the counties must propose a pro-
gram including HIV/AIDS prevention and education for
inmates and staff, HIV counseling and testing, HIV primary
Table 16.  HIV/STD education and prevention programs for inmates, 1997 results of the
validation study (VS)
 Systems in VS Facilities From These Percentage in
Central Office Policy  With This Policy Systems in VS Agreement
Instructor-led education in all facilities 7 20 75
Mandatory intake education 11 30 57
Mandatory prerelease education 7 25 60
Peer-led education in all facilities 1 1 100
Pre-/posttest counseling in all facilities 10 28 100
Multisession prevention counseling in
  all facilities 5 17 59
Videos/audiovisual materials in all facilities 11 29 76
Written materials in all facilities 12 31 97
Source:  NIJ/CDC surveys.
care and case management, and aftercare/transitional plan-
ning.  The HIV/AIDS prevention and education component
must include “most or all” of the following elements:
• Orientation.
• Peer education.
• Community-based prevention and education.
• Individual prevention and education, on request.
• Written and audiovisual materials.
• Prevention and education in prerelease, day reporting,
and pretrial populations.
• Gender-specific programs at facilities housing women.
• Expansion of HIV curriculums to cover other commu-
nicable diseases.
• Programs and materials available in Spanish and En-
glish.
In addition, each county program must commit to funding
50 percent of a full-time HIV/AIDS coordinator for the jail,
with the State funding the other 50 percent.2
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Table 17.  Topics covered in HIV/STD education for inmates, 1997
Covered in Education Sessions
    U.S. State/Federal Prison Systems      U.S. City/County Jail Systems
            (n = 51)          (n = 41)
Topics No. of Systems % No. of Systems                     %
Basic HIV information 51 100 35 85
Basic STD information 46   90 32 78
Meaning of HIV test results 51 100 38 93
Meaning of STD test results 48   94 36 88
Safer sex practices 34   67 29 71
Negotiation skills for safer sex 21   41 19 46
Safer injection practices 23   45 20 49
Tattooing risks 42   82 22 54
Alcohol/drug risks 41   80 30 73
Self-perception of risk 30   59 27 66
Identifying barriers to behavioral change 28   55 23 56
Triggers for behavior relapse 29   57 22 54
Referral to other services 49   96 36 88
Planning for positive test 40   78 26 63
Source:  NIJ/CDC survey.
Instructor-Led Education and
Educational Materials
Seventy-one percent of State/Federal prison systems and 5
percent of city/county jail systems reported that HIV/STD
education was mandatory for all incoming inmates; 20
percent of State/Federal but no city/county systems reported
mandatory HIV/STD education at release.  Fifty-one per-
cent of State/Federal systems and 44 percent of city/county
systems reported voluntary HIV/STD education at release.
The Illinois Departments of Corrections and Public Health
jointly planned a prerelease HIV education and referral
program being presented by existing prerelease counselors
and inmate peer educators who were specially trained to
provide these services in prerelease centers.
The smaller percentages of city/county systems with man-
datory education programs no doubt relate to the shorter
lengths of stay and more rapid turnover of inmates in jails as
compared with those in prisons.
The validation study revealed some discrepancies regarding
whether educational sessions were mandatory.  Substantial
percentages of facilities in systems with “mandatory” HIV/
STD education at intake or release reported that these
sessions were not in fact mandatory for all inmates (table16).
Table 17 shows the topics covered in HIV/STD education
programs, according to the 1997 NIJ/CDC survey results.
Basic information on the diseases and the meaning of test
results tend to be covered in almost all systems’ education
programs.  However, topics pertinent to behavioral-risk
reduction—including safer sex practices, negotiating safer
sex, safer injection practices, and triggers for behavioral
relapse—are less commonly included.  These are the types
of topics that are likely to be intensively covered in
multisession prevention programs.
Similarly, validation study results indicate that discrepan-
cies between central office and facility responses are most
frequent on topics relating to behavioral-risk reduction (see
table 18). This may be because these topics are more
controversial.  The left side of table 18 shows the extent of
agreement in systems reporting that the listed topic is cov-
ered in their education programs.  For example, in seven
systems reporting that negotiation skills for safer sex were
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Table 18.  Topics covered in HIV/STD education for inmates, 1997 results of the
validation study (VS)
Systems in
Systems in  Facilities From VS That Do Facilities From
VS That    These Systems % in Not Cover These Systems % in
Central Office Policy Cover Topic in VS Agreement Topics in VS Agreement
Basic HIV information 16 40 98 0  —  —
Basic STD information 15 38 89 1   2   0
Meaning of HIV test results 16 40 95 0  —   —
Meaning of STD test results 14 34 91 1   2   0
Safer sex practices 12 28 68 3   4 50
Negotiation skills for safer sex   7 20 45 8 16 50
Safer injection practices   9 23 35 6 12 67
Tattooing risks 13 32 78 2   4 25
Alcohol/drug risks 14 33 82 1   2   0
Self-perception of risk 11 28 68 4   8 38
Identifying barriers to
  behavioral change 10 23 56 5 12 67
Triggers for behavior relapse   9 22 45 6 14 71
Referral to other services 16 40 98 0  — —
Source:  NIJ/CDC survey.
Table 19.  Providers of HIV/STD education
and prevention services, 1997
Percentage of Percentage of
State/Federal City/County
Systems Using Systems Using
Categories Category Category
of Providers (n = 51) (n = 41)
Security staff 8 0
Correctional
  medical staff 100 71
Public health
  department 67 78
Community-
  based org./
  AIDS service org. 69 56
Inmate peer
  educators 41 7
Source:  NIJ/CDC surveys.
included in their education, fewer than half (45 percent) of
facilities reported that this topic was in fact covered. Con-
versely, in eight systems reporting that this topic was not
covered in HIV/STD education, half of the facilities re-
ported that it was included.  Thus, some individual facilities
are going beyond the educational topics ostensibly pre-
scribed by their central offices.
Table 19 shows the categories of providers of HIV/STD
education and prevention programs in correctional systems.
Very few systems are using security staff to conduct HIV/
AIDS education, whereas the involvement of public health
departments, AIDS service organizations, and other
community-based organizations is widespread. This indi-
cates an increasing willingness on the part of correctional
systems to permit outside organizations to offer programs in
their facilities.
Accessibility and understandability of educational programs
and materials are critical to their effectiveness with inmates.
In this regard, issues of language, literacy, and cultural
competence are pertinent.  Thirty-nine percent of State/
Federal prison systems and 49 percent of city/county jail
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Forensic AIDS Project,
San Francisco Department
of Public Health
Forensic AIDS Project (FAP) staff offer “risk reduction groups” in all San Francisco jail facilities.3  About 15–20
sessions are held each week according to a master schedule,  ensuring that all facilities are covered.  These group
meetings are voluntary, normal attendance is between 10 and 20 inmates (with as many as 60 participants at
sessions in structured program settings such as substance abuse treatment programs), and the sessions last 1
to 2 hours, depending on the facility’s schedule and flexibility and the cooperativeness of custody staff.
Deputies vary widely in their degree of cooperativeness, FAP staff report.  Some are extremely helpful and
supportive, and others appear to go out of their way to obstruct FAP’s efforts.  For example, one deputy confiscated
a dildo used for a condom demonstration.
Topics covered in these sessions include general health; nutrition; practical risk-reduction strategies (condom use
and cleaning of injection material); information on HIV/AIDS, STDs, and TB; HIV testing; and early intervention.
The session format includes a lecture, a discussion, videos, and guest speakers.  The educators also use games
with prizes to involve the inmates in the sessions.  Condom distribution occurs in the context of regular risk-
reduction groups.  The risk-reduction groups originally were planned with the assumption that each inmate would
attend one session.  However, with varying lengths of stay, the same inmates may attend multiple sessions, so
educators vary their plans to avoid duplicating material.
Different educators have different approaches and concerns.  For example, one educator reported that she does
not do condom demonstrations in all-male classes because she feels it would undermine her authority.  Therefore,
she asks a male inmate to do the demonstration in these classes.  In an effort to achieve greater consistency across
educators, FAP has developed standard lesson plans for the sessions, synthesizing the ideas, strategies, and
games/exercises used by the different educators.
FAP offers enhanced counseling to inmates who are identified as high risk by self-report or staff observation.  This
is multiple-session individual counseling designed to help inmates adopt and maintain risk-reducing behaviors.
Special counseling is provided on the importance of partner notification.  When possible, FAP facilitates
postrelease counseling with partners.
systems report offering HIV/STD educational sessions in
Spanish.  These percentages remain virtually unchanged
from the 1994 survey (39 percent and 41 percent, respec-
tively).  Fifty-five percent of State/Federal systems and 66
percent of city/county systems reported having HIV/STD
educational materials for Latinos.  Forty-one percent of
State/Federal systems and 58 percent of city/county systems
said they had materials especially for African-Americans,
and 84 percent and 70 percent, respectively, reported having
materials especially for women.  Similar percentages were
reported in 1994.  More attention should probably be paid to
the development and distribution of culturally appropriate
HIV/STD educational materials.  The mean grade level of
HIV/STD materials used by reporting correctional systems
was 6.4 (SD = 1.8), which seems appropriate.
Three examples of  instructor-led HIV/STD education and
prevention programs observed as part of site visits con-
ducted for the NIJ/CDC survey are presented in the follow-
ing text boxes.
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Corrections AIDS Prevention Program,
 New York City Department of Health
The Corrections AIDS Prevention Program (CAPP) at the Rikers Island jail complex is operated by the Division
of Special Populations of the New York City Department of Health, with funding from the Centers for Disease
Control and Prevention.4  In collaboration with the Department of Corrections, CAPP has established “an
aggressive approach . . . to HIV/AIDS prevention education,” which includes HIV/STD orientation for incoming
inmates and ongoing prevention groups.  Condoms are also made available to inmates.
Orientation sessions on HIV/AIDS and STDs are mandatory for all incoming inmates at Rikers Island.  CAPP
educators present basic information on transmission and prevention, as well as on counseling and testing, and
ways to access additional information and assistance.  During a site visit for the NIJ/CDC survey, an orientation
session with about 60 men at the C–76 men’s facility was observed.  The educator presented HIV/AIDS and STD
risks in a direct, simple, and explicit manner.  She spoke very directly about the risks of anal intercourse and the
prevalence of this behavior in jail.
Ongoing prevention groups are held in several Rikers Island facilities.  A health educator conducts a series of
meetings with inmates who have longer sentences or are in drug-treatment programs.  These meetings provide
opportunities to build rapport and to explore topics in greater depth than can be done in an orientation session.
During a group meeting with about 15 men in a drug-treatment unit of the C–73 men’s facility, the educator engaged
the men directly by asking questions.  She effectively prevented anyone from getting distracted or losing attention
by involving them in the discussion.  She did a condom demonstration, discussed issues of sexual risk and the
role of drug use in sexual risk, openly asked the men to consider what “your women are doing while you’re in jail,”
and discussed the precautions they should take when they rejoin their women on the outside.  The educator asked
the inmates about the definitions of man and boy, emphasizing that a real man takes real responsibility for himself
and his loved ones.  She also asked how many of the inmates “always” use condoms; most raised their hand, but
one said “A lot of people are lying here.”  The educator spent a good deal of time on STDs.  She passed around
enlarged color photographs of the conditions that can result from various STDs.  The inmates seemed quite
affected by these photographs.
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Massachusetts Department of Youth Services
In 1989 the Massachusetts Department of Youth Services (DYS) and the Massachusetts Department of Public Health
(DPH) entered into an interagency agreement to provide an HIV/AIDS prevention program with CDC funding for two
full-time bilingual (Spanish) and bicultural health/AIDS educators.  One educator covers the Boston area and North and
South Shore suburbs, and the other covers the rest of the State from her base in Worcester. An important program
component is a small group of well-trained HIV-positive speakers who participate in varying formats, including youth-
controlled question-and-answer sessions and presentation of personal stories with questions during and at the
conclusion of each session.
The educators primarily provide HIV and STD prevention education to youths in DYS facilities and programs, group
care, assessment programs, day reporting centers, shelter care programs, secure detention programs, and secure
treatment programs. In addition, the educators train DYS frontline child care and casework staff so that they understand
and support, rather than contradict or undermine, the education and prevention messages presented to the youths.
Although increased knowledge has helped reduce concern about occupational HIV infection, educators still emphasize
the importance of universal precautions in their staff education.
Two full-time educators alone cannot reach the entire DYS population on a regular basis or conduct the intensive
interventions probably needed to produce significant behavioral changes.  Possible methods of increasing coverage
of HIV/AIDS and STD issues include hiring additional educators, increasing staff training and “weaving” these topics
into the overall activities and programs of the various facilities, and using community-based resources as well as print
and audiovisual materials.
The  DYS education sessions primarily emphasize teaching the basic facts about HIV and STDs in a comprehensible
and engaging manner. For example, in a session observed at St. Mary’s/Cornerstones, DYS educator Eduardo Tautiva
effectively used games and understandable images to present complicated HIV facts, including a game demonstrating
the potentially quick transmission of HIV among people with interconnected sexual relations and extended Pac-Man
imagery showing the action of HIV in infecting cells and multiplying infected cells.
The DYS educators also work to dispel myths and misinformation by eliciting the youths’ active involvement in the
discussions and then answering their questions with care and respect.  In the session we observed, Tautiva
demonstrated that he was at ease with the youths and the subject matter, which in turn helped participants feel more
comfortable, safe, and open about sharing experiences and expressing  concerns.  The ability to connect and to
establish trust and rapport with a youthful audience is essential in developing a two-way process in which DYS staff both
learn from youths and teach them.  It is always important to be sensitive to the youths’ mental and emotional state, their
level of literacy and cultural identification, and their mingled senses of invulnerability and fear.
The DYS educators try to show program participants that they can succeed in learning something and that they can
change their lives, if given clear goals and objectives and a realistic definition of success.  The educators focus on
practical risk-reduction strategies, such as condom use and proper cleaning of drug-injection material.  However, since
relatively few of the DYS youths are injection-drug users, the greater emphasis is properly placed on how use of
marijuana, alcohol, and other drugs can lead to poor decisionmaking and high-risk sexual activity. While DYS does not
object to frank and open discussion of risk-reduction strategies,  condoms are not distributed for use within facilities;
youths being released or going out on passes are given condoms.
An HIV-positive speaker observed at Connolly Secure Treatment gave an extremely powerful presentation that  strongly
affected her audience. She hopes that the story of her life can at least “plant the seed”  in kids’ minds that things can
be different, that a better life is possible.  The speaker says that she is “living proof” that things can change for the better,
even if one is HIV infected.
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Peer-Based Programs
Inmate peer-based programs have four key advantages:
credibility, range of services, cost-effectiveness, and ben-
efits to peer educators themselves.  Peer educators probably
have more inherent credibility with inmates than represen-
tatives of “the system.”  They speak the language of inmates
and have had similar life experiences.  To be effective,
however, it is important and challenging for peer educators
to avoid being seen as allies of or spokespersons for the
system, particularly in programs in which correctional offi-
cials play evident roles in their selection.
Peers can offer a range of services, including orientation
(“AIDS 101”); individual and group risk-reduction counsel-
ing; and informal interaction with inmates in the yard,
during programs, and at other times and places apart from
structured meetings and presentations.  Peer educators often
go on to work with inmates with HIV disease, explaining
drug regimens and improving adherence, serving as “bud-
dies” and offering other supportive services, and providing
hospice care for terminally ill patients.  Elizabeth Mastroieni,
Coordinator of AIDS Counseling and Education (ACE) at
New York’s Bedford Hills women’s facility, one of the first
and best established HIV peer inmate programs, described
some of ACE’s tangible and intangible benefits.
I witness miracles here every day. I see women. . .
sharing their commissary and sharing their experi-
ences.  I witness women volunteering their time to
nurse women back to health, to educate them about
their health and cry with them about the experience
of loss.  I have been filled by the bittersweet
memorial services where a woman’s life is cel-
ebrated as her memory fills the room and enlivens
the spirit.
For three years I have witnessed the energy of
brainstorming, creating, planning, and physically
walking to raise money for children they do not
know but care for because of their emotions as
wife, mother, lover, aunt, sister, and friend . . . .
There is laughter.  There is community.  There is a
sense that I can do for others and they can and want
to do for me.  There is support. . . . There are many
miracles here at Bedford.5
Peer programs can be highly cost effective.  Peers can
provide formal and informal services almost around the
clock.  They are often available when regular staff  are not.
The only substantial costs of peer programs are likely to be
for training the peers. It is advantageous to have regular
inmate work slots designated for peer educators (as at the
Albion women’s facility in New York State and at several
California prisons), but inmate wages are very low and in
many systems are negligible, so this should not represent a
large expense, particularly in comparison with the cost of
other models of delivering education and prevention pro-
grams. The Oklahoma Department of Health developed a
peer program for women inmates in that State for $4,000 in
outside grant funds.6
Finally, inmate peer educators commonly report tremen-
dous improvements in self-esteem, knowledge, and com-
mitment to the community based on their experiences in
these programs. Many go on to paid positions in HIV
prevention following their release from prison. Kathy
McGrath became a peer educator at Massachusetts Correc-
tional Institution–Framingham and now works as an HIV
educator for Great Brook Valley Health Center in Worces-
ter.  McGrath reported that “becoming a peer educator was
the start of my life” after years of drug addiction and
repeated incarceration.  Moreover, she stated, “There are so
many women like me who have everything it takes inside,
but no outlet for it.”7 Miguel Cruz was the first HIV peer
educator at Hampden County (Massachusetts) Correctional
Center and is employed as an HIV outreach worker at
Holyoke Health Center.  Cruz spent 18 years of his life as a
heroin addict and dealer.  According to a coworker:
Miguel is a man at peace with himself, and he is
enjoying what life has to offer him for the first time
in two decades—going to the movies, playing
sports, doing a job he loves and doing it well,
owning a car and nice clothes.  These are the
rewards of a new life and he is not about to give that
up.  His old friends from the street, he says, were at
first skeptical just waiting for him to do that first
bag.  This hasn’t happened and that skepticism is
being replaced with unmistakable respect and ad-
miration.  Miguel, their old compatriot, who was
every bit one of them, now has turned his life
around and is back to the same old streets, trying to
help his buddies in any way he can to do the same.
. . .
Miguel’s 18-year training program for his present
job gives him the ability to accomplish things on
the street that I, for example, simply never could.
His mere presence on the street, as living proof to
all his old neighbors that the evil power of addiction
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can be beaten, has more life-changing potential
than 10 doctors trying to patch these people up and
to keep them alive. . . . Miguel is not a doctor, but
he is a healer. 8
Although HIV/AIDS peer programs are finding increasing
acceptance among correctional administrators, there may
still be resistance.  Opposition is most often based on
suspicion of initiatives that seek to “empower” inmates.
Some administrators may view any empowerment of in-
mates as an ultimate threat to discipline and order in their
facility.  At one Federal facility, a new warden discontinued
HIV/AIDS orientation presented by peer educators because
he considered this an “inappropriate” role for inmates.
Inmates themselves may have to address and overcome
stigma that may result from their involvement.  It may be
assumed, for example, that anyone volunteering to be an
HIV peer educator must be HIV infected.
Inmate peer programs are easiest to implement in prison
systems in which inmates stay long enough to have a stable
group of educators.  However, peer programs have been
successfully established in jail systems as well.  In jails, peer
educators are generally drawn from sentenced inmates.  As
of the end of 1995, nine county jails in Massachusetts had
established HIV peer education programs with funding from
the State’s Department of Public Health (DPH).9  All of the
Massachusetts county jails were expected to implement peer
education in 1998 as part of comprehensive HIV/AIDS
programs funded by DPH.10
Factors in successful peer-based programs include the fol-
lowing:
• Working closely with correctional officials in planning
the program.  To address common objections and
overcome resistance, a written proposal should be sub-
mitted describing the program and its benefits.
• Involving outside organizations, such as public health
agencies or AIDS service organizations, in leading or
otherwise key roles to demonstrate the program’s inde-
pendence  from the correctional system and thereby to
build credibility with the inmates.
• Carefully screening peer educator candidates for moti-
vation, sincerity, commitment, and absence of emo-
tional problems and inappropriate personal “agendas.”
Candidates’ length of time left to serve should be
sufficient to allow them to contribute significantly to
the program before they are released.
• Ensuring that peer educators reflect the linguistic, ra-
cial, and cultural profile of the inmate population.
• Giving peer educators specific goals and incentives,
such as academic credit, prison job slots, or “good
time.”
• Developing a peer-driven curriculum rather than one
that is driven primarily by the goals of the correctional
system.
• Being sensitive to the stigma still associated with HIV/
AIDS in many correctional facilities that may adversely
affect the recruitment of peers and attendance at pro-
grams.
• Providing counseling and support for peer educators as
necessary.11
The advantages of peer programs and the factors facilitating
the success of such programs are well illustrated by case
studies of programs in the adult correctional systems of
Louisiana and California and the Los Angeles County juve-
nile system, observed during site visits for the survey.
Louisiana
Between 1992 and 1997, under the leadership of the late
William Crawford, HIV/AIDS Services Education and Train-
ing Coordinator at the Louisiana Office of Public Health,
peer education and counseling programs were established at
six Louisiana State prisons—Angola, Avoyelles, Dixon,
Hunt, and Washington (men’s facilities), and the Louisiana
Correctional Institution for Women, St. Gabriel.  More than
150 inmates were trained as peer educators/counselors.  In
addition, about 400 correctional staff in health services,
mental health, and security received 2-day training sessions
on HIV/AIDS and STDs.
The inmate peer educators/counselors provided HIV/AIDS
and STD orientation sessions to all inmates at intake and
prerelease.  They also offered one-on-one counseling for
inmates considering HIV antibody testing and others with
concerns about HIV/AIDS and STDs, provided educational
sessions to inmate clubs and organizations, gave support to
inmates living with HIV or AIDS and those with loved ones
living with HIV or AIDS outside, and acted as liaisons for
inmates hospitalized with HIV disease.
In their educational presentations and individual prevention
counseling, the peers were permitted to discuss practical risk
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reduction—for example, condom use and cleaning proce-
dures for drug-injection material—in frank and open terms,
but they were not permitted to distribute condoms or bleach.
In informal conversations, however, inmates from several
prisons stated that condoms and bleach were fairly readily
available—condoms “on the walk” (in the exercise yard) in
exchange for cigarettes, and bleach from dorm-cleaning
crews.
Crawford emphasized the importance to the success of the
peer programs of gaining and keeping the trust and support
of the correctional system and its staff.  It is necessary to
understand and be sensitive to the “gargantuan” task that
prison administrators face and to accept the ground rules the
correctional system sets for a peer program.  Within these
ground rules, Crawford stated, much can be accomplished.
However, it is counterproductive to “press an agenda” for
condom distribution or other controversial measures.  In-
stead, it is better to reach agreement on what can and cannot
be done.  Crawford noted that “you can get a lot more with
a smile than with a frown.”
To succeed, the program needs the full support of the
administration at central office and facility levels.  An
advocate within the system is critical to overcoming the
suspicion that inevitably greets suggestions for establishing
inmate peer programs and to obtaining initial agreement.
Once agreement is reached on scope and ground rules of the
program, peers’ specific responsibilities can be negotiated.
Inmate peer educators/counselors in Louisiana were re-
cruited and selected by nominations from other peers and
from the mental health and health services staff of the
facility.  Inmates interested in being peer educators/counse-
lors could also apply.  The existing peers did the initial
screening and recommended 12–15 inmates.  At Avoyelles,
the mental health director and peer program coordinator
made final selections based on conviction offense, sentence,
prison disciplinary record, and any handicaps.  A critical
criterion for selection was the inmate’s agreement to be a
role model in terms of personal behavior.  In particular, this
meant that the inmate would have to commit himself or
herself to abstaining from all sexual activity and drug use in
prison.  Final selections of peers had to be approved by the
facility’s warden.
State Public Health Office staff conducted the training for
the peer educators/counselors.  The class consisted of a
minimum of 12 inmates. Three or four classes were trained
at each participating facility each year to ensure continuity
and effective performance of responsibilities.  As part of the
training, each trainee was required to prepare and deliver an
orientation presentation chosen from a list of possible topics
distributed to the class.  At Avoyelles, one inmate asked to
prepare a presentation on a topic of his own choice that was
not on the list.  This involved conducting and presenting the
results of a survey of inmates on risk behaviors for HIV and
levels of perceived risk. Peer programs at the Louisiana
State Penitentiary at Angola and the Avoyelles Correctional
Center are described in the text boxes on the following
pages.
A major issue for the Louisiana peer educators was over-
coming stigmatization and stereotyping by other inmates.
One of the peers reported that his attendance at the training
caused him to be “diagnosed with AIDS by my peers.”
Another peer educator described this as a “powerful learning
experience” regarding attitudes toward people with HIV/
AIDS that “could have been taught no other way.”   How-
ever, the peers were quite successful in winning the trust and
support of the inmate population.  Almost 50 inmates
attended the first session offered by the peer educator who
reported being initially stigmatized.  He stated that there is
much concern about HIV/AIDS among inmates, even though
many will not speak openly about it.
A primary objective of any education/prevention program is
to bring about positive change in the attitudes and behaviors
of the target population.  However, with efforts such as the
Louisiana inmate peer education/counseling program, ex-
tremely important benefits can be achieved among peer
educators themselves.  They develop positive focus and
purpose in their lives, become empowered, and perceive
their own ability to influence others in ways they never
believed they could do.  The presentations by Louisiana peer
educators during the site visit demonstrated the poise, con-
fidence, and commitment the program has helped these
inmates to develop.  Andrew Joseph, an Angola inmate, has
changed his attitudes regarding HIV/AIDS dramatically.  In
1987, Joseph wrote in The Angolite, the inmate magazine,
that he wanted nothing to do with inmates with AIDS.
Within a few years, Joseph had become a leader of the peer
education/counseling program at the prison and was master
of ceremonies at the 1996 HIV/AIDS education conference.
Greg Lehtonen, a peer educator at Avoyelles, wrote about
the way his HIV-positive status and his involvement in the
peer program had changed his life:
My attitude is much different now.  My life here in
prison isn’t about being tough and playing games.
I find myself caring much more about others, and
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The first facility in Louisiana to establish an inmate HIV/STD peer education and counseling program was the
Louisiana State Penitentiary, Angola, an extremely large (approximately 5,000 inmates) maximum-security prison.
The peer program at Angola was established in September 1993, when William Crawford trained 42 inmates.  Four
of these inmates became Angola’s first HIV/AIDS Peer Education Team.
Between 1993 and 1996, peer educators provided HIV/AIDS and STD education sessions to more than 1,200
incoming inmates at Angola.  Peer Education Team members divided the topics included in the orientation: technical
information on HIV/AIDS and STDs; strategies for surviving prison “games” and avoiding high-risk behaviors and
situations; overcoming myths about HIV/AIDS; and modeling hope with a view to engendering it in others.  The inmate
peer educators counseled new inmates to get involved in positive activities such as educational and self-
improvement programs.  The peers also provided informal one-on-one counseling to inmates.  Several members of
the Peer Education Team were enrolled in a Baptist seminary through Angola and were authorized to provide pastoral
counseling to inmates with HIV disease.  The peer educators also provided education and training to orderlies and
members of numerous prison organizations, including the CPR T.E.A.M., Drama Club, Latin American Cultural
Brotherhood, and Amateur Boxing Association.  The CPR T.E.A.M. presented HIV/AIDS education sessions at
various locations throughout the sprawling prison, the Camp D Social Orientation Club conducted classes in the
Camp D area, and the Angola Jaycees offered HIV/AIDS awareness sessions in the main prison.  Members of the
Latin American Cultural Brotherhood were trained as peer educators and offered HIV/AIDS education and
counseling services in Spanish.  They distributed Spanish-language fliers on HIV and STDs and presented a series
of three weekly HIV/STD seminars on Friday evenings. More than 400 inmates signed up for the first series.
Several other features of the Angola program are noteworthy.  First, with the collaboration and cosponsorship of the
prison administration, the State Office of Public Health–AIDS Services Program, and the Delta Region AIDS
Education and Training Center, the peer program  presented three annual HIV/AIDS education conferences at
Angola.  The conference held in November 1996 attracted more than 400 health professionals, educators,
correctional staff, and others from Louisiana, Arkansas, Mississippi, and Texas.  The attendees were eligible for
continuing education credits and heard a variety of presentations on HIV/STD peer education and counseling and
related subjects.
A second feature of the Angola program is the work of the Drama Club.  This group travels to other prisons and
settings in the State to present its dramas and skits on HIV/AIDS, STDs, and other themes.  These are written,
produced, and acted entirely by the inmates.
Third, the Angola Peer Education Team established mechanisms for networking with peer programs in other prisons
and jails.  It published a newsletter to share information across the programs.  The peer educators also attended and
spoke at conferences and meetings of organizations throughout the State as well as at juvenile confinement facilities.
Peer Program at Angola
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AIDS Counseling and Trust—Avoyelles Correctional Center
The Avoyelles Correctional Center is a medium-security men’s facility with about 1,475 inmates.  The AIDS Counseling
and Trust (ACT) program was established at Avoyelles in 1994 with the training of 12 peer educators/counselors.  At
the time of our visit, a total of 60 had been trained, and 40 peer educators were active in the program.  According to
Shirley Washington, ACT Coordinator, the basis of the program is the belief that the best person to provide education
and counseling to inmates is “one of their own.”
ACT member Bobby Weatherton designed and wrote a brochure entitled Johnny’s Home from Prison, and . . . He Has
AIDS.  This brochure tells the story of a man who has engaged in homosexual intercourse while in prison but does not
know that he is HIV infected. Unwittingly, he infects his female lover soon after he is released.  The brochure describes
the “hidden” culture of homosexuality in prison in which men who play the dominant role in homosexual relations (that
is the insertive partners in anal intercourse) often do not consider themselves homosexual or do not believe that they
can become infected.  Only the receptive partner is at risk of infection, many of these “straight men” believe.  On the
back of the brochure is a piece of advice to the potential sexual partners of men coming out of prison:  “Do not assume
a man is disease free because he has been in prison.  Do not rely on his denial of risky behavior. DEMAND THAT HE
BE TESTED!!”  The brochure is printed and distributed by the Louisiana Office of Public Health’s HIV/AIDS Services
unit.
The ACT educators at Avoyelles were responsible for providing orientation sessions on HIV/AIDS and STDs for all new
inmates.  They used a video produced by inmates in a New Mexico State prison and followed this with an extensive
question-and-answer session.  During a “staged” question-and-answer session observed at a site visit to Avoyelles,
ACT peers presented explicit information on practical risk-reduction measures.
ACT also provided HIV/STD prevention sessions for all inmates 30 days prior to their release. Inmates were referred
to community-based providers.  The ACT peer counselors prepared nine regional directories listing all types of health
care and mental health services, substance abuse programs, benefit programs, and housing and employment services,
with addresses and telephone numbers.  Each inmate being released was provided with a copy of the directory for the
region to which he or she was being released.  The ACT peers also went through the directory with all inmates before
they were released to make sure they understood what was available to them.  Released inmates were also provided
with “health care packages” that included condoms and bleach kits.
Individual counseling was available on request through the mental health department or informally in the prison yard
and housing units at Avoyelles.  One-on-one counseling was provided in a private room with no correctional officers
or other staff present and was kept strictly confidential.  The following issues were commonly addressed in individual
counseling:  Should you get tested?  What do the results mean, and how would you deal with them?  What should you
do/not do if you are positive?  What should you do/not do if you are negative?
Other ACT activities included educational sessions for sports clubs, self-help and religious groups, and other
organizations at the prison; periodic Friday evening videos on HIV/AIDS and STDs; a drama group, patterned after the
Angola Drama Club, presenting skits on HIV/AIDS written and performed by inmates (during the visit, the group
presented an excellent skit on using knowledge and understanding to combat the stigmatization of and discrimination
against persons with HIV and AIDS); a weekly support group consisting of about 15 inmates with HIV disease that
encouraged inmates to “live healthy with HIV” and dealt with medications, side effects, and a range of psychosocial
issues; and a Street Outreach Program in which members made presentations and provided services at parish jails,
where inmate turnover is too rapid to permit effective peer programs.
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my mind is on more serious matters . . . I constantly
pray and hope that I will see my family again,
whom I have not seen in so many years, due to my
lifestyle!  I always knew that I was a good person
inside, and I want my family to see and know that
side of me—instead of remembering the monster
who did all those bad things.  I used to not care
about dying. Now I want to live and let people see
the good Greg!
Two former ACT counselors from Avoyelles are now work-
ing for AIDS service organizations in the community.  Other
peer educators currently in prison are also interested in
continuing this work when they are released.  Many of them
have shown an ability to overcome stigmatization and hos-
tility and to become effective educators, counselors, and
supporters of positive change among inmates.
California
The Public Health Section of the California Department of
Corrections’ Health Services Division is working closely
with facility administrators and the custody and health
services staff  to implement standardized HIV peer educa-
tion programs at all State prisons.12  The Public Health
Section is preparing a video on the peer programs in several
State prisons.  When completed, this video will be used for
educational purposes as well as to help recruit new peer
educators.  The peer programs at San Quentin, Frontera, and
Vacaville are described below.
California State Prison, San Quentin
The average daily population of San Quentin is 5,500 to
6,000 men.  About 60 percent of the population of this
medium-security facility are reception center inmates who
are processed within 45 days and sent off to their assigned
facilities in the system.  The rest of the inmates are “en-
dorsed” to San Quentin.  Between 1986 and 1997, the
California Department of Corrections and the Marin (County)
AIDS Project (MAP) collaborated on HIV education and
prevention programs at San Quentin.  In 1997 MAP’s role
was assumed by Centerforce, another community-based
service organization. Since 1991, the Center for AIDS
Prevention Studies (CAPS) at the University of California,
San Francisco, has been conducting collaborative evalua-
tions with the staff of the San Quentin programs.  The
programs have evolved over the years with input from peer
educators and strong support across the prison administra-
tion, from the warden and upper management to correctional
counselors and officers.
The inmate peer education program is the centerpiece of San
Quentin’s HIV prevention initiatives.  It began in 1986 with
prerelease sessions facilitated by program staff and has since
expanded to include comprehensive peer education train-
ing.  Peers may facilitate most educational interventions,
including new inmate orientation and other health-related
services. San Quentin has five paid HIV peer educator
prison work positions.  The average tenure as a peer educator
is 6 months, although many educators have served substan-
tially longer.
Peer educators receive 5 days of comprehensive training.
Centerforce staff and community experts present 2 of these
training courses per year to 25–30 inmates.  Graduates
receive certificates as peer educators.  The graduates receive
an additional day of special training to present orientations,
one of the key duties of the peer educators.  The goals of this
training are to create a pool of inmate peer educators, to
introduce participants to public speaking techniques, to
increase their awareness of the relationship between sub-
stance use and high-risk behaviors, to increase multicultural
awareness, and to provide a broad perspective on the impact
of HIV/AIDS on U.S. society and worldwide. Besides the
usual attention to the basics of HIV/AIDS, antibody testing,
and the related issues of STDs and TB, the training includes
sessions on the real meaning of HIV/AIDS statistics, family
issues, racial/ethnic diversity, gay sensitivity, and grief and
loss.  All participants also prepare and deliver timed talks to
practice public speaking techniques.  These talks are cri-
tiqued by the instructors and the class.  Some classes have
made videotaped public service announcements that have
been broadcast on the prison’s closed-circuit television
station.
Peer educators observed during a site visit to San Quentin
appeared to be highly dedicated and committed to their
work. One of them noted that a year earlier he could not have
imagined doing this work, but now he was committed to
“giving something back” and felt very rewarded for the
effort.  Another peer educator said he originally signed up
thinking that it would be an easy “kick back” job.  Quickly,
however, he realized that it was an intense, demanding job
and accepted the challenge.  Prison is the “perfect place” to
do HIV education and prevention with this population, one
of the peers noted, because the inmates are off drugs and
have “clear heads.”
The program staff have to play a difficult balancing act to
gain and keep the trust of both the inmates and the prison
administration.  If they are seen with inmates too much, they
run the risk of having the officers and administration suspect
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them of joining “the enemy.” Conversely, if they work too
closely with the administration, they may cause suspicion
among the  inmates.  The programs tend to emphasize “harm
reduction” over strict abstinence, in part because this helps
to overcome the resistance of the inmates, who otherwise
might feel that “we’re just telling them what to do.”  By
succeeding in maintaining this balance, the program staff
are able to educate both the inmates and the administration.
They report that officers often ask them questions about
HIV.
The peer educators are a diverse group, including  African-
Americans, Latinos, and whites, and gay and straight in-
mates with various drug and alcohol histories.  Most of the
peer educators are HIV positive, but about half of a recent
group of trainees were HIV negative.  Peer educators appear
to be very supportive of one another.  Several said they
hoped to continue doing this work in the community after
their release.  One had already written to several commu-
nity-based organizations (CBOs) asking about possible em-
ployment.
Orientation sessions. Inmate peer educators present re-
quired HIV orientation sessions for approximately 18,000
new inmates at San Quentin each year.  This program was
mandated in 1991 after focus groups with soon-to-be-
released inmates suggested the need for more HIV informa-
tion and education.  The orientation is mandatory, but only
about 75 percent actually receive it.  Scheduling and other
logistical problems preclude providing orientation to all
incoming inmates.
The orientation is presented by teams of peer educators to
groups of about 20 inmates in a classroom dedicated to this
purpose.  The session seeks to “put a face on the epidemic”
and to increase inmates’ awareness of their own risky
behavior by having an HIV-positive peer educator present
his own story.  Subsequently, the following topics are
covered in the orientation:  the difference between HIV
infection and AIDS; the four body fluids that can transmit
the virus; modes of transmission; safer sex issues; the role of
substance use in high-risk behavior; and HIV-antibody
testing.  Ample time is allowed for questions and answers.
The peers attempt to dispel myths about HIV, including the
apparently persistent belief that HIV cannot be acquired
heterosexually, and to encourage HIV-antibody testing.
Another strategy is to focus on the inmate’s desire to protect
his family from HIV as a way of resisting peer pressure to
engage in high-risk behavior.  The ultimate objective of the
orientation and additional education that peers provide is to
induce inmates to reduce their own risky behaviors.
In addition to making the presentations, the peer educators
prepare paperwork for inmates interested in HIV testing
(substantial numbers of inmates take advantage of voluntary
HIV testing, but the precise rates are in dispute), document
attendance, distribute and collect evaluations, and maintain
the classroom.  Bilingual educators are available to meet the
needs of monolingual Spanish-speaking inmates.  The peers
also participate in training sessions for new educators.
Centerforce staff provide ongoing supervision, education,
and other support to the peer educators, spending approxi-
mately 10 hours per week on site for these purposes.  There
is a weekly supervision meeting involving the peer educa-
tors, Centerforce staff, a prison counselor, and/or program
sponsor.
CAPS and Centerforce conducted a collaborative study of
the orientation component.  In a randomized design, a total
of 2,295 incoming inmates were assigned to orientation by
an inmate peer educator, to orientation by a professional
educator, or no intervention.  All participants completed a
survey of knowledge and behavioral intentions.  The two
intervention groups had similar outcomes, both outperform-
ing the no-intervention group in intention to use condoms
and seek HIV-antibody testing.  The intervention groups
also had significantly higher self-perceptions of HIV risk
than the no-intervention group.  The inmate participants
overwhelmingly favored HIV-positive peer educators over
other providers of the intervention.13
HIV intervention. Centerforce staff team up with one of the
inmate peer educators to present HIV education sessions to
various groups and in various settings in the prison, includ-
ing prerelease classes (a  2-hour session during the voluntary
3-week prerelease program), English as a second language
(ESL) classes, vocational classes, and others.  The objec-
tives of these sessions are to present the “personal side” of
HIV/AIDS, to raise inmates’ self-perceptions of risk, and to
increase general knowledge of HIV, testing issues, and
resources available in the community following release.
Prerelease “booster” intervention. A prerelease booster
invention is presented on a voluntary basis to inmates 7–14
days prior to release.  As part of a research study, prerelease
inmates who agreed to participate were randomized to an
intervention or no-intervention group.  All participants
received an extensive baseline survey of knowledge, atti-
tudes, and behaviors, conducted one-on-one by a staff
interviewer.  The intervention group also participated in a
30-minute one-on-one prevention booster session with an
HIV-positive peer educator.  This session was specifically
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designed to encourage risk reduction through condom use,
avoidance of substance use, and safer substance use strate-
gies. Participants also received referrals to community-
based services.  The no-intervention group received only
written materials and referrals.  Inmates being released from
San Quentin received an HIV prevention brochure designed
and written by the peer educators that contains practical risk-
reduction suggestions described in frank language with
drawings.  Between 1 and 4 weeks after release, 43 percent
of participants completed a telephone followup survey re-
garding risk education and risk behaviors.  Intervention
group participants were significantly more likely than com-
parison group members to report condom use in their first
postrelease sexual encounter and were less likely to report
using drugs or sharing needles in their first weeks after
release.14
Centerforce and CAPS are also completing a 3-year project
for HIV-infected inmates, funded by the universitywide
AIDS Research Program at the University of California.
This program includes a comprehensive 2-week “prerelease”
education intervention with a focus on staying healthy and
accessing community service providers upon release from
custody.  A  unique aspect of this program is a resource fair
of service providers from counties to which the inmate
participants are being released.  This allows the inmate and
the community service provider to make face-to-face con-
tact and a personal connection prior to release.
Peer educator support. HIV-positive peer educators pro-
vide support to other inmates who are newly diagnosed with
HIV.  This counseling includes discussion of the meaning of
HIV infection, circumstances of the inmate’s learning his
status, his current physical and psychological state, disclo-
sure of status, sexual risk reduction, and policies for housing
and treating inmates with HIV.  The initial session lasts 20–
30 minutes; followup sessions are offered.  Inmate peer
educators spend 2 hours per week doing this counseling.
Centerforce staff provide support and educational backup
for the peers.
HIV education for female visitors. Centerforce and CAPS
are developing and evaluating a peer HIV education pro-
gram for women visiting male inmates at San Quentin.
Formative data reveal that female visitors are in need of HIV
education,  support, and community referrals.  Inmate peer
educators are planning and conducting group discussion
sessions with women visitors in the visitor center.  CAPS
will evaluate the intervention in terms of utilization of
community resources and self-reported behavioral change.
Two other peer programs in California State adult correc-
tional facilities are described in the following text boxes.
Programs in Los Angeles County Juvenile System
Los Angeles County has the largest number of confined and
probationary youths of any juvenile system in the United
States.  About 27,000 enter the system annually, and the
average daily population of confined and probationary youths
(that is, those involved in school or other programs at a
juvenile facility) is about 4,000. Two peer-based HIV pre-
vention programs for youths in the Los Angeles County
juvenile system, the AIDS Video Project and the Peer HIV
Education Project, are discussed below.
AIDS Video Project.  The AIDS Video Project (AVP)
provides youths on probation with interactive and culturally
appropriate HIV and STD education.  The AVP seeks to
increase participants’ knowledge and application of HIV risk-
reduction practices through classroom education and training
to become peer educators.  The video production component
is the final stage in an educational process designed to teach
as well as involve students, inducing them to “open up” about
their risk factors and the behavioral changes needed to reduce
their risks for HIV and other STDs.
To be certified as a peer educator, a student must success-
fully complete an eight-session educational program.  More
than 80 youths undergo this training each year.  Once
certified, the peer educators work in teams to create an HIV
prevention video that can be shown as part of educational
sessions that the peer educators help to present in their own
and other juvenile facilities.  The AVP has created about six
videos each year since its inception in 1989 and reached
about 600 youths with HIV and STD education.
At the conclusion of these education sessions, the attendees
receive an information packet and, if the facility permits it,
condoms.  The information packet includes a resource guide
developed by AVP, which lists testing/counseling, family
planning, and related services at little or no cost within a 5-
to 10-mile radius of each community education center.
Peer educator training.  The peer educator training consists
of eight 2-hour sessions offered primarily in the community
school facilities attended by youths on probation who are
living at home.  The former AVP coordinator noted that this
is best, since “there’s nothing like when they’re actually . . .
able to have sex . . . [and] do drugs as opposed to when they
were locked up. . . . That’s when they’re really struggling with
issues like why it’s so hard a subject to talk about, or did they
use condoms this weekend.”
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The California Institution for Women (CIW), Frontera, is one of five State prisons for women in California.  The
average daily population of the facility is about 1,600, of whom 38 were known to be HIV positive at the time of the
site visit.  New diagnoses of HIV disease average one per month.  About 125 women per month receive voluntary
HIV testing, a considerable increase from the period before establishment of the peer program.
CIW’s HIV peer education program, started in 1994 by a public health nurse working at the facility, is staffed by 24
volunteer peer educators and 2 who receive “good time” credit (“day for day”) for their work.
Peer program volunteers are carefully screened, and the inmates selected must be free of disciplinary action, highly
motivated, able to communicate effectively, and capable of building rapport and trust with other inmates and staff.
HIV-positive candidates and those with some previous knowledge of HIV/AIDS are preferred. Each applicant must
obtain a recommendation from her correctional counselor, undergo an interview, and write a paragraph explaining
why she wants to be in the program.  Facility captains must approve all applicants before final selection to guard
against women who may want to use the program to advance an independent “agenda.”  Selected applicants receive
weekly training for 3 months provided by HIV Women’s Voices, a community-based Orange County organization.
The CIW peer educators present classes for the  general inmate population, substance abuse treatment programs,
mental health groups, new intakes at the reception center, prerelease inmates, and inmates slated to attend forestry
camps.  During a site visit to CIW, four peer educators who were observed conducting a session for the general
inmate population effectively spoke the inmates’ language and established good rapport. Several had loved ones
with HIV/AIDS; at least one was HIV positive. Each briefly told her own story; explained why she wanted to be a peer
educator;  and described how doing something positive for others made her feel better about herself.  In their
presentations, the peer educators repeatedly stressed personal responsibility and personal control—“you have the
future in your hands” and “knowledge is power.”
One educator effectively described the complex process of HIV infection and replication of infected cells by drawing
Pac-Man-like figures on the board.  Educators also used humor: in introducing an explicit discussion of sexual risk
behaviors, one  said, “They call me Dr. Ruth.”  This created a light atmosphere and encouraged the inmates to open
up with their own stories and concerns.
Educators used games to engage participants in a discussion of risky behaviors.  In “red light/green light,” the class
discussed a long list of very specific behaviors, and for each one decided whether the behavior posed no risk, low
risk, or high risk of transmitting or acquiring HIV.  Along with descriptions of proper condom use, proper cleaning
of injection material, and introduction of the female condom, inmates discussed risk-reduction strategies for
particular situations.  The discussion also provided opportunities to address misconceptions.  For example, when
several inmates said that they considered it very risky to hug someone with HIV, one of the HIV-positive educators
immediately hugged them, and the rest of the class reinforced the point that this posed no risk because it involved
no exchange of body fluid.  The discussion also addressed risks specific to prison life.  For example, the educators
cautioned that the common prison practice of using guitar strings for tattooing is particularly risky because the
grooves in the strings can catch and hold blood.
The peer educators at CIW also conduct weekly pretest counseling classes.  These classes take place under staff
supervision to ensure consistency.  The pretest classes generally have 25–30 inmates in attendance and last 1 to
11/2 hours.  Individual posttest counseling is provided by health services staff, not by peer educators.
California Institution for Women, Frontera
42 1996–1997 Update:  HIV/AIDS, STDs, and TB in Correctional Facilities
California Medical Facility, Vacaville
The California Medical Facility (CMF) in Vacaville is the major medical and mental health treatment facility for the
male inmates of the California Department of Corrections.  The average daily population is about 3,200.  The facility
includes Unit 4, a segregated housing unit for inmates with HIV disease.  Inmates in Unit 4 are eligible to participate
in programming with the general population.
CMF has 10 paid HIV peer educators.  Inmates apply to be peer educators and undergo a screening process.  Jan
Burrow, the program coordinator, trains the peer educators. Two peer educators are certified pre- and posttest
counselors, although they do not perform this counseling in the prison.
The peer educators orient all new inmates and see about 800 inmates per month in group settings.  They also provide
informal education and counseling in housing units, the exercise yard, and program areas.  The peer education
program publishes a magazine, PEP Talk, whose contributors are inmates.  All articles are in English and Spanish.
A recent issue included articles on protease inhibitors, viral load monitoring, and the importance of forgiving one’s
self and others.  The peer education program’s “mission” and “oath” are printed on the back of each issue.  These
stress the spiritual and nurturing foundation of the work.
The peer educators offer a monthly schedule of hour-long educational sessions in housing units (including Unit 4),
work sites, and program areas in the facility and in the prerelease center.  Inmates must sign up to attend these
sessions.  In the minimum-security part of the facility, the peer educators offer a 5-week program with weekly
meetings.
The educators employ a “stages of change” approach in some of the sessions, attempting to induce inmates to
contemplate and then initiate changes in risk-reduction behavior.  They discuss real-life situations—for example,
exploring the relationship between substance use and high-risk sex.  They use all media and a variety of strategies,
including posters, audiovisual materials, stories, and games.
With support from the program coordinators, the peer educators are free to discuss practical risk-reduction strategies
in their sessions with inmates.  Although the peers always stress that sex in prison is against the rules and that
regulations prohibit the distribution of condoms in the facility, relevant preventive methods are discussed.  The peers
used to be very explicit in suggesting alternatives to condoms—for example, the fingers of latex gloves—until the
Department of Corrections (DOC) required a less specific message—for example, “use something latex; use your
imagination.”  Moreover, if inmates ask about specific alternatives such as latex glove fingers, the peers answer the
questions directly and honestly.  For example, if an inmate asks about plastic wrap as an alternative to a condom,
the peer educator will respond that “it’s better than nothing.”  The educators also can make specific risk-reduction
recommendations in the context of “what you should do when you return to the community,” but this approach still
provides suggestions that can be implemented inside the facility.
In their group meetings with HIV-infected inmates, the peer educators spend substantial time discussing the new
medications and urging inmates to seek early intervention.  Their theme is “knowledge is power.”  Educators also
stress the importance of good nutrition and health habits, spiritual development, and avoidance of reinfection.
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The training sessions are presented by the AVP coordinator
and a health educator assistant.  They follow an established
curriculum that includes exercises focusing on making de-
cisions, clarifying values, enhancing self-esteem, and ex-
ploring practical methods of HIV and STD risk reduction.
Extensive use is made of games and interactive exercises to
gain and hold students’ attention.  One session includes a
presentation by an HIV-positive speaker.
In the session attended during a site visit for this study, the
educators used several methods to involve the students.
They passed around a “question box” into which students
could place any questions they wanted answered, and the
educators tried to answer all of them.  The educators used
cartoon depictions of techniques for cleaning drug-
injection equipment, demonstrated proper condom use and
factors for selecting condoms, and employed a game (the
“condom relay”) to enable students to practice proper con-
dom use.  The educators also provided good, understandable
discussions of the natural history of HIV disease and the
differences between confidential and anonymous testing.
Video production.  As with the peer educator training, most
of the video production takes place at community schools
that the youths attend while living at home.  The videos are
the results of the collaborative efforts of the students, the
educators, and an independent filmmaker.  Only 3 days are
allocated to the production of each video, from concept
development to final product.  Thus, things must move
quickly.  The first day is spent deciding on the concept and
the story.  The students develop the story, and the filmmaker
helps them storyboard the elements of their story, cutting
sections that do not fit or are impossible to shoot.  All filming
must be done in the facility, so sets and props are limited—
“You notice a lot of ‘beds’ that look like desks.”  The filming
of the 5- to 8-minute videos must be done in two 5-hour days
of work.  Shooting scripts are not used because of the
students’ low literacy levels, so each scene must be done as
a rehearsed improvisation.  The students all double as actors
and crew members, getting an opportunity to learn about
filmmaking as well as acting and the substantive issues
involved in the story.  Scenes are shot numerous times from
different angles.  Once shooting is completed, the students
decide on music to be included and the filmmaker edits the
video.
The filmmaker generally notes significant changes over the
3-day production period.  The students often begin by being
“kind of aloof” but become increasingly involved with and
committed to the project.  Their level of involvement is
sparked by employing a monitor that allows the students to
see simultaneously what is being filmed.
Completed AVP videos have used a variety of genres,
including comedy, musical, and drama.  In “Captain Con-
dom,” a “condom-adorned” superhero appears magically in
a couple’s living room to provide advice on safer sex.  “Class
reunion” explores the reaction of a class to the news that a
member has died of AIDS.  “Lunatic Rap” features a female
rap duo performing “HIV is in the ‘Hood.’”
Once the video is completed, the peer educators present it to
the other students in the school as part of an HIV education
session.  The former AVP coordinator states that this is “the
best day on the planet.”  The students are proud of their
achievement, and the other students generally respond fa-
vorably and with respect.  The day ends with AVP giving a
party for the video makers.
Evaluation.  AVP attempts to follow up with all peer
educators at 3 and 6 months following their completion of
the program.  Tracking the population is difficult, so followup
rates are fairly low.  Of 61 peers trained in fiscal year 1994,
17 (28 percent) provided followup interviews.  Low followup
may indicate biased selection, so conclusions based on these
samples may overstate positive outcomes.  In any event,
more than three-quarters (76 percent) of the 1994 peer
educators who provided followup interviews reported an
increase in HIV risk-reduction behaviors—condom use
and/or cleaning of injection material.  Among 662 confined
and probationary youth exposed to AVP education sessions,
the average pre- to postknowledge gain was 23 percent.
Recent data reveal an average pre- to postknowledge gain of
more than 90 percent among the youths being trained as peer
educators.  Followup at 3 and 6 months revealed that more
than 80 percent reported an increase in at least one risk-
reduction behavior.
It is also important to recognize the intangible and immea-
surable positive outcomes of AVP.  The former coordinator
notes that it is important to give these kids, many of whom
are “set up to fail,” a place where they can succeed at
something.  “And if you have kids who feel that they’re
succeeding, it will be easier for them to use a condom.”
Peer HIV Education Project.  The Peer HIV Education
Project (PHEP) was operated by JWCH Institute and sup-
ported by the Los Angeles County Health Department using
funds from the CDC Health Education and Risk Reduction
Cooperative Agreement.  The PHEP presented mandatory
HIV/STD education sessions in county juvenile facilities,
including community education centers, juvenile halls, and
camps.
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PHEP began operations in October 1995 using teams com-
posed of a peer educator and an adult professional.  The
PHEP curriculum consisted of 4-hour sessions and included
numerous games and interactive exercises.
An evening PHEP session at Camp Routh was observed as
part of the site visit for this study.  This was a condensation
of the four-session curriculum into one 2-hour session, and
it seemed to work quite well.  The adult educator and the two
peer educators involved in this session worked very well
together, trading off sections of the presentation quite
smoothly.  All seemed comfortable with the subject matter
and seemed able to establish rapport with the students.  The
peer educators spoke effectively from their own experiences
with HIV risk behavior and used humor and understandable
slang terms very well.
A particularly effective part of the session was an outside
speaker’s disclosure of his HIV-positive status in the midst
of his presentation.  He was not identified at the outset as an
HIV-positive person but rather “sprung” his disclosure in
the course of a discussion of heterosexual risk.  Once he had
disclosed his status, he said, “It pisses me off that so many
of you think [based on your responses to the pretest] that you
can’t get HIV through sex with a woman.”  The speaker went
on to challenge the notion that one can’t deal with being HIV
positive.  It is admittedly very hard in some ways, he said, but
it can also be rewarding and fulfilling to help others protect
themselves against HIV.  He acknowledged that he does not
have sex very much anymore because he is scrupulous to
disclose his status, and most women do not want anything to
do with him once they know he is HIV positive.
The session also included the “Virus Z” game, in which
handshakes among the group are used to demonstrate how
a network of transmission can develop very quickly.  The
educators demonstrated proper condom use and involved
students in this demonstration as well.  In the course of the
demonstration, the educators discussed common condom
substitutes and cautioned against the use of microwavable
plastic wrap because it has microscopic holes.  Female
condoms and dental dams were discussed and shown to the
group.  Another useful item of advice included in the
presentation was to avoid oral sex within 4 hours of brushing
teeth.  Toothbrushing can cause small cuts in the mouth, thus
providing a possible avenue of transmission.  Finally, the
educators passed around graphic photographs of STD con-
ditions, and these seemed to have a strong impact on the
youths.
Evaluation forms submitted at the end of this and other
PHEP sessions observed during the site visit revealed over-
whelmingly positive participant responses, particularly re-
garding the approach taken by the educators and the rapport
they were able to develop with the participants.  The follow-
ing are some examples of these comments:
• I think Tricia and Kay are good speakers and make good
games that are fun and let you learn at the same time.
They’re cool too, and respected us.
• I thought the speakers knew how to talk to us.  I felt
really comfortable with them.
• I thought I knew a lot about HIV/AIDS, but I guess not.
And now I’m more interested in learning about my
health!!!
• I really learned a lot and changed my mind about getting
an HIV test.  I was scared, but now I’m going to take the
test.
• I would like to thank you all for taking the time for us.
I’m glad you didn’t take advantage of us being inmates.
Thank you for treating us like real people.
• I think the class is very helpful.  The teachers are great.
They get down to the point.  That’s how it should be
done.
• I feel this is important because it is something we all
have to learn about, because it’s not a fairy tale.
Conclusion
The 1997 NIJ/CDC survey reveals that HIV/AIDS and STD
education programs are becoming more widespread in cor-
rectional facilities but that most facilities still do not provide
a comprehensive program of HIV prevention.  In particular,
more intensive interventions such as multisession preven-
tion counseling and peer-based programs should be ex-
panded.  Peer-based programs offer distinct advantages of
credibility, cost-effectiveness, and benefit to the peer educa-
tors themselves.  Although systematic evaluation of peer
programs has been limited, there are strong indications from
many programs, including those described in this chapter,
that peer-based programs can be effective in reaching in-
mates with practical information on HIV and STD prevention.
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Chapter 4
HIV Transmission and Risk Factors,
Precautionary and Preventive Measures
Theodore M. Hammett and Patricia Harmon—Abt Associates Inc.
Key Findings
• High-risk behaviors for HIV transmission—sex, drug use, sharing of injection materials, and tattooing—occur
in correctional facilities.
• HIV transmission among correctional inmates has been shown to occur.
• Comprehensive and intensive education and prevention programs represent the best response to these
facts, although the precise content of such programs is controversial.
• Rape and coerced sexual activity also occur in correctional facilities but require a different response, one
based on inmate classification, housing, and supervision.
• Implementation of “universal precautions” represents the heart of a correctional infection control program
and the first line of defense against the occupational transmission of HIV.
• Condom distribution and other harm-reduction strategies have not been widely adopted in American
correctional systems.
• Experience with harm reduction in correctional facilities in Europe and elsewhere may warrant the attention
of U.S. correctional administrators.
There is evidence of high-risk behaviors and HIV transmis-
sion in correctional facilities but also  an ongoing debate as
to what precautionary and preventive measures against HIV
should be implemented in these settings.  The principle of
equivalent responses within and outside the walls is chal-
lenged by demands from correctional officers’ unions, the
rules of correctional facilities, and the perception that in-
mates should not and cannot be treated like other people
with relationship to HIV prevention. This chapter discusses
risk factors and HIV transmission in correctional facilities
and addresses some of the key issues in formulating a policy
response.
HIV Transmission and Risk Behaviors
in Correctional Facilities
The possibility of HIV transmission among correctional
inmates remains a politically charged issue, although there
have been few recent studies of this.  At this writing, it is
possible that a study of HIV transmission in the Texas prison
system will be undertaken.  The most recently published
study is from Florida and was based on voluntary HIV
antibody testing of inmates continuously incarcerated since
before the appearance of HIV in the United States.  Although
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this study revealed apparent in-prison HIV seroconversions,
it presented a misleadingly high seroconversion rate by
using as a denominator only those inmates who consented
to be tested rather than all of the inmates eligible for the study
on the basis of the length of their incarceration.  The study
also failed to calculate annual seroincidence rates based on
total time of exposure (incarceration) represented in the
study population.1   The Illinois Department of Corrections
replicated the Florida study, identifying 191 inmates con-
tinuously incarcerated since 1977, of whom 140 (73 percent)
had either been previously tested for HIV antibodies in
prison or consented to be tested for this study.  Only 1 of these
inmates (0.7 percent) was HIV seropositive.2
The important point, however, is that most studies have
found evidence of at least some HIV transmission among
prisoners, albeit at low rates.  Further study is clearly war-
ranted based on evidence of inmates’ high-risk behaviors for
HIV transmission. Focus groups with former inmates in New
York State and New York City elicited reports of widespread
sexual activity and drug use within correctional facilities.3
A survey of Nebraska inmates revealed fairly high rates of
participation in consensual and forced sexual activity within
the State’s prisons.4  An Australian study demonstrated the
existence of a network of needle sharing and associated HIV
infections in prison.5  A small random survey of male and
female inmates in two Canadian Federal prisons revealed
that 28 percent had injected drugs in prison and 64 percent
of these reported having shared needles.  Thirty-three per-
cent of the sample reported receiving a tattoo in prison.
Thirty-eight percent of the surveyed inmates reported hav-
ing engaged in sex in the correctional facility.6
Rape and Coerced Sexual Activity
The issues of rape and HIV transmission are separate and thus
require separate and distinct responses.  The primary means
of addressing HIV transmission ought to be comprehensive
programs of HIV education and prevention, whereas rape
and other forms of sexual victimization must be addressed
by better programs of detection and enforcement.  By no
means do all prison rapes result in HIV transmission, just as,
conversely, by no means are all HIV transmissions in prison
attributable to rape.  The danger in treating the two issues as
if they were interchangeable is that other important aspects
of HIV prevention and rape prevention may be ignored or
given insufficient attention.
It is nevertheless clear that rape and coercive sex are serious
and possibly widespread problems in correctional facilities.
Dramatic accounts of sexual slavery such as contained in
Stephen “Donny” Donaldson’s “Punk’s Song”7 and the
testimony of former Illinois inmate Michael Blucker in his
lawsuit against the correctional system8 indicate the poten-
tial horrors of prison life for those who are vulnerable.  Such
accounts and other evidence strongly suggest the need for
better strategies to prevent sexual and other forms of victim-
ization of prison inmates.
“Universal Precautions” Versus
Correctional Officers’ “Right to
Know”
Very few correctional systems have policies for routinely
notifying correctional officers of inmates’ HIV status.  How-
ever, many systems do have policies regarding notification
if a possible transmission incident occurs.  Some of these
policies are based on legal or regulatory requirements.  The
advent of postexposure prophylaxis for HIV infection in
health care settings is also pertinent to correctional facilities.
Some correctional officers’ unions and some individual
officers continue to assert their “right to know” the names of
all known HIV-seropositive inmates, claiming that such
knowledge will enable them to take special precautions
when dealing with these inmates.  There are several problems
with this approach.  First, no testing policy can identify all
HIV-infected individuals because of ongoing
seroconversions and individuals testing negative while in
the “window period” of infection.  Indeed, there is evidence
that a person may be most infectious while in the acute stage
of infection but may still be HIV-antibody negative.9  A
mandatory and universal testing and notification policy
may lull officers into a false sense of security, leading them
to think that they know who all the HIV-infected inmates are.
Second, even if it were possible to identify all HIV-infected
inmates, officers might not be able to remember all of them.
This would be a particular problem in systems with large
numbers of HIV-infected inmates.
These problems seem to point to the wisdom of the alterna-
tive:  maintaining confidentiality but systematically prac-
ticing “universal precautions.”  The principle of universal
precautions, promulgated by the CDC in the mid-1980s and
given full legal force by the Occupational Safety and Health
Administration in 1991, means that one should treat all
persons as if they are HIV infected, avoiding unprotected
contact with body fluids that are considered potentially
infective, especially blood and semen.  Universal precau-
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tions are not necessary for contact with saliva, tears, sweat,
vomitus, urine, or feces unless they contain visible blood.10
Many correctional systems have issued their own policies
regarding universal precautions, and administrators should
ensure that all staff receive training on these policies and that
these policies are implemented in everyday practice.  Uni-
versal precautions are also important for preventing hepati-
tis C transmission.  Hepatitis C is prevalent but commonly
undiagnosed in the inmate population, and there is no
vaccine or reliable treatment for the severe morbidity that
may result from the infection.
It is important to note that written policies and procedures,
no matter how detailed, cannot teach correctional officers
how to act in every situation.  Many incidents in prisons and
jails require that officers and other staff decide what to do
very quickly.  Training and knowledge are important and
helpful, but in specific situations staff must exercise their
own discretion and judgment.
Condom Availability
An important component of HIV/STD education is the
presentation and frank discussion of practical risk-reduction
strategies.  However, a major challenge to effective HIV
prevention in correctional facilities is that in most prisons
and jails the means to carry out practical risk-reduction
strategies are not officially available.  Indeed, in the vast
majority of correctional facilities inmates are prohibited
from possessing condoms.  Table 20 shows that only six
correctional systems make condoms available to inmates for
use in their facilities.  These are the same six systems that
have had this policy for a number of years:  Vermont,
Mississippi, New York City, San Francisco, Philadelphia,
and Washington, D.C.  No additional systems have made
condoms available since the early 1990s.
In contrast to the U.S. situation, condoms are available in
most European11 and Canadian prisons (although there have
reportedly been some problems with ready and discreet
accessibility in some facilities in Canada),12 and pilot pro-
grams of condom distribution have been undertaken in
correctional facilities in New South Wales (Australia) and in
Western Australia.  In announcing the expansion of the
condom program in New South Wales prisons,  Minister for
Corrective Services Bob Debus said, “[T]his is a public
health issue:  only by providing condoms in our gaols can
we ensure they don’t become breeding grounds for diseases
which will eventually be spread to the wider community.”13
In launching a condom distribution trial at Western
Australia’s Wooroloo  Prison Farm, a Justice Ministry spokes-
man said, “[We]’re not condoning sex in prisons, but we’re
not naive, we know it happens, and we’re trying to make sure
there’s some sort of way to stop the spread of sexually
transmitted diseases like hepatitis and AIDS.”14
Bleach Availability
Research findings suggest that bleach may not be effective
for HIV disinfection unless it is used at full strength and in
strict accordance with recommended procedures.  CDC’s
revised procedures call for repeating the following sequence
of steps three times:  rinsing the needle and syringe with
clean water, then with full-strength bleach, then with clean
water again.  The needle and syringe should be shaken for 30
seconds during each rinse.  Bleach disinfection is considered
a much less desirable risk-reduction method than using a
new needle and syringe for each injection.15
As shown in table 20, 20 percent of correctional systems
responding to the 1997 NIJ/CDC survey make bleach avail-
able to inmates within facilities “for any purpose.”  The
survey question was phrased this way because few if any
correctional systems would be likely to report that they make
bleach available specifically for cleaning injection equip-
ment.  However, if bleach is available to inmates for cleaning
or other legitimate purposes, it is quite possible that it will
be available in practice for cleaning injection equipment.
Table 20.  Availability of condoms and
bleach, 1997
  State/Federal    City/County
Prison Systems   Jail Systems
        (n = 51)        (n = 41)
Policy   n   % n %
Make condoms
available for use
within facility 2  4 4 10
Make bleach
available for
any purpose 10 20 8 20
Source:  NIJ/CDC survey.
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Officially sanctioned distribution of bleach for cleaning
injection equipment is more widespread in correctional
systems outside the United States.  Half of the 20 European
systems responding to a 1997 survey had such policies.16  A
successful pilot bleach kit distribution program at a Cana-
dian Federal prison in New Brunswick led to the expansion
of the program to all Federal facilities.  An inmate survey at
the New Brunswick facility found overwhelming support
(99 percent) for bleach kit distribution, and 63 percent of
staff also felt that making bleach available to inmates as a
preventive measure is “important.”17  In a survey of inmates
in six Ontario provincial prisons, 52 percent of respondents
expressed positive feelings about the distribution of bleach
in their facilities.18
Needle and Syringe Exchange
Possession of needles and syringes in prisons and jails in the
United States is a violation of law and/or of correctional
regulations.  However, needle/syringe exchange programs
have been successfully implemented in Swiss prisons since
1992.  Eight Swiss prisons have needle exchange programs.
Evaluation of the program in the Hindelbank women’s
facility  in Switzerland found that contrary to some predic-
tions, drug consumption did not increase, and needle shar-
ing declined markedly.  Also, there were no reports of needles
being used as weapons.  There were no incident cases of HIV
or hepatitis B infection among program participants.  The
program was well received by inmates and staff.19  In October
1997 the Swiss Federal Office of Justice adopted an official
statement that needle distribution in prisons was legal and
that prison administrators had a duty to implement such
programs in the context of an overall HIV prevention strat-
egy.  The issuance of this statement has led to discussion of
prison-based needle exchange in at least seven Swiss can-
tons and its adoption in all four major correctional facilities
in the canton of Berne.20
Based on the experience of the Swiss facilities, needle/
syringe exchange programs have been initiated in three
prisons in Germany and one prison in Spain.  An official at
the Hamburg (Germany) prison stated:
[S]taff are members of the public as well.  They
started seeing that what was done outside is to the
benefit of all drug users and the public, and started
questioning . . . whether it would not be possible
and beneficial to extend harm-reduction measures
to prisons.21
A recent study in Australia found that needle/syringe ex-
change was feasible in prisons and recommended initiation
of a pilot exchange program if the following conditions were
met: (1) prison-based drug treatment was available; (2)
security and health staff were thoroughly trained in the
program; (3) the method of needle/syringe distribution was
chosen jointly by inmates and security and health staff; (4)
distribution was on a strict one-for-one exchange basis; and
(5) changes in risk of infection to staff, inmates, and visitors
resulting from the program were assessed.  At this writing, the
pilot needle/syringe exchange program has not been imple-
mented in Australia.22  Seventy percent of inmates surveyed
in Ontario expressed negative feelings about needle distri-
bution in prisons.23
Methadone Maintenance
Methadone maintenance is offered in correctional facilities
in only five countries.24  However, methadone maintenance
may be an effective strategy for reducing needle use and
potentially reducing HIV and hepatitis transmission in
prisons.  A study of former New South Wales (Australia)
inmates with histories of injection-drug use found that
individuals receiving methadone maintenance in the 3
months preceding their incarceration and those receiving
methadone maintenance at a dose of  at least 60 mg during
incarceration reported significantly fewer injections per
week in prison than those who had not received methadone
maintenance.25
Reduction of Risk Associated With
Tattooing
Tattooing is extremely common in correctional facilities.  If
unsterile equipment is used, it can be as risky for the
acquisition of HIV and hepatitis B or C as other forms of
needle use.  The correctional department of New South
Wales (Australia) has published an informative booklet on
risks and risk reduction for prison tattooing.26  Indeed, one
of  the key points made in the booklet is that prison tattooing
is inherently unsafe and should therefore be avoided in favor
of visiting a professional tattoo artist following release.  An
experienced prison tattooist is quoted as saying:  “I learnt
very early in my sentence that there is ABSOLUTELY NO
WAY a tattoo can be performed hygienically or safely in
prison.”  Importantly, the booklet notes, “[T]att guns made
in gaol are virtually impossible to sterilise.”  The booklet
lists precautions for inmates who still wish to be tattooed in
prison.  These include the following:
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• Make sure your tattooist wears gloves.
• Wash and shave the area to be tattooed.
• Make sure the gun is cleaned in bleach.
• Replace cotton each time the gun is used.
• Cover the gun with latex.
• Take care of your new tattoo; apply antiseptic and keep
it out of the sun.
Conclusion
There is evidence of high-risk behaviors for HIV and STD
transmission in correctional facilities, as well as of actual
transmission of HIV infection among inmates.  Rape and
sexual victimization are also known to occur in prisons and
jails, but these problems require a policy response indepen-
dent from the problem of HIV and STD transmission.  The
practice of universal precautions remains the first line of
defense against the occupational transmission of HIV and
hepatitis B and C in correctional settings.  Postexposure
prophylaxis for HIV should also be considered.  Harm-
reduction approaches to prevention, such as making
condoms, bleach, and sterile injection equipment available,
have not been widely adopted in U.S. correctional facilities,
although they are finding increasing acceptance elsewhere.
There have been no additions since the early 1990s to the
short list of correctional systems making condoms available
to inmates.  Correctional administrators should continue to
consider the experience of other countries in implementing
harm-reduction strategies.
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Chapter 5
Counseling and Testing, Confidentiality
and Disclosure
Theodore M. Hammett and Patricia Harmon—Abt Associates Inc.
Laura Maruschak—Bureau of Justice Statistics
Key Findings
• Most correctional systems provide HIV-antibody testing, although testing policies differ widely.
• In 1997, 17 State correctional systems and the Federal Bureau of Prisons had policies for the mandatory HIV-
antibody testing of inmates at intake and/or release.
• Few correctional systems have mandatory or routine pregnancy testing for female inmates.
• Ongoing assessment of HIV-antibody and pregnancy-testing policies is warranted in light of changing
community standards for the treatment of HIV/AIDS.
• Very few correctional systems have policies for the notification of correctional officers regarding inmates’ HIV
status.
• Few correctional systems routinely screen inmates for STDs.
Policies for HIV counseling and testing have become more
and more important as early intervention with antiretroviral
therapy has produced increasingly promising results.  After
the HIV antibody test became available in 1985, debate
about testing in correctional facilities focused on whether it
could or should be used in conjunction with housing segre-
gation to prevent transmission among inmates.  During that
period, there was no therapeutic reason for the early identi-
fication of HIV infection, since there was nothing to offer
patients.
Beginning with the advent of zidovudine (AZT) treatment
in the early 1990s, the terms of the debate began to change.
Subsequently, with the availability of protease inhibitors
and combination antiretroviral therapy in 1996, the value of
early identification and intervention increased dramati-
cally. The Bureau of Justice Statistics (BJS) surveys revealed
that 79 percent of State inmates in 1997 and 60 percent of
local jail inmates in 1995–96 had been tested for HIV
antibodies.
HIV-Antibody Testing Policies
The most recent data on correctional HIV-antibody testing
policies come from BJS’ 1996 National Prisoner Statistics
and from the Ninth National Survey of HIV/AIDS, STDs, and
TB in Correctional Facilities sponsored by  NIJ and  CDC.
The BJS survey results offer an overall view of HIV-testing
policies in the correctional systems of the States, Federal
Government, and the District of Columbia, and the NIJ/CDC
survey results yield a mutually exclusive categorization of
testing policies for incoming inmates in State/Federal and
city/county systems.
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Overall HIV-Antibody Testing Policies in State,
Federal, and D.C. Systems
Forty-nine States, the District of Columbia, and the Federal
Bureau of Prisons test inmates based on certain criteria (see
table 21, summarized in table 22).  Only one State, Delaware,
did not report whether it tested its inmates for HIV.  Most
jurisdictions (42 out of 51) test inmates if they have HIV-
related symptoms or if the inmates request a test.  Twenty-
four States test inmates after involvement in an incident, and
14 States test inmates who belong to specific “high-risk”
groups.
Sixteen States test all inmates who enter their facilities.
Three of these States (Alabama, Missouri, and Nevada) and
the Federal Bureau of Prisons also test inmates upon leaving
the facility.  Two States (Nevada and Rhode Island) reported
testing inmates not only upon entering but also while in
custody.
States also test inmates selectively, based on the special
circumstances of an inmate.  Forty States test for HIV upon
inmate request; 38 test if the inmate exhibits HIV-related
symptoms; 24 test after involvement in an incident; and 14
test inmates who belong to specific “high-risk groups.”  Only
four States (Maine, Massachusetts, Wisconsin, and New
Mexico) and the District of Columbia test solely upon
inmate request.  The Federal Bureau of Prisons, Florida, and
New York randomly test their inmates for HIV.
HIV-Antibody Testing Policies for Incoming
Inmates
Table 23 presents a mutually exclusive categorization of
HIV-antibody testing policies for incoming correctional
inmates, according to the 1997 NIJ/CDC survey.
Mandatory and Routine Testing
Between the 1990 and the 1997 surveys, there was no change
in the list of 16 State prison systems that conducted manda-
tory testing of all incoming inmates.  (However, since the
1997 survey was completed, South Carolina initiated man-
datory HIV-antibody testing of incoming inmates, raising
the total number to 17.)  As in previous surveys, no city/
county jail systems reported mandatory testing at intake.
The correctional systems with mandatory testing generally
have low HIV seroprevalence among their inmates.
Some clinicians are calling for the mandatory HIV testing of
correctional inmates because they believe that incarceration
provides a critical opportunity for therapeutic interventions
with an extremely high-risk and previously underserved
population.  These clinicians typically argue that no policy
of mandatory testing should be implemented unless the
correctional system is fully committed to offering commu-
nity standard of treatment to all HIV-infected people.  In this
context, they believe that the clinician’s ethical imperative
to offer treatment overrides the patient’s right to decide
whether to be tested.
As shown in table 23, two correctional systems have moved
to “routine” testing, an intermediate point between manda-
tory and voluntary testing, in which patients are informed
that they will be tested unless they specifically refuse.  More
recently, the Texas State system has also decided to adopt
routine testing.1
Offered and On-Request Testing
Most correctional systems continue to rely on voluntary
testing to identify inmates who might benefit from therapeu-
tic intervention.  Table 23 shows that two-thirds of State/
Federal systems and 80 percent of city/county systems have
policies for offering HIV testing or providing testing on
request.  Dividing “voluntary” testing into these two policy
choices in the 1997 NIJ/CDC survey was intended to distin-
guish between (1) systems in which staff enthusiastically
offer or recommend testing to those who seem to be at risk
based on a health history and assessment, and (2) systems in
which inmates are not tested unless they request it.  In other
words, the distinction is between an active and a passive
approach to testing.  Table 23 indicates that correctional
systems with voluntary testing are fairly evenly divided
between these two approaches.  The results of the validation
study (table 24) reveal more discrepancies between central
office and facility responses regarding offered and on-
request testing than regarding mandatory testing, indicating
possible confusion between these categories either in com-
plying with policy or responding to the survey.
Most studies show that HIV seropositivity rates from volun-
tary testing in correctional settings are lower than
seroprevalence rates found in blinded studies of samples of
inmates representative of the entire incoming inmate popu-
lation.  In Maryland, for example, 2.5 percent of inmates
receiving voluntary testing in 1991 were HIV-seropositive,
as opposed to 8.5 percent of incoming inmates in a blinded
study.2   The major reasons adduced for voluntary testing
programs understating the true HIV seroprevalence among
Maryland inmates are that many truly at-risk inmates do not
believe that they are at risk for HIV, and that inmates are in
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Table 21.  Testing policies for antibodies to the human immunodeficiency virus,
by jurisdiction, 1995
Jurisdiction Entering All Inmates High-Risk Inmate Clinical Involvement Random Other
In Custody Upon Group Request Indication in Incident Sample
Release
Federal System X X X X
Northeast
Connecticut X X X X
Maine X
Massachusetts X
New Hampshire X X X
New Jersey X X
New York X X X X X
Pennsylvania X X X
Rhode Island X X X X X
Vermont X
Midwest
Illinois X X X X
Indiana X X X
Iowa X
Kansas X X
Michigan X X X X
Minnesota X X X X
Missouri X X X X X
Nebraska X X X X X
North Dakota X
Ohio X X X X X
South Dakota X X
Wisconsin X
South
Alabama X X X
Arkansas X X X X
Delaware
Dist. of Columbia X
Florida X X X X X
Georgia X X X
Kentucky X X X
Louisiana X X X
Maryland X X X
Mississippi X X X X
North Carolina X X X X X
Oklahoma X X X
South Carolina X X X
Tennessee X X X X
Texas X X X X
Virginia X X
West Virginia X X
West
Alaska X X
Arizona X X X
California X
Colorado X X X X
Hawaii X X
Idaho X
Montana X X
Nevada X X X
New Mexico X
Oregon X X X
Utah X X
Washington X X X
Wyoming X
Source: BJS 1996 National Prisoner Statistics.
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denial about their risk status and, for this and other reasons,
avoid being tested.3   In California, 0.8 percent of voluntarily
tested inmates were HIV seropositive in 1994, while
seroprevalence in a blinded study of incoming inmates the
same year was 2.5 percent.4
There are several possible explanations for the lower HIV-
seropositivity rates commonly found among voluntarily
tested inmates as compared with those from blinded studies
(presented in chapter 1).   One is that many HIV-positive
inmates may already know their status.  In the context of
“voluntary” testing programs, a critical question is how
testing is presented to inmates and whether inmates trust that
the system will maintain their confidentiality and provide
them needed services if they accept testing.5   In Massachu-
setts a program that encourages voluntary testing and offers
state-of-the-art medical treatment for HIV diseases has gen-
erated a sixfold increase in requests for testing.6   However,
HIV-infected inmates may not have this level of trust.  Of
course, there are other possible explanations for inmates
declining to be tested, including fear of discrimination and
mistreatment, facing the consequences of being HIV posi-
tive,  and psychological denial.  All of these issues should
be addressed in educational and counseling sessions.7
Occasions on which testing can be offered include intake
medical screening, HIV/AIDS orientation sessions, and other
education and prevention sessions.  Individual risk assess-
ments and pretest counseling sessions provide other oppor-
tunities to offer and recommend testing. Staff of the Forensic
AIDS Project (FAP) of the San Francisco Department of
Public Health conduct risk-assessment counseling with
inmates in all jails.  This involves individual counseling on
HIV risk behaviors and behavioral risk reduction.  Disclo-
sure counseling, or post-test counseling, is provided to all
tested inmates upon receipt of their results.  In this counsel-
ing, FAP staff focus on the importance of risk reduction
regardless of whether the inmate is positive or negative.  Staff
attempt to help inmates acquire and develop the skills
needed to practice risk reduction when they return to the
community.  HIV-positive inmates are referred to FAP’s
Early Intervention Team for in-jail services and develop-
Table 22.  Summary of HIV-Antibody
Testing Policies
Testing Policy  No.  of Jurisdictions
Upon inmate request 40
Upon clinical indication 38
Upon involvement in incident 24
All incoming inmates 16
High-risk groups 14
All inmates at time of release 4
Random sample 3
All inmates in custody 2
Note: Detail adds to more than 52 because a jurisdiction may have
more than one testing  policy.
Source: BJS 1996 National Prisoner Statistics.
Table 23.  Mutually exclusive
categorization of HIV-antibody testing
policies for incoming inmates, 1997
  State/Federal    City/County
Prison Systems   Jail Systems
      (n = 51)       (n = 41)
Policy   n   % n %
Mandatory 16 31   0 —
Routine   1  2 1   2
Offered 18 35 14 34
On request 16 31 19 46
No policy   0 —   7 17
     Total 51 99* 41 99*
*Due to rounding.
Source:  NIJ/CDC survey.
Table 24.  HIV-antibody testing policies,
1997:  Results of the validation study (VS)
Facilities
Systems in VS in Percentage
Central Office in VS With These in
Testing Policy This Policy Systems Agreement
Mandatory* 6 11 100
Offered 8 23 35
On request 2 6 33
*Screening of all incoming inmates or all releases.
Source:  NIJ/CDC surveys.
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ment of a treatment plan.  All inmates are given materials on
HIV prevention and referred to community-based resources.
In New York State both anonymous and confidential testing
are offered to inmates through the AIDS Institute of the State
health department.  Inmates who receive anonymous testing
also have the option of converting to confidential status so
they can receive services.  Anonymous testing programs may
be affected by the increasing movement to the mandatory
reporting of HIV infection.
Testing of Pregnant Women
Because of the findings of the AIDS Clinical Trials Group
(ACTG) 076 trial that AZT treatment during pregnancy and
delivery  reduces the chances of perinatal HIV transmission
by two-thirds—from the previous 25–30 percent to 8–10
percent8 —early identification and treatment of pregnant
HIV-infected women has become a major focus of testing
policy.  Public Health Service (PHS) guidelines issued in
1995 call for the routine counseling and voluntary testing
of pregnant women as early as possible in their  pregnancies.9
At this writing, the Institute of Medicine is engaged in a
study mandated by the Ryan White Care Act Amendments
of 1996 designed to evaluate State efforts to reduce perinatal
HIV transmission, including efforts to increase the availabil-
ity and acceptance of HIV testing in many settings, such as
correctional facilities.
There are obviously two steps in identifying pregnant HIV-
infected women.  The first is to identify pregnant women and
the second is to determine which are HIV infected.  Thus,
policies for both pregnancy testing and HIV testing are
pertinent. Table 25 shows that less than half of correctional
systems provide routine pregnancy testing of incoming
female inmates, and the vast majority offer pregnancy test-
ing on request.  A summary of HIV-testing policies for
pregnant women, shown in table 26, reveals that mandatory
testing is the most common policy in State/Federal prison
systems (39 percent), and offered testing is most common in
city/county jail systems (51 percent).
The lists of State/Federal prison systems with routine preg-
nancy testing of incoming women and those with mandatory
or routine HIV testing of incoming pregnant women are quite
different.  Thirteen States and the Federal Bureau of Prisons
(FBOP) (27 percent of the total of 51) have both policies (of
these 14, 13 States do mandatory screening of all inmates at
intake; the FBOP does mandatory screening of all inmates
at release).  Nine systems (18 percent) have routine preg-
nancy testing but some form of voluntary HIV testing (all of
these States do all HIV testing on a voluntary or on-request
basis).  Fourteen systems (27 percent) have mandatory or
routine HIV testing of all incoming pregnant inmates but not
routine pregnancy testing (7 of these 14 States have manda-
tory HIV testing of all incoming inmates).  This leaves 14
State systems (27 percent) that have neither policy and rely
on voluntary/on-request testing for both pregnancy and HIV
testing.
Overall, therefore, most systems have the same policy for
HIV testing of pregnant females that they have for HIV
testing of all inmates.  Only seven State systems and the
FBOP have mandatory or routine HIV testing of incoming
Table 26.  HIV-antibody testing for
pregnant female inmates, 1997
  State/Federal    City/County
Prison Systems   Jail Systems
      (n = 51)       (n = 41)
Policy   n   % n %
Mandatory 20 39   1 2
Routine   8  16 6   15
Offered 16 31 21 51
On request 7 14 9 22
No policy   0 —   4 10
     Total 51 100 41 100
Source:  NIJ/CDC survey.
Table 25.  Pregnancy testing for female
inmates, 1997
  State/Federal    City/County
Prison Systems   Jail Systems
      (n = 51)       (n = 41)
Policy   n   % n %
Routine testing
    of all incoming
    women 23 45 12 29
On request  43 84 38 93
Clinical indications 51 100 39 95
Source:  NIJ/CDC survey.
58 1996–1997 Update:  HIV/AIDS, STDs, and TB in Correctional Facilities
pregnant women but voluntary/on-request HIV testing for
other new inmates. Those with voluntary testing conform
with the PHS guidelines recommending that HIV testing of
pregnant women remain voluntary.10   However, the NIJ/
CDC survey data do not reveal whether pregnant inmates in
systems with voluntary HIV testing are being routinely
counseled regarding testing, which PHS also recommends.
Confidentiality and Notification of
HIV Test Results
Confidentiality is an extremely important ingredient in—
some would say prerequisite for—effective HIV diagnosis
and treatment programs.  As noted earlier, people may be
discouraged  from coming forward for voluntary HIV anti-
body testing, and thereby perhaps fail to receive timely
therapeutic intervention, if they fear unauthorized disclo-
sure of their HIV status and attendant discrimination or
mistreatment.  This may be a particularly challenging prob-
lem  in correctional facilities, where confidentiality is more
difficult to maintain and the consequences of breached
confidentiality are more severe.  However, it is possible to
preserve confidentiality in a correctional setting, and many
correctional systems are quite successful in doing so.   Most
of the blatant, systemic violations of confidentiality com-
mon in the earlier days of the epidemic—such as obvious
flagging of medical records and posting or allowing free
access to lists of HIV-infected inmates—have been elimi-
nated.  In an era of triple combination antiretroviral thera-
pies, the most serious threat to confidentiality is the need for
patients on these therapies to “keep on person” or swallow
at a “pill line” large numbers of capsules that the inmate
grapevine easily identifies as HIV medications.  A health
care provider in the Colorado prison system commented on
other continuing challenges of maintaining confidentiality
of inmates’ HIV status and other medical information:
During transport of inmates, the medical charts are
given to the transporting correctional officers in a
container that they are not supposed to open.  If
security requests medical information  (e.g., con-
cern for safety of an inmate during a forced cell
entry) we are supposed to tell them only if there is
or is not a problem that they should be aware of, but
not necessarily the actual disease/reason for con-
cern.  The system works fairly well but it depends
greatly on the individual provider.  Similarly,
security information is relatively inaccessible to
[health care]  providers.  In reality, the barrier is
somewhat porous to information flow in both direc-
tions.11
In general, it is far preferable for policies to specify clearly,
by category of individual, who is to receive notification of
inmates’ HIV status and under what specific circumstances.
Policies providing for disclosure to persons with a “need to
know” should be avoided because the definition of such
persons is almost sure to be a matter of dispute. The Clinical
Director for the Vermont Department of Corrections com-
mented that such “need to know” policies leave “far too
much room for subtle and not-so-subtle pressure to be
exerted on clinical staff by custody supervisors and officers
whose perception of risk is generally much higher than it
actually is.”12
Some States have laws or regulations requiring HIV testing
and the notification of results following incidents involving
the possible occupational transmission of HIV to correc-
tional officers, law enforcement officers, emergency medical
technicians, and other emergency response or health care-
specified workers. In fact, California has a law on the books,
resulting from a referendum, that requires notification to
correctional officers of all HIV-seropositive inmates under
their supervision. The Forensic Services staff of the San
Francisco Department of Public Health reached a compro-
mise with the correctional officers’ union, however, in which
an incident-based testing and notification policy was sub-
stituted for the mandated blanket notification. In Rhode
Island, similarly, a compromise for an incident-based policy
was reached with the correctional officers’ union that has
periodically called for disclosure of the HIV status of all
inmates.
Table 27 summarizes correctional systems’ policies regard-
ing the disclosure of inmates’ HIV-antibody-test results.
Predictably, disclosure to the inmate and the inmate’s at-
tending health care provider is virtually universal, followed
by notification to a public health department.  In recent
months there has been considerable advocacy for and dis-
cussion of expanded reporting to public health departments.
Although at the time of the survey HIV infection was
reportable in only 29 States, 46 State/Federal correctional
systems claimed to be reporting HIV infections to public
health departments.
Only 12 percent of State/Federal systems and 7 percent of
city/county systems reported official policies of notifying
correctional officers of inmates’ HIV test results.  Fewer than
half reported notification to correctional management at the
central-office or institutional levels or to parole agencies.
Finally, policies for notification to victims of sexual or
physical assault and sexual or needle-sharing partners are
also relatively uncommon.  Laws in some States require HIV
testing of persons convicted of (or, in some jurisdictions,
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persons charged with) sexual assault and notification to
victims of the results.
Validation study results (table 28) indicate facilities’ rela-
tively high but not complete compliance with central office
policy to notify correctional management and correctional
officers but poor compliance with policies to notify victims
and sexual or needle-sharing partners.  Central office prohi-
bitions against notification of particular categories of per-
sons are in general more often consistently followed by
facilities.  In particular, 34 facilities in 14 systems were 100
percent in agreement with the central office policies not to
notify correctional officers of inmates’ HIV status.
Table 28.  Notification of HIV-antibody test results, 1997:  Results of the validation study
(VS)
Systems in Facilities Systems in Facilities
VS That From These % in VS That Do From These % in
Person or group Notify Systems in VS Agreement Not Notify Systems in VS Agreement
Inmate 16 40 100 0 — —
Attending health care provider 16 38 95 0 — —
Correctional management 8 14 43 8 25 64
  (central office)
Correctional management 7 14 50 9 25 80
  (institution)
Correctional officers 2 5 60 14 34 100
Public health department 14 35 83 2 4 50
Victims of sexual/physical
  assault by inmate 8 12 33 6 17 76
Spouse/sexual partner(s) 6 15 27 6 12 67
Needle-sharing partner(s) 6 15 27 6 12 83
Source:  NIJ/CDC surveys.
Table 27.  Policies regarding notification of inmates’ HIV-antibody test results, 1997
   State/Federal    City/County
Prison Systems   Jail Systems
        (n = 51)        (n = 41)
Policy to Notify   n   % n %
Inmate 51 100   36 88
Attending health care provider 51 100 33 83
Correctional  management (central office) 21 41 6 15
Correctional management (institution) 19 37 6 15
Correctional officers 6 12 3 7
Public health department 46 90 29 70
Victims of sexual/physical assault by inmate 24 47 10 24
Parole agency 15 29 0 —
Spouse/sexual partner(s) 16 31 6 15
Needle-sharing partner(s) 14 27 4 10
Source:  NIJ/CDC survey.
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STD Screening in Correctional Facilities
Correctional inmates are disproportionately infected with
and at high risk for other sexually transmitted diseases.
Therefore, as with HIV/AIDS, correctional facilities are
promising settings for the diagnosis and treatment of STDs.
Jail-based programs of rapid syphilis screening and treat-
ment funded by CDC have shown promising results.13
Indeed, it is possible that aggressive correctional STD screen-
ing and treatment programs could help reduce community-
wide STD morbidity.14
Table 29 suggests an unrealized opportunity to initiate more
aggressive STD screening and treatment in correctional
facilities.  Almost all State/Federal prison systems have
mandatory or routine syphilis screening for incoming in-
mates, but coverage is much poorer for gonorrhea and
chlamydia.  In city/county systems, mandatory or routine
STD screening is a relatively rare exception. A separate CDC
survey of jails in 1997 also found that few facilities con-
ducted routine STD screening, and those that had such
policies tested fewer than half of the inmates. Few jails
followed CDC’s STD screening and treatment guidelines.15
Conclusion
Most correctional systems in the United States continue to
provide HIV-antibody testing on a voluntary basis for all
categories of inmates, including pregnant women.  Discus-
sion of  mandatory testing is now driven more by the
potential for early medical intervention than by the belief
that primary prevention can be achieved.
Confidentiality of HIV status remains an extremely impor-
tant issue in correctional facilities, as inmates may be dis-
couraged from accepting voluntary testing if they fear the
unauthorized disclosure of their results and the associated
discrimination or mistreatment.  However, correctional sys-
tems appear to be improving their performance in the protec-
tion of inmates’ confidentiality.
Although the treatment implications of STD testing are
relatively simple and straightforward, they are much more
complex for HIV/AIDS. As described in chapter 7,  the new
HIV/AIDS regimens are challenging and complex and often
have significant side effects. Thus, ongoing evaluation of
policies for testing and early detection in light of factors
likely to affect decisions to initiate antiretroviral therapy is
extremely important.
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Chapter 6
Housing and Correctional Management
Theodore M. Hammett and Patricia Harmon—Abt Associates Inc.
Key Findings
This chapter presents findings from the 1997 NIJ/CDC
survey regarding housing policies for inmates with HIV
disease, as well as work assignments, conjugal visits, and
early release programs.  In chapter 7, case management,
discharge planning, and continuity of care are discussed.
Housing Policies for Inmates With
HIV Disease
Correctional housing policies for inmates with HIV disease
have changed dramatically since the beginning of the epi-
demic, with the continuing eclipse of  segregation.  The
changes were particularly pronounced during the period
1985–92.  Table 30 shows that by 1997 only three State
prison systems had policies for segregating all inmates with
confirmed AIDS—Alabama, Mississippi, and California—
down from four in 1994.  In Alabama and Mississippi, the
only two State prison systems that segregated all known
HIV-infected inmates, from the asymptomatic through those
with confirmed AIDS, the segregation is complete.  Inmates
known to have HIV infection and AIDS are totally separated
from the rest of the inmate population residentially and
• Only a small number of correctional systems segregate inmates with HIV disease, and the number of systems
with segregation policies has declined sharply since the late 1980s.
• Some correctional systems still limit the work assignments for which inmates with HIV are eligible.
• Few correctional systems permit conjugal visits for any inmates, and even fewer allow such visits for inmates
with HIV.
• Policies for the early or compassionate release of inmates with terminal illness, including end-stage AIDS,
are quite common, but relatively few inmates are being released under such policies.
Table 30.  Decline of segregation policies
in State/Federal systems (n = 51), 1985–97
      Systems With Segregation Policies for:
 HIV-Infected  Inmates With
Inmates AIDS
   No. of    No. of
 Year Systems    % Systems %
1985 8 16 38 75
1986 8 16 30 59
1987 5 10 41 80
1988 6 12 20 39
1989 4   8 16 31
1990 4   8 9 18
1992–93 2   4 5 10
1994 2   4 4   8
1997 2   4 3  6
Source: NIJ/CDC surveys.
64 1996–1997 Update:  HIV/AIDS, STDs, and TB in Correctional Facilities
programmatically.  Since Alabama and Mississippi have
mandatory HIV-antibody testing of all incoming inmates,
these States probably identify and segregate a large percent-
age of HIV-infected inmates.
In most correctional facilities in California, inmates with
AIDS live separately, but the majority of these inmates go out
into the general population for work assignments, educa-
tional and vocational programs, and other activities.  Several
California facilities do house inmates with AIDS in the
general population.  In all California facilities, inmates with
asymptomatic HIV infection and symptomatic HIV disease
short of an AIDS diagnosis are housed in the general popu-
lation.
In 1998 the South Carolina State correctional system initi-
ated policies of mandatory HIV-antibody testing and assign-
ment of inmates with HIV to one maximum-security facility
regardless of their security classifications.  However, in-
mates with HIV disease are not segregated in this facility.
These changes were prompted primarily by a desire to
identify inmates with HIV in a timely manner so that they
could be offered early-treatment intervention.
Tables 31 and 32 compare  prison and jail systems’ housing
policies for inmates with AIDS and asymptomatic HIV
infection in 1994 and 1997.  The main change in State/
Federal prison systems was the increase in the number of
systems with policies providing for general-population
housing with no restrictions.  These increases came primarily
at the expense of policies for the case-by-case determination
of housing for inmates with confirmed AIDS and of policies
for general-population housing with restrictions for asymp-
tomatic HIV-infected inmates.  Among city/county jail
systems, the number and percentage of systems with policies
for general-population housing without restrictions of in-
mates with asymptomatic HIV infection and AIDS increased
from 1994 to 1997, whereas the number of systems making
housing decisions on a case-by-case basis declined by
similar amounts.  The major policy shift between 1994 and
1997 reversed the trend noted between 1992 and 1994 from
general-population housing policies to case-by-case deter-
mination.
Table 33 represents the results of the validation study
regarding the housing of asymptomatic HIV-infected in-
mates and inmates with AIDS.  Agreement is generally higher
for the blanket policies under which all inmates in the
category are either housed in the general population or
segregated.  Case-by-case policies are inherently more am-
biguous in that they may operationally shade over into
blanket policies.  The converse is also true, which may
Table 31.  State/Federal prison systems’ housing policies for inmates with AIDS and
asymptomatic HIV infection, 1994 and 1997
       State/Federal Prison Systems
             AIDS           Asymptomatic HIV
     1994      1997     1994     1997
Housing Policy n % n % n % n %
General population
     No restrictions 8 16 17 33 28 55 31 61
     With precautions 3 6 1 2 4 8 1 2
Permanently segregated 4 8 3 6 2 4 2 4
Case-by-case determination 36   71 30   59 17 33 17 33
     Total 51         101* 51 100 51 100 51 100
*Due to rounding.
Source: NIJ/CDC surveys.
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Table 33.  Housing of inmates with asymptomatic HIV infection and AIDS:  Results of the
validation study (VS)
 Systems in VS Facilities in VS Percentage in
Central Office Housing Policy With This Policy in These Systems Agreement
Asymptomatic HIV-infected
General population 8 19 79
Segregated 2 2 100
Case-by-case 6 16 25
AIDS
General population 3 7 29
Segregated 3 5 60
Case-by-case determination 10 24 58
Source:  NIJ/CDC surveys.
explain why the agreement rate in systems with central office
policies for general-population housing of inmates with
AIDS was quite low (29 percent).  The divergent facilities all
reported case-by-case housing assignment.
Work Assignments and Other
Programming
The predominance, noted above, of policies for the unre-
stricted housing of inmates with HIV disease offers such
inmates access to all work assignments and other programming.
Table 32.  City/county jail systems’ housing policies for inmates with AIDS and
asymptomatic HIV infection, 1994 and 1997
           City/County Jail Systems
             AIDS           Asymptomatic HIV
     1994      1997     1994     1997
Housing Policy n % n % n % n %
General population
     No restrictions 1 3 10 24 14 48 32 78
     With precautions 0 — 1 2 2 7 0 —
Permanently segregated 0 — 2 5 0 — 2 5
Case-by-case determination 28   97 28   68 13 45 7 17
     Total 29 100 41           99* 29 100 41 100
*Due to rounding.
Source: NIJ/CDC surveys.
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However, the eligibility of HIV-infected inmates for some
program and work assignments remains controversial. In
particular, some correctional systems continue to exclude
HIV-infected inmates from food service jobs. One State
correctional system spokesperson gave the following justi-
fication for this policy: “It’s simply a health and safety issue.
. . . Because people may get cut working in food service, we
consider it prudent and responsible to eliminate the possi-
bility, however slight, of exposing a great number of other
people to the AIDS virus.”
When informed of the CDC’s position that there is no
scientific basis for the exclusion policy, the correctional
spokesperson said that “it’s more a matter of perception than
a health issue. It was a political concession made to the
legislature some years back.”1  These statements exemplify
an important problem. In fact, HIV/AIDS is a health issue, and
policy decisions should be based on accurate health infor-
mation rather than on “perception” or “political conces-
sion.”  Indeed, as in the case of the exclusion of HIV-infected
inmates from food service work, policies without basis in
accurate health information may encourage erroneous and
dangerous perceptions that HIV may be transmitted through
casual contact. Such policies may also undermine the cred-
ibility of education  regarding the true means of HIV trans-
mission. It is very important that policies and educational
messages be consistent.
Conjugal Visits
The number of State/Federal prison systems permitting
conjugal visits dropped from eight in 1994 to six (12
percent) in 1997. Of the six systems permitting conjugal
visits, five allow HIV-infected inmates to have such visits.
All six systems permitting conjugal visits make condoms
available to inmates participating in these visits.
Compassionate Release and
Medical Furlough
With the dramatic advances in treatment for people with
HIV/AIDS, inmate AIDS deaths have declined in many
correctional systems.  Thus, there are generally fewer in-
mates with terminal AIDS who might qualify for early release
or furlough programs.
Nevertheless, inmates continue to die from a variety of
diseases, so policies making it possible for them to die at
home or somewhere other than prison remain important.
Table 34 shows that almost two-thirds (65 percent) of State/
Federal prison systems and almost half (44 percent) of city/
county jail systems permit early/compassionate release based
on either specific written policies or simply practice.  Fewer
systems, about one-third (37 percent) of State/Federal prison
systems and less than one-fifth (17 percent) of city/county
jail systems, permit medical furlough. Table 35 reveals that
12 State/Federal systems granted early/compassionate re-
lease to a total of 143 inmates during 1996, and 8 State/
Federal systems medically furloughed a total of 30 inmates.
Fifteen city/county jail systems granted early release to a
total of 171 inmates, and 3 jail systems furloughed a total of
only 10 inmates in 1996.
Conclusion
Policies of segregating inmates with HIV and AIDS contin-
ued their decline among U.S. correctional systems in 1997,
although the most dramatic reductions occurred between
1985 and 1992.  The unrestricted housing of inmates with
HIV disease generally means that inmates have full access to
work assignments and other programs offered in the facility.
However, some systems exclude inmates with HIV from food
service work assignments, which is problematic in that it
may lead to the erroneous belief that HIV can be transmitted
through food.
Few correctional systems permit conjugal visits for any
inmates, and even fewer permit such visits for inmates with
HIV/AIDS.  Most systems have some form of compassionate
release or medical furlough program on the books, but in fact
relatively few inmates with HIV/AIDS have been released
under such programs.  One reason for this may be the
Table 34.  Compassionate release and
medical furlough, 1997
  State/Federal    City/County
Prison Systems   Jail Systems
       (n = 51)         (n = 41)
Policy   n   % n %
Early/compassionate
    release 33  65 18 44
Medical furlough 19 37 7 17
Source:  NIJ/CDC survey.
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improved medical condition and increasing survival of
patients receiving the new combination antiretroviral thera-
pies.
Table 35.  Inmates receiving compassionate release and medical furlough, 1996
 State/Federal Prison Systems   City/County Jail Systems
  No. of      No.   No. of       No.
Systems Released Systems Released
Compassionate Release
     Released no inmates 14 0 1 0
     Released some inmates 12 143 15 171
     Missing/don’t know 7 — 2 —
     Don’t permit compassionate release 18 0 23 0
     Total 51 143 41 171
Medical Furlough
     Furloughed no inmates 8 0 1 0
     Furloughed some inmates 8 30 3 10
     Missing/don’t know 3 — 3 —
     Don’t permit medical furlough 32 0 34 0
     Total 51 30 41 10
Source:  NIJ/CDC survey.
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Chapter 7
Medical Treatment and a
Continuum of Care
Theodore M. Hammett and Patricia Harmon—Abt Associates Inc.
Key Findings
Inmate populations are disproportionately affected by a
range of health problems, including HIV/AIDS, STDs, TB,
other infectious and chronic diseases, high-risk sexual be-
havior, and substance abuse.  Despite their high levels of
need, however, most inmates have been seriously underserved
in terms of medical care, drug treatment, and psychosocial
services when they arrived at correctional facilities.  Many
have never had regular primary health care or dental care.  In
Connecticut 64 percent of about 200 HIV-infected inmates
reported that they were first offered antiretroviral therapy in
prison.1
Female inmates may have particularly serious health and
psychosocial problems:  higher rates of substance abuse than
male inmates, almost universal histories of sexual and emo-
tional abuse, high rates of homelessness and other housing
problems, and serious child custody and family issues.
Although alcohol and drug use does occur in correctional
facilities, inmates are much more likely to be substance free
while incarcerated than when they were in the community.
In general, there are fewer distractions in prison than on the
street.  Therefore, periods of incarceration, however brief,
• Protease inhibitors and combination therapies have brought dramatic improvements in the medical
condition and survival of people living with HIV, at least over the relatively short term that has been available
for study to date.
• The new therapeutic combinations pose challenges for patient adherence, and failure to adhere consis-
tently to the regimens may have serious public health consequences if drug-resistant strains are transmitted
to others.
• New drugs and reduced dosing currently under study offer hope of more “patient-friendly” regimens.
• Clinicians must work closely with patients to make the best therapeutic decision.
• A continuum of services including early identification, timely and effective treatment, case management,
discharge planning, and community linkages will make for optimal clinical and psychosocial outcomes for
inmates with HIV disease.
• Continuity of care and bridging to community services also contribute to positive patient outcomes.
• Existing program models have not been rigorously evaluated yet probably warrant replication based on
anecdotal evidence.
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offer extremely important opportunities to treat many seri-
ous conditions, to introduce inmates to primary care, and to
provide a wide range of health interventions.
This chapter discusses the availability of new antiretroviral
drugs and combination therapies in correctional settings as
well as the complex issues crucial to the selection and
maintenance of regimens.  It also discusses an ideal con-
tinuum of services for inmates, from screening and identify-
ing health problems to discharge planning and community
linkages.
Medical Treatment for HIV/AIDS
Since 1996 the treatment of HIV/AIDS has been revolution-
ized by the introduction of protease inhibitors and combi-
nation antiretroviral therapy.  However, the average cost of
the new drugs is $12,000 per patient per year.  The
Government’s AIDS Drug Assistance Program (ADAP) is
generally not available to pay for the treatment of State
inmates, but in some States, such as Massachusetts, it may
cover county inmates.
The new HIV therapies appear to offer the possibility of  long-
term delay in HIV disease progression, the long-term reduc-
tion of HIV viral loads to undetectable levels, and conse-
quent prolonged survival with HIV disease.2  There have
already been reductions in the numbers of AIDS deaths, both
in the total U.S. population and in some prison systems,
attributable initially to AZT monotherapy and two-drug
combinations and even more markedly in the last 2 years
following the introduction of protease inhibitors and triple
combination therapy.  A recent study found that the in-
creased intensity of antiretroviral therapy produced in-
creased reductions in morbidity and mortality.3
These new drugs and combination therapies, as well as AZT
therapy for pregnant women, are widely available in correc-
tional systems (table 36). Viral load monitoring, which is
critical to the ongoing assessment of treatment effectiveness
and adjustment of regimens, is not as widely available in
correctional systems (80 percent of State/Federal systems
and 59 percent of city/county systems).
Table 37 presents the results of the validation study regard-
ing the availability of HIV-related therapies and monitoring
methods.  Rates of agreement regarding the availability of
protease inhibitors, combination therapy, bactrim, and CD4
and viral load monitoring are very high.  At the same time,
in the one system whose central office reported that protease
inhibitors and combination therapy were not available, the
one facility in the validation study reported that these
therapies were in fact available there.
Although survey results show the wide availability of thera-
pies, interviews with staff  and prisoner advocates in several
major correctional systems indicate that a combination of
factors—including high medication costs; inmate reluc-
tance to seek testing and treatment based on denial, fear, and/
or mistrust; and uneven clinical competence and lack of
uniform treatment standards—may limit the availability of
appropriate HIV treatment regimens to inmates.4
Clinical trials offer another mechanism for expanded inmate
access to new HIV therapies. A study conducted in 1995
found that 9 of 32 correctional systems surveyed had proce-
dures in place for inmate participation in trials, and 19 others
prohibited inmate participation in clinical research.5  More
recently, according to the 1997 NIJ/CDC survey, 242 in-
mates in 7 State systems were enrolled in trials of anti-HIV
medications.
Table 36.  The availability of HIV therapies
and monitoring, 1997
  State/Federal    City/County
Prison Systems   Jail Systems
     (n = 51)      (n = 41)
Policy     n   % n %
Protease inhibitors 46  90 38 93
Combination therapy 46 90 37 90
    (protease inhibitors
    with antiretrovirals)
Bactrim 50 98 41 100
    (prophylaxis
    for PCP)
AZT for pregnant
    women 47 92 38 93
CD4 monitoring 51 100 38 93
Viral load monitoring 41 80 24 59
Source:  NIJ/CDC survey.
71Medical Treatment and a Continuum of Care
Guidelines for Antiretroviral Therapy
Leading HIV clinicians identify the following key objec-
tives of antiretroviral therapy:
• To achieve maximum durable suppression of HIV viral
replication.
• To preserve optimal immune function.
• To delay development of drug resistance.
• To maximize patient adherence by selecting a tolerable
and understandable regimen.
• To maximize future treatment options in the event of
failure.6
Two complementary sets of guidelines for HIV antiretroviral
therapy have been issued.7 These provide principles and
algorithms for selecting regimens that apply to all persons,
including pregnant women.  These guidelines strongly
recommend aggressive combinations of two nucleoside
reverse transcriptase inhibitors (NRTIs) with a potent pro-
tease inhibitor or,  as a generally less desirable alternative,
one non-nucleoside reverse transcriptase inhibitor (NNRTI)
with two NRTIs.  Combination therapies for pregnant women
must include AZT.8  Combinations of two NRTIs and all
monotherapies are strongly discouraged.  The baseline
measurement and ongoing monitoring of HIV viral load and
CD4 counts at specified intervals are essential.  The combi-
nation of these two measures provides the best assessment of
disease progression and treatment effectiveness.  The state
of the art in HIV treatment continues to evolve.  New drugs
and new combinations, including “protease sparing” regi-
mens, as well as reduced dosing schedules for existing drugs
are also being evaluated. Promising results on some of these
fronts were presented at the 12th World AIDS Conference in
Geneva in July 1998. The hope is that effective but more
“patient-friendly” therapies will be widely available soon.
New guidelines have also been issued for the prevention of
opportunistic infections in persons with HIV disease.9  Johns
Hopkins University conveniently summarized the guide-
lines for  antiretroviral therapy and prevention of opportu-
nistic infections in The Hopkins HIV Report.10
The most dramatic benefit from the new therapies has been
demonstrated most clearly in patients with advanced dis-
ease, whereas the risk-benefit ratio for initiating antiretroviral
therapy in the early stages of HIV disease remains uncertain.
Uncertainty about very early intervention is based on the
relatively slow progression of untreated HIV infection, the
possibly time-limited efficacy of the new therapies, the
evolving knowledge of side effects, the potentially in-
creased problems of adherence in patients who are entirely
asymptomatic,  possible adverse drug interactions, and
potential drug resistance and consequent limits on future
treatment options.11  Nevertheless, as already discussed in
chapter 4 with regard to pregnant women, it is important to
consider policies for HIV counseling and testing—and
particularly how aggressively to recommend testing to
patients who appear to be at high risk—in the context of
developing knowledge about the timing and efficacy of
treatment.
Finally, the emergence of postexposure prophylaxis (PEP)
for HIV infection poses interesting challenges and possibili-
Table 37.  The availability of HIV therapies and monitoring:  Results of the validation  study
(VS)
 Systems in VS Facilities in VS Percentage in
Central Office Policy With This Policy in These Systems Agreement
Protease inhibitors 15 37 84
Combination therapy 15 38 87
(protease inhibitors with antiretrovirals)
Bactrim 16 39 92
(prophylaxis for PCP)
CD4 monitoring 16 39 95
Viral load monitoring 14 34 82
Source:  NIJ/CDC surveys.
72 1996–1997 Update:  HIV/AIDS, STDs, and TB in Correctional Facilities
ties for correctional clinicians and administrators.  The
strategy of administering a course of antiretroviral drugs
immediately after parenteral or cutaneous exposure to HIV-
containing body fluids is already a routinely recommended
practice in health care systems.12  PEP is currently under
study in five U.S. cities in nonoccupational contexts.  In the
correctional setting, such exposure could occur through
consensual or forced sexual intercourse, sharing of drug-
injection or tattooing equipment, or fights among inmates
or between inmates and staff.  Given the prohibited nature of
some of the activities that might prompt an initiation of PEP,
the administrative issues are probably even more challeng-
ing than the clinical issues.
Rapid expansion and frequent change in the best practice
with regard to HIV interventions require that clinicians keep
constantly abreast of new developments and that the appro-
priateness of correctional policies for the clinical manage-
ment of HIV disease undergo continuous evaluation.  Some
of the complex and challenging issues in delivering HIV care
are discussed below.
Selection and Initiation of
Antiretroviral Therapy
In selecting an antiretroviral regimen, it is critical to “get it
right the first time” because failure of the first regimen can
lead to cross-resistance to other drugs of the same class,
which in turn limits future treatment options.  In addition to
proper combinations of drugs for maximum biological effi-
cacy, patient characteristics and environmental factors must
be considered because adherence to regimens is essential to
treatment success with triple combination therapies.  These
complex decisions require knowing the patient, taking and
considering his or her history and prior treatment, under-
standing and considering possible side effects and drug
interactions, and considering patient characteristics and
environmental factors that may affect adherence to a treat-
ment regimen.
Beyond patient-specific costs and the consequences of
treatment failure, the emergence of drug-resistant strains of
HIV, which may be transmitted to others, threatens the larger
public health.  Thus, complex and challenging ethical issues
surround the very decision to initiate antiretroviral therapy.13
These issues may be particularly difficult with regard to the
populations likely to be in correctional facilities—people
with serious substance abuse problems and highly chaotic
and stressful lives.  A clinician’s fundamental ethical obli-
gation is to do what is best for the patient.  Doing what is best
for the patient in terms of treating HIV disease involves
selecting the best treatment regimen from at least three
different perspectives: (1) what will work best biologically;
(2) what will be most tolerable to the patient; and (3) what
will gain maximum patient adherence.  Because these per-
spectives, considered separately, will not always lead to the
same treatment decision, they must be weighed together in
the overall decision regarding a treatment.
One of the most important ways to prevent the development
of drug resistance is to have the patient adhere to the
prescribed regimen.  Interruption of any one of the medica-
tions in a regimen for more than a few days is likely to present
problems and, indeed, may be worse than discontinuing the
entire regimen.
Even substantial adherence may be difficult to achieve
among correctional populations.  However, many of the
antiretroviral regimens are complicated and challenging for
even the most highly organized and motivated patients, in
terms of dosing schedule, number of pills to be taken, and
other requirements (for example, with or without food), as
well as possible side effects.   There may also be the problem
of the continued availability of a regimen in the community,
which could lead to potentially dangerous forced changes
in drug combinations.  Thus, in some cases, and particularly
in jail settings from which most inmates are released very
quickly, clinicians may reluctantly conclude that it would
be more harmful for the patient and for the community to
initiate antiretroviral therapy only to have the patient fail to
adhere to the regimen or be unable to maintain access to the
drugs, perhaps develop serious drug resistance, and transmit
drug-resistant HIV to others.  New and more “patient-friendly”
regimens may help to address these adherence issues.
The Patient-Clinician Relationship
An open, trusting relationship between clinician and patient
is essential to making the best decisions regarding HIV/
AIDS treatment (that is, if at all possible, “getting it right the
first time”) and to maximizing the likelihood that adherence
to the selected regimen will be high both during incarcera-
tion and, even more important, following the inmate’s return
to the community.  The necessary clinician-patient relation-
ship cannot develop from a single, short interview.  Indeed,
the optimum model of care provides for initially intensive
consultation and regular subsequent contact, and for a
continuity of providers both during incarceration and from
the correctional facility to the community.  As described
later in this chapter, some correctional systems have been
able to implement such models of care.
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Female inmates may need even more intensive interaction
with clinicians and even more complete continuity of care.
Research advancing a “relational model” of women’s psy-
chology suggests that women attach more importance to
personal relationships in making key life decisions than do
men. At the same time, the “other-directedness” commonly
observed among women may mean that they resist giving
precedence to caring for themselves,14 and so they might
have difficulty adhering to complicated and demanding
treatment regimens without substantial support.  Clinicians’
experience with HIV-infected female inmates confirms these
observations and indicates that treating women with HIV/
AIDS poses challenges for correctional health care but offers
opportunities for successful clinical and psychosocial outcomes
in the hands of committed providers and administrators.15
Ideally, the clinician and the patient work together to decide
on the best treatment strategy, exploring and considering all
relevant clinical and behavioral factors as well as logistical
issues posed by the correctional setting such as the inmate’s
work, program, and meal schedule.  The provider should
present the options in terms of regimens and methods of
administration available in the facility—for example, the
“keep on person” versus “attending a pill line” approach and
making sure that the patient understands potential threats to
confidentiality and the stigmatization associated with these
methods.
To win the trust of the inmate, the provider should also tell
the whole truth regarding the proposed regimen—dosing
schedule and number of pills to be taken at each time, as well
as possible side effects—and make sure that the patient
understands this information.  For example, if the patient has
not been clearly informed about the number of pills to be
taken, he or she may be surprised at the number and may be
suspicious of being given a dangerous overdose. Such
concerns may be common in the correctional setting, where
inmate mistrust of the “system” and suspicions regarding
medications may be pervasive.
The clinician should emphasize the importance of the
patient’s adherence to the regimen and the likely serious
consequences of nonadherence.  It is important to bear in
mind that one of the few areas over which inmates may exert
control is whether or not to take medications. They may
therefore have psychological impulses to resist adherence.
To address these and other potential issues, the patient’s
“buy-in” to the treatment must be obtained and specific
adherence goals clearly set.
A Continuum of Care for Inmates
An integrated continuum of care with continuity of provid-
ers is the best model for addressing the multiplicity of
medical and psychosocial problems of inmates both within
correctional facilities and following their return to the
community.  Such models are more and more commonly
being implemented for inmates with HIV and AIDS.  How-
ever, they are also needed for inmates with chronic diseases
and other serious medical problems, those with substance
abuse problems, and those who are medically healthy but
behaviorally at risk for HIV/AIDS and STDs.  In short, almost
all inmates could benefit from such services.  Moreover,
comprehensive and integrated services may result in down-
stream savings in costs of treatment and reincarceration if
they offer timely and effective interventions and help to
reduce recidivism.
The key components of this continuum of care include the
following:
• Screening and identification of medical and psychoso-
cial problems.
• Case management.
• Psychosocial support services.
• Hospice care.
• Substance abuse treatment.
• Discharge planning.
• Continuity of care and community linkages.
Examples of programs in prison and jail settings that incor-
porate all or some of these components are presented below.
Screening and Identification of Medical and
Psychosocial Problems
The important relationship between HIV- and STD-testing
policies and timely and effective treatment has already been
discussed.  However, testing is only part of an overall
strategy for identifying inmates’ physical and mental health
problems.  A comprehensive medical and psychosocial
screening should be provided to all inmates as part of the
intake process.  At the Hampden County (Massachusetts)
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Correctional Center, all new inmates receive comprehensive
screening within 10 days of their arrival.  This includes
screening for infectious diseases, chronic noninfectious
diseases, and high-risk behavior such as substance use, high-
risk sexual practices, and violence.  Women are screened for
pregnancy as well as reproductive and gynecologic health
needs.  Registered nurses conduct daily triage in all Hampden
County housing units.  The nurses work closely with security
staff on the units to ensure inmates’ access to care.  The
procedure enables all inmates with a need for medical care
to be seen quickly while also avoiding congestion of the
system with unnecessary visits, as often occurs in a tradi-
tional “sick-call” model.
Case Management
For care to be coordinated and consistently delivered as
prescribed, someone should be in charge of the overall
treatment plan.  In many correctional settings, case managers
play this role, which involves coordination, monitoring, and
patient advocacy.  Case managers are employed primarily
for inmates with HIV/AIDS and other serious medical prob-
lems, but a case management model can be used for preven-
tion as well as treatment.
In response to recommendations from its AIDS Task Force,
the Massachusetts Department of Corrections directed its
health services contractor to add infectious disease case
managers to its staff.  Regional case managers work with all
Massachusetts inmates with HIV/AIDS and other infectious
diseases.  In Hampden County, case managers who are dually
based at the correctional center and the community health
centers work with all inmates with HIV/AIDS and those with
serious mental health problems.
At the Central California Women’s Facility in Chowchilla,
the Henry J. Kaiser Family Foundation and the California
Endowment funded a demonstration case management pro-
gram for female inmates with HIV/AIDS.16  This is presented
as a social rather than a medical model of case management
in which a full-time AIDS case manager is trained to identify
and advocate for the holistic care of inmates’ medical,
mental health, and social problems.  The case manager also
conducts discharge planning with inmates and works to link
them with services in the communities to which they will be
released.  However, this is not, strictly speaking, a continuity
of care model, since the community-based service providers
do not work with the inmates in the facility prior to their
release.  For most inmates, the distances from the facility to
their home communities make such continuity infeasible.
However, even without continuity of care, the Chowchilla
case management program has helped to reduce recidivism
among women with AIDS being released from the facility.  In
the project’s first 21 months, 114 HIV-seropositive inmates
were paroled from Chowchilla, of whom only 19 percent
returned to prison during this study period.  The recidivism
rate among HIV-infected women prior to the program’s
initiation had been 76 percent.17
Psychosocial Support Services
Inmates with HIV/AIDS and other serious medical problems
generally need psychosocial support to cope with their
illness as well as medical care to address their clinical
conditions. Psychosocial services may be offered in a variety
of ways.  Table 38 shows that about two-thirds of prison and
jail systems offer support groups led by AIDS service orga-
nizations.  Less frequently offered are support groups led by
correctional staff or by inmate peer leaders.  At Avoyelles
Correctional Center in Louisiana, the peer-based AIDS
Counseling and Trust program offers support groups for
inmates with AIDS. Individual peer support to inmates with
HIV/AIDS is also provided in some facilities.  At Stateville
Correctional Center in Illinois, a peer educator lives in the
infirmary, where he provides support and medical advocacy
for inmates with HIV/AIDS.  At San Quentin prison in
California, HIV-infected peer educators provide counseling
support to other inmates who have recently been diagnosed
with HIV disease.  The counseling includes discussion of the
meaning of HIV infection, circumstances of the inmate’s
learning of his or her status, his or her current physical and
psychological state, disclosure of status, sexual risk reduc-
tion, and the correctional system’s policies for housing and
treating inmates with HIV/AIDS.
Hospice Care
With the advent of effective new HIV/AIDS therapies and the
resulting decline of AIDS deaths in at least some prison
systems, there may be fewer terminal patients appropriate for
hospice care.  However, these services will still be needed in
some cases.
Several prison systems have established hospice programs
within correctional facilities.  Many of these use inmate
volunteers in key care-giving roles. Some also use
community-based organizations to provide services.18
The first prison hospice in the Nation is at the Federal Bureau
of Prisons’ Medical Center in Springfield, Missouri.  This
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was established through the cooperation of the security and
health care staff, with training provided by community-
based organizations, and with heavy reliance on inmate
volunteers.  The hospice team at Springfield includes a
chaplain and two nurse managers.  There are two 20-bed
wards, one for patients with cancer and the other for AIDS
patients.  The inmate volunteers receive 30 hours of initial
training in counseling and supportive services and subse-
quently participate in twice-monthly training sessions.  The
inmates often become surrogate family members to the
patients and are commonly with them at their deaths.19
In January 1997 a hospice was opened at the Stiles Unit of
the Texas Department of Criminal Justice in Beaumont as a
result of legislation sponsored by State Senator Michael
Moncrief.  Moncrief stated that inmates “have a right to die
with dignity.” The Stiles hospice is “designed to do inside
what a hospice does outside the walls,” that is, to provide care
based on dying patients’ spiritual, psychological, and medi-
cal needs.  Thirty-five trained inmates work in the hospice,
keeping the patients company, reading to them, and writing
letters for them.  One inmate hospice volunteer explained the
importance of his work as follows: “[A] lot of them [the
patients] don’t have nobody.  They are human.  Everybody
has downfalls.”20
Substance Abuse Treatment
Most inmates with HIV/AIDS also have drug or alcohol
problems. Indeed, according to a recent report from the
Center on Addiction and Substance Abuse (CASA) at Co-
lumbia University, almost 80 percent of the more than 1.7
million people incarcerated in U.S. prisons and jails are
seriously involved with drugs and alcohol. In short, as the
CASA report bluntly states, “[S]ubstance abuse and crime
are joined at the hip in America.”21
Despite exploding numbers of incarcerated people, largely
the result of more aggressive drug enforcement beginning in
the early 1980s, and despite the unprecedented opportunity
to provide substance abuse treatment in correctional facili-
ties, treatment within the walls has become less available in
the last few years in terms of treatment slots per inmate.
According to the CASA report, the number of inmates in need
of treatment increased from 688,000 to 840,000 between
1993 and 1996, but the number of inmates in treatment
remained level at about 150,000.  Moreover, much of this
treatment was short term and inadequate to address most
inmates’ deep-seated problems.  Long-term counseling and
residential treatment, such as therapeutic community-model
programs, remain quite rare in correctional facilities.  Even
where they exist, they can accommodate only a small frac-
tion of those who might benefit from them.22
Some evaluations of prison-based drug treatment programs
have shown positive results, but these studies have often
suffered from methodological problems such as lack of
control or comparison groups and flawed measurement of
outcomes.23  Despite these technical problems with the
evaluation of programs, it is clear that treatment does work
for some people in some settings and that inmates and
correctional facilities offer treatment opportunities too im-
portant to miss.  Substance abuse treatment is one of the types
of health interventions in correctional facilities that may
result in downstream savings in the costs of incarceration by
helping to reduce recidivism rates.  Economic benefit would
also accrue in the form of income to newly productive and
employed citizens.  The CASA report estimates the cost of
a year of a comprehensive program of in-prison drug treat-
ment, aftercare, and vocational training at $6,500 per person,
whereas the first-year benefits would be $68,800 per success-
ful inmate, using conservative assumptions.  Thus, even if
only 10 percent of inmates in treatment were successful in
staying sober and employed in the year following their
release, the total cost of inmate drug treatment would be more
than repaid.  Successful treatment of 10 percent of the
estimated 1.2 million inmates who are substance abusers
would bring more than $8.2 billion in total economic benefit
in the first year following their release.  This is more than
$456 million in excess of the total treatment, training, and
aftercare costs for all substance-abusing inmates.24
Table 38.  Psychosocial and supportive
services for inmates with HIV/AIDS, 1997
  State/Federal    City/County
Prison Systems   Jail Systems
     (n = 51)      (n = 41)
Policy     n   % n %
Peer support groups 17  33 2 5
Support groups led 32 63 13 32
    by correctional
    staff
Support groups led 34 67 25 61
    by outside AIDS
    organizations
Source:  NIJ/CDC survey.
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Discharge Planning
Whether they have HIV disease or other serious medical
conditions or not, all inmates can benefit from assistance in
making the difficult transition from a correctional facility to
the community.  Those with health problems need particular
types of assistance and linkages to community-based ser-
vices, but the others will almost certainly need help with
housing, benefits, drug treatment, job training and place-
ment, and child custody and family issues. Community
corrections agencies should be brought into integrated
aftercare programs, perhaps helping to ensure that ex-
offenders with HIV/AIDS obtain their medications and
adhere to their regimens and providing HIV/STD prevention
and risk-reduction counseling to their at-risk clients.
Table 39 summarizes the discharge planning services pro-
vided for inmates with HIV disease, according to the 1997 NIJ/
CDC survey.  Ninety-two percent of State/Federal systems and
76 percent of city/county systems reportedly provide some
discharge planning for inmates with HIV disease.  Specific
types of clinical and psychosocial services covered in dis-
charge planning include enrollment in Medicaid and related
benefit programs, monitoring of CD4 counts and HIV viral
load, access to HIV medications, drug treatment, HIV counsel-
ing, other psychosocial support, and STD services.
Inmates in most State/Federal systems and in some city/
county systems are given referrals for most of these services.
As part of an 11-session health promotion series for HIV-
positive inmates about to be released from San Quentin
prison in California, participants are encouraged and helped
to link up with services in the communities to which they will
return. At Avoyelles Correctional Center in Louisiana, peer
educators from AIDS Counseling and Trust conduct sessions
for all inmates 30 days prior to their release.  At these sessions,
the inmates are given one of nine regional directories provid-
ing contact information for all types of health care and
mental health services, substance abuse programs, benefit
programs, and housing and employment services.  The peer
educators go through the directory with all of the inmates to
make sure that they understand the services available to
them.
As shown in table 39, fewer systems actually make appoint-
ments for inmates to receive these services in the community.
Although good referrals are important, the frequent absence
of appointments and additional support and assistance in
making contact with and keeping appointments for services
means that many released inmates never make contact and
never receive the services they need.  Instead, many quickly
relapse to substance use and crime, often returning yet again
to jail or prison.
Table 39.  Discharge planning services, 1997
Percentage of State/Federal Percentage of City/County
Prison Systems Providing Jail Systems Providing
Services (n = 51) (n = 41)
Discharge planning 92 76
     for HIV+ inmates
Referral Appointment Referral Appointment
Made Made Made Made
Medicaid/related benefits 78 35 56 29
CD4 monitoring 71 24 54 17
Viral load monitoring 61 22 46 20
HIV medications 82 31 66 27
Substance abuse treatment 75 22 63 24
HIV counseling 73 27 61 32
Psychosocial support 73 24 54 27
STD prevention and
    treatment 65 22 46 17
Source: NIJ/CDC survey.
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Improved discharge planning, stronger community link-
ages, and continuity of care between the correctional facility
and the community will help offenders negotiate the treach-
erous postrelease period more successfully and give them a
better chance to make significant positive changes in their
lives, obtain the services they need, reduce their risks of
acquiring or transmitting HIV and STDs, and avoid returning
to crime and incarceration.  In designing programs, it is
essential to bear constantly in mind that issues of HIV/AIDS
prevention and treatment may be only one in a long list of
serious problems faced by ex-offenders being released to the
community.  The immediate problems of housing, food,
employment, and substance abuse treatment are likely to be
more pressing.  Thus, programs must place HIV services in
their appropriate context and seek to help participants
address their immediate survival needs and other ongoing
psychosocial problems.
Several programs that offer comprehensive services bridg-
ing from correctional facilities to the community are de-
scribed below. There are exemplary programs in both State
prisons and county jails. A serious challenge to the success-
ful development of true continuity of service from correc-
tional facility to community is the great distance that often
separates an inmate’s facility from his or her home commu-
nity. This is especially true in large State systems, where
prisons are often in rural areas far from the cities that are home
to most inmates. A possible strategy for solving this problem
is to consider transferring soon-to-be-released inmates to
State or even county facilities closer to home for the last few
months before their release so that they can be linked directly
and personally with service providers in their communities.
Continuity of Care and Community Linkages
Rhode Island program. The first program to provide true
continuity of medical care for people with HIV/AIDS be-
tween the correctional facility and the community was
established in Rhode Island in the late 1980s.  The program
was initiated by Brown University, Miriam Hospital, the
Rhode Island Department of Corrections, and the Rhode
Island Department of Health.  Infectious disease physicians
from Brown and the Miriam Hospital provide care for in-
mates with HIV/AIDS in the correctional facility and con-
tinue caring for them after their release.  The program has
been expanded to include about 40 community-based orga-
nizations and service providers, with comprehensive dis-
charge planning and linkages to community services.25  The
program is now available to both HIV-positive inmates and
high-risk but HIV-negative inmates.  Initial results reveal
reduced recidivism rates among released females who are
associated with participation in the program.26  Dr. Timothy
Flanigan of Miriam Hospital pointed to one of the key factors
in the success of the Rhode Island program: the providers
who will be working with the individuals in the community
come into the prison and work with them there first. Dr.
Flanigan emphasized that simply “giving an inmate a phone
number and a piece of paper doesn’t work.  The inmate needs
to see and meet the person he or she will be working with in
the community.”  This dramatically increases the likelihood
of follow-through after release.  Indeed, the Rhode Island
program has produced sharp increases in adherence to medi-
cal regimens and “show rates” for appointments with service
providers.27
Hampden County (Massachusetts) Correctional Center
(HCCC).  HCCC, in partnership with community health
centers, has developed and implemented a public health
model of correctional health care that incorporates the
following key components:
• Early detection and effective treatment.
• Education and prevention.
• Case management and discharge planning.
• Continuity of care from HCCC to the community.28
The model is also based on an integration of care both
vertically (providing a comprehensive, holistic range of
services) and horizontally (providing a seamless continuity
of care from the facility to the community).  To date the model
has been implemented at a very reasonable cost of about $6
per inmate day within a health services budget representing
only 9 percent of the entire facility’s.29
Based on ZIP Code of residence, patients with HIV/AIDS and
other serious medical and mental health conditions are
assigned to four dually based health teams who work in the
correctional center and in four community health centers.
Eighty percent of the inmates come from the catchment areas
of these four community health centers, and, on an average
day, 1.5 percent of the populations of these catchment areas
are incarcerated at HCCC.
Case management and discharge planning are currently
provided by dually based case managers for all inmates with
HIV/AIDS and serious mental health issues.  A discharge
planning nurse at HCCC provides similar services for in-
mates with chronic diseases.  Discharge planning helps to
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ensure continuity of care and community linkages with
appropriate health providers.  In 1997, more than 70 percent
of persons with HIV/AIDS released from HCCC kept their
first appointments at their assigned community health cen-
ter.  Releasees are also linked with community-based agen-
cies that can address issues of family reintegration, housing,
employment training and readiness, and benefit programs.
All of these linkages have contributed to lower recidivism
rates among people with HIV/AIDS released from HCCC
with a linkage to Brightwood Health Center (46 percent over
one year) versus the overall population of HCCC releasees
(72 percent).  This is not a perfect comparison for evaluation
purposes but it may be suggestive of the program’s efficacy.
Additional evaluation of this and similar programs is needed.
Continuity of care between the facility and the community
for patients with HIV/AIDS, chronic diseases, and other
serious conditions is a hallmark of the model.  This horizon-
tal integration of care is strongly fostered by discharge
planning and by the well-developed partnerships among the
correctional center, the community health centers, and other
community-based providers.  The HCCC’s partnerships
with the community health centers have helped to promote
an integration of community-based health services in Greater
Springfield.
The Hampden County program serves a compact metropoli-
tan area with a population of about 500,000 in which
distances are short enough to make real continuity of care
possible. Because 80 percent of the metropolitan areas in the
United States have populations in this range—between
100,000 and 1 million—the Hampden County model should
be replicable in many other places.  Indeed, the Massachu-
setts Department of Public Health intends to fund similarly
constituted comprehensive HIV/AIDS care programs in all
of the State’s county facilities.30
ETHICS Unit. In New York City, the Nation’s largest
metropolitan area, the ETHICS Unit provides discharge
planning and comprehensive transitional services for in-
mates with HIV disease being released from Rikers Island
and New York State prisons.31  The ETHICS Unit is a program
of the Fortune Society, an organization founded by ex-
offenders in 1977 to help ex-offenders make better transi-
tions to the community, and is funded as a Special Program
of National Significance by the U.S. Health Resources and
Services Administration, with additional funding from the
New York City Department of Health.
Currently, five caseworkers and six peer counselors work in
the ETHICS Unit. Most of them are ex-offenders and/or
recovering addicts.  One caseworker does all of the outreach
and discharge planning at Rikers Island and the State prisons
as well as the remaining casework staff work with clients in
the community following their release from prison or jail.
The individual caseworkers have developed specialties and
extensive contacts in housing, hospital care, substance
abuse treatment, and benefits eligibility.
The peer counselors assist with outreach, meet new clients
when they are released, and escort them to appointments
with service providers.  The peer counselors also provide
informal counseling in the office where clients often come
to receive support or just “hang out.”
The ETHICS Unit has an open-door policy.  Clients are
always welcome in the office.  They can take advantage of
the educational, vocational, and other programs available at
the Fortune Society.
The ETHICS Unit establishes relationships with its clients
on a voluntary basis.  The program does not accept “man-
dates” from probation or parole and will not provide infor-
mation on its clients to these authorities except general
reports on attendance, and then only if the staff member feels
comfortable with the particular parole or probation officer.
The program does not divulge information on drug use.
ETHICS Unit staff recruit clients through regular outreach
visits to Rikers Island and to various New York State prisons.
The site visit conducted for this study included observation
of an outreach session in a Rikers Island unit housing and
treating inmates with HIV disease. Because the session
clearly and powerfully illustrates the challenges posed and
the opportunities offered by these types of programs, it is
worth describing it in some detail.
The first priority when ETHICS begins to work with an ex-
offender is to help him or her achieve basic stability.  This
often means meeting clients at the jail, prison, or bus terminal
to help them get through the first hours, when the temptation
to relapse is particularly severe.  The caseworkers find the
person a place to stay and, if appropriate, help arrange
medical care.  Goals, objectives, and a treatment plan are
worked out with the client.  The caseworkers try to act as role
models—demonstrating that it is possible to change one’s
life for the better—and to provide a positive and positively
structured social network, but they avoid setting unreason-
ably high expectations.  “We don’t try to move too fast,” a
caseworker reported.  They focus on getting the client
stabilized and housed and then move on to employment
issues.
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An ETHICS Outreach Session at Rikers Island
William Whitaker, a 41-year-old African American,32 grew up in “the system,” entering the Spofford Youth Center at age
12, “graduating” to Rikers Island at 16, and then doing stretches for felonies in several facilities “upstate.”  After he was
released from prison 6 years ago, he decided to change his life so that he would never be sent back.  He got sober
and has stayed sober.  Referred to the Fortune Society by his parole officer, Whitaker started as a client and then
volunteered for several years before becoming a caseworker.  He is driven to offer others the gift of new life he received
through his own efforts and with the support of the Fortune Society.  Whitaker describes looking down from the DOC
bus on the way to Rikers and fixing his eyes on the driver of a car, wishing  he was on that journey rather than on his
way to jail.  Now, Whitaker says, the people on the bus to Rikers are looking down at him, and he wants to help as many
as he can to get off that seemingly endless bus trip and onto the journey to a new life.
Nanci Ryan, a 35-year-old white woman, grew up in a family where it was “funny” to get a 6-year-old child drunk, and
it was evidence of “love” when her parents beat each other up.  She began drinking early and turned to increasingly
serious drug use, prostitution, and crime.  Ryan also passed through the juvenile system, was a frequent inmate at
Rikers, and served time at Taconic and Bedford Hills State prisons.  She has three felony convictions and is HIV positive.
Ryan, too, made it to the Fortune Society as a client, got sober and stable, and became a peer counselor for the ETHICS
Unit.  Ryan displays the same intensity of purpose as Whitaker.
Whitaker and Ryan work as a team, doing outreach for the Fortune Society’s ETHICS Unit at Rikers and at State prisons.
Their session in Ward 4 of North Infirmary Command began slowly.  The patients, prodded to attend,  paid slight attention
when Whitaker began his presentation as the TV blared in the corner.  Whitaker turned down the TV and told his story:
“Look at me,” he said.  “I’ve been here . . . I know what it’s like . . . I got through it . . . I’m sober . . . I have a job and a
place to live . . . I’m here to tell you about a program that will help you if you make the commitment to change. . . . Call
me . . .  I’ll stay with you; I won’t let you fall. . . . It can happen. . . .There is hope. . . . I’m living proof.” A few inmates started
to pay attention.  Whitaker  encouraged the inmates to participate in a short intake interview and to begin thinking about
what they’ll do when they get out.  “We can help you make a discharge plan and help you live up to it. . . .The decision
is yours.”
One inmate spoke up: “This is all b------t . . . I’m in here for something I didn’t do. . . .  The police planted a bag of dust
on me.”  Once a con, there’s no hope of getting out of it, he said.  He slouched in his chair, angry and brooding.  “Wait
a minute,” Whitaker said, “I want to talk to you,” and he walked toward him.  Then he presented the essence of his
message:  “Sure, the system is bad, but you can’t do anything to change it; you can only make the decision to change
your own life and I can help you once you do that. . .  It’s up to you. . .  There will always be a bed for you here at Rikers
Island. Do you want to find yourself a better bed outside this place?” The inmate began grudgingly to listen.  Whitaker
talked privately with him for a while; the inmate agreed to call him—“Sure I will,” he said. (Later, I asked Whitaker whether
he thought the inmate would really call him. “Maybe,” he said. “I know he was listening; I’ll keep working on him.”)  “Can
a person with felony convictions get a job?” another inmate asked. “Yes,” replied Whitaker, “I have felonies and I have
a job.”
Nanci Ryan also told her story in language the inmates could understand.  “I thought I was hopeless . . . I thought it was
God’s plan for me to be a junkie.”  With tears in her eyes, Ryan talked about the friends she made in prison and on the
street who have died of AIDS or drug addiction or gunshot wounds because they weren’t able to make the choice for
their own lives or make it in time.  She also talked of those, like herself, who had made that choice and were trying to
maintain it day by day.  Her passion for the cause was clear, particularly when she told the inmates that by staying in
the cycle of drugs, crime, and incarceration, they were only fulfilling, and helping to perpetuate, society’s expectations
for them.  “Why not prove society wrong?. . . You can do it. . .  We’re here to help you.” About half of the inmates who
attended the outreach session that day completed the intake interview for Fortune’s ETHICS Unit.  It is only a first step.
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ETHICS staff report that housing and medical care are the
most critical and difficult-to-arrange services for their cli-
ents, many of whom are homeless when they are released.
Ironically, the task is simpler if the client has AIDS.  These
clients qualify for a number of housing, treatment, and
medication programs.  However, those who are asymptom-
atic or have symptomatic non-AIDS are much more difficult
to place.  Dually or triply diagnosed individuals are also very
hard to place.  These categories of clients are more likely to
end up in single residence occupancy (SRO) apartments or
in the shelter system, where the temptations to return to drug
use and crime are virtually irresistible.  The old coping skills
(getting high) are harder to avoid in the horrendous condi-
tions of the shelters, and many of the SROs are essentially
shooting galleries with around-the-clock drug activity.  Even
in the face of these challenges, the ETHICS staff are persis-
tent.  As noted, the caseworkers have developed specialties
and identified many little-known referral resources.
Although no formal evaluation of the program has been
done, the ETHICS Unit director reports that hundreds of
clients have succeeded in turning their lives around with the
help of the program.  Many clients go on to become peer
counselors, and some become paid staff members of the
program.
A group of ETHICS clients expressed uniformly positive
feelings about the program during the site visit conducted
for this study.  One client remarked that the ETHICS Unit had
helped her to come to terms with, and accept, her HIV disease.
“I’m not so afraid of it,” she said, “there’s no more blaming.
I look at what I did to put myself in this situation and move
on from there.”
Many of the clients feel that the program is their home and
the staff is their family.  This feeling was clearly reflected in
an emotional “Celebration of Life” that was held during a
site visit conducted for this study.  This celebration honored
16 clients who had “completed” the program to the extent
that they are drug free, have stable housing, and are follow-
ing their treatment plans.  The clients told their stories: they
are people who seemingly had no hope but who have been
able to achieve remarkable transformations in their lives
with the help of the ETHICS Unit.  They have gotten sober
and stayed sober, developed a positive social network,
found inspirational role models, found stable housing, ac-
quired job skills, and are firmly committed to finding regular
employment.  Many of the clients had found a spiritual basis
for their lives and the changes they had achieved.  They
spoke openly of how their religious faith, as well as the
support of ETHICS, had seen them through the hard times to
lives of brighter possibility.  Clients and staff expressed great
affection for one another; strong and lasting bonds had
clearly developed.  This is where the clients come for support
and encouragement, and they receive it in full measure.  The
celebration also honored several people from community-
based organizations and the community at large who had
supported and assisted ETHICS clients.
The decision to include a client in the “Celebration of Life”
is made jointly by the client and his or her caseworker.  This
milestone can be reached after 6 months to 2 years of
enrollment in the program.  The unit resists referring to the
“Celebration of Life” as a “graduation” because this would
imply completion and separation when it is but part of an
ongoing process and clients are encouraged to stay in touch
and stay involved in the program after the ceremony.
Health-Link.  Another program in New York City, Health-
Link, works with women and adolescents who are being
released from Rikers Island to the South Bronx or Central
Harlem and who have substance abuse problems and are at
risk for HIV/AIDS.33  People with HIV disease are also
eligible.  Health-Link provides educational and commu-
nity-based supportive services to help women and adoles-
cents make better transitions to the community.  The pro-
gram has been operated by the Hunter College Center on
AIDS, Drugs, and Community Health since 1992, with
funding from the Robert Wood Johnson Foundation (RWJF).
In phase 3 of Health-Link, which began in 1997, the Fortune
Society is providing all case management services in jail and
in the community.  The Health-Link staff includes 10 full-
time equivalent case managers, 1 casework supervisor, and
1 casework coordinator.
Health-Link offers a structured and comprehensive program
beginning with empowerment groups for women and ado-
lescents at Rikers Island, linkages with a large network of
community-based services in the South Bronx and Central
Harlem, and case management with continuity of care—that
is, the same case manager who works with the individual in
jail continues to work with the individual in the community.
The network of community-based providers, assembled in a
Community Coordinating Council (CCC) that also includes
the Department of Corrections (DOC), offers a comprehen-
sive array of services designed to help ex-offenders make
successful transitions to the community.  These include
educational, vocational, employment, housing, substance
abuse treatment, HIV/AIDS prevention, and health care
services.  It is a holistic approach, in which clients are
encouraged to analyze critically their life experiences and
make their own decisions about where they want to go with
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their lives and how they can get there.  A rigorous evaluation
of Health-Link employing a randomized design is being
carried out.
The program maintains a careful balance between emphasiz-
ing individual responsibility and its philosophy of provid-
ing comprehensive social support.  All clients are required
to work with their case manager to develop a discharge plan
(including commitment to a primary community placement)
and to sign a contract to abide by it. Case management
services are provided for 1 year following discharge.  In most
instances clients are escorted to their community placement.
They are expected to meet with their case managers several
times a week during the first 10 weeks following discharge.
The number of meetings tapers off subsequently, depending
on caseloads and client needs.
The relationship between Health-Link and its clients is
voluntary; that is, participation in the program is not a formal
alternative to incarceration or condition of probation or
parole.  However, Health-Link staff realized that they could
not treat the relationship with clients as if the criminal justice
nexus did not exist.  Therefore, Health-Link staff do work
with their clients and serve as advocates with the probation
and parole authorities.
Health-Link clients are recruited through empowerment
groups at the women’s and adolescent facilities at Rikers
Island.  Case managers lead the groups in teams of two; those
recruited to the case management component will be as-
signed to one of these case managers but will also know
another person to contact if the primary case manager is not
available.
To be eligible for enrollment in the Health-Link case man-
agement program, an inmate must have less than 1 year to
serve before his or her release.  Adult women must have
attended three empowerment group meetings; because of
generally shorter lengths of stay, adolescents must attend
two group meetings to be eligible for case management.  All
clients must sign a discharge plan contract.  They must also
agree to receive services in the South Bronx or Central
Harlem neighborhoods, although they need not live in these
neighborhoods.  Many of the program’s clients were home-
less when they were sent to jail.
An extremely important facet of the Health-Link program is
the mobilization of community-based providers to meet the
needs of ex-offenders as they return to the community.  The
CCC of Health-Link now comprises an array of about 40
organizations in the South Bronx and Central Harlem.  The
CCC meets each month, with the meeting place rotating
among organizations so that participants can take a closer
look at the settings and services of member organizations.
Each meeting is chaired by a representative of the host
organization.
There are various relations between Health-Link and CBOs.
One important facet is that Health-Link helps build the
capacity of CBOs to serve ex-offenders by raising the orga-
nizations’ level of knowledge and sensitivity regarding the
needs of ex-offenders. For example, ex-offenders may con-
sider highly structured and regimented drug-treatment pro-
grams to be too much like jail, so programs may need to be
a bit more flexible and nonregimented, bearing in mind that
ex-offenders tend to do best in fairly structured situations.
Health-Link also advocates for more attention to the particu-
lar needs of women in substance abuse treatment programs
—for example, for child care services.
The DOC is also represented on the CCC of Health-Link.
This involvement offers good opportunities to establish and
strengthen lines of communication and coordination be-
tween CBOs and the DOC, as well as for the CBOs and the
DOC to “educate” each other about their respective needs,
roles, and concerns.  As a result of their involvement in the
CCC, more CBOs have been able to provide services in, and
receive referrals from, Rikers Island.
The planned enrollment for Health-Link in phase 3 is 92
women and 92 adolescents in the first year and 115 in each
group in the second year.  This is, of course, far short of the
need for such services.  Indeed, discharge planning at Rikers
Island and other New York City facilities is currently very
much a “hit or miss” proposition.  In part because of rapid
turnover and short lengths of stay, many inmates receive no
discharge planning—they are simply turned loose to fend
for themselves.  Many of them are homeless and have
substance abuse and/or mental health problems.  With these
problems, and with no transitional help, they are almost
guaranteed to return to jail.  Health-Link wants to make
discharge planning an integral part of services for all in-
mates, arguing that this is likely to be very cost-effective in
terms of reduced recidivism.  The New York City DOC has
established a committee to work toward the “institutional-
ization” of discharge planning.
As previously discussed, inmates who are not infected with
HIV but are behaviorally at high risk of becoming infected
are probably as much in need of discharge planning, transi-
tional assistance, and continuity of service from jail or prison
to the community as are those with HIV disease.  However,
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there are still relatively few programs available to the high-
risk uninfected.  The Rhode Island program and Health-
Link, already described, are open to the uninfected.  Two
programs in Massachusetts county jails specifically target
this group.
Search Out Another Road (SOAR).  SOAR, a “reintegration
program” of the South Shore AIDS Project in Brockton,
Massachusetts, works with inmates about to be released from
the Plymouth, Barnstable, and Bristol County jails.34  The
SOAR reintegration counselor leads an eight-session course
encouraging participants to reflect upon their lives and to
focus on realistic behavioral changes.  Following release,
participants meet with the same counselor once a month for
at least 6 months to assess issues of work, addiction, and risk
reduction.  The SOAR program works to place releasees in
residential drug treatment or intensive outpatient treatment.
After-Incarceration Support Systems (AISS).  AISS, in
Hampden County, Massachusetts, provides transitional as-
sistance to inmates without serious medical problems.35  A
resource room has been established at the correctional center
where inmates may view and explore a range of materials and
computer databases.  These cover resources and referrals in
education, job training, job readiness, health services,
housing, substance abuse prevention and treatment, family
counseling, stress reduction, violence prevention, and
leisure activities.  Counseling is available for participants
before they are released, and support groups are offered in the
community for participants who have been released.
Conclusion
New drugs and combination therapies have brought dra-
matic improvements to HIV/AIDS care but also pose chal-
lenges for implementation, which may be especially diffi-
cult for correctional inmate populations. However, new and
more “patient-friendly” regimens offer the hope of address-
ing these challenges.  In any event, clinicians must work
closely with patients to make decisions regarding treatment
regimens that consider efficacy as well as maximum likely
adherence, particularly following release from incarcera-
tion.  Nonadherence may mean not only treatment failure for
the patient but also danger for the larger public health in
terms of the development and transmission of drug-resistant
strains of HIV.
Inmates with HIV, STDs, and other medical and psychoso-
cial problems will benefit from a continuum of care that
includes early detection, effective treatment, case manage-
ment, psychosocial services, hospice care when appropriate,
substance abuse treatment, discharge planning, and linkage
to community-based services.  Continuity of care and bridg-
ing to the community are particularly important for the
maintenance of adherence to HIV/AIDS treatment regimens.
This chapter has described extremely promising approaches
to providing this continuum and continuity of care, includ-
ing programs in Rhode Island; Hampden County, Massa-
chusetts; New York City; and California.  Although there is
a need for a more systematic evaluation of these programs
and approaches, preliminary data indicate that they may be
cost-effective in terms of promoting positive transitions to
the community, reducing recidivism, and producing down-
stream savings in costs of treatment and reincarceration.  The
available evidence suggests that these program approaches
deserve widespread replication.
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Chapter 8
Tuberculosis
Theodore M. Hammett and Patricia Harmon—Abt Associates Inc.
Key Findings
• In recent years there have been declines in the incidence of TB disease both in the overall U.S. population
and among correctional inmates, although its incidence remains much higher among inmates.
• Most State/Federal prison systems appear to be following CDC guidelines regarding TB screening, isolation
and treatment, and preventive therapy, whereas city/county jail systems are less adherent to CDC guidelines.
• However, better collection and reporting of screening data would help to document the burden of TB infection
and disease among inmates.
• Improvements are also needed in the use of directly observed therapy and directly observed treatment of
tuberculous infection, as well as in postrelease adherence to TB treatment and preventive therapy.
This chapter summarizes available statistics on tuberculosis
(TB) disease and infection among inmates and describes
correctional policies regarding the screening of inmates and
staff, management of suspected and confirmed TB disease,
preventive therapy, discharge planning, and education.
Tuberculosis Disease and Infection
Concurrent with the rapid increase of the HIV epidemic and
facilitated by the prior dismantling of tuberculosis control
programs and increased immigration from areas of high TB
prevalence, there was a resurgence of TB disease in the
United States in the late 1980s and early 1990s.  However,
CDC surveillance data reveal that the incidence of TB
disease has dropped off again in recent years as control
measures have been rapidly reinstituted.1
The incidence of TB disease among inmates has followed a
similar pattern since the late 1980s but with much higher
rates than in the total population.  Since 1993, the CDC case
report form for TB disease has included a question as to
whether the person was a resident of a correctional facility
at the time of diagnosis.  This enables CDC to provide fairly
complete surveillance statistics on TB disease in correc-
tional facilities.  The numbers of new cases among correc-
tional inmates declined from 1,065 in 1994 to 729 in 1997,
the latest year for which data are available.  In 1997, inmate
cases represented 3.7 percent of the total in the U.S. popula-
tion.2
New TB cases and incidence rates among inmates in New
York State, where a serious outbreak of multidrug-resistant
TB occurred in 1991, also declined from 1991 through 1997,
as shown in Figure 1.  A new and aggressive policy for
screening inmates and staff, initiating and completing pre-
ventive therapy, and managing cases of TB disease was
probably responsible in large measure for this decline.
However, the incidence of TB disease among New York State
inmates in 1997, about 30 cases per 100,000, was still much
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higher than the 13 per 100,000 found in the total population
of the State.3
Data on new cases of TB disease among inmates from the NIJ/
CDC surveys in 1994 and 1997 are remarkably similar to the
statistics reported by CDC—768 cases under treatment  in
1997 and 919 cases in 1994.  However, reporting to the NIJ/
CDC survey on TB disease was very incomplete, with almost
one-third of State/Federal systems and 12 percent of city/
county systems in the survey not providing this information
(table 40).  This indicates that CDC surveillance data may
undercount the actual incidence of TB disease among in-
mates.  The correctional systems participating in the 1997
NIJ/CDC survey also reported 64 cases of drug-resistant TB
among inmates.
Data on TB infection reported to the 1997 NIJ/CDC survey,
indicated by a positive result on a purified protein derivative
(PPD) skin test, were also incomplete, as shown in table 41.
More than half of the State/Federal systems and more than
a third of city/county systems failed to report numbers of
PPD-positive inmates.  Among those reporting, six systems
had PPD positivity rates of 10 percent or higher among
inmates over the preceding 12 months.  Altogether, 24 State/
Federal systems and 25 city/county systems reported more
than 45,000 positive PPDs in the 12 months prior to the
survey.
Correctional employees may be at risk of contracting TB
infection and TB disease, depending on the control mea-
sures in place.  One correctional officer died during the
multidrug-resistant TB outbreak in New York State, and
correctional staff and unions in many jurisdictions have
been active in demanding more aggressive control mea-
sures. According to CDC surveillance data, approximately
18 correctional staff were diagnosed with TB disease during
1997, although it is not known how many of these cases
resulted from occupational exposure.4  Among New York
State correctional staff, occupational exposure to TB reached
a peak in 1992 and has declined since.
In 1992, one-third of all 466 PPD skin-test conversions
identified among New York State prison employees were
attributed to occupational exposure.  Higher odds ratios for
PPD conversion related to occupational exposure were
found in the prisons with known inmate TB cases and in the
categories of correctional employees likely to be in direct
contact with inmates.5
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The Role of Policy Change
Although tuberculosis is an airborne infection, its transmis-
sion can be well controlled through aggressive implemen-
tation of screening and disease management policies. The
declining incidence of TB in New York prisons since the
1991 outbreak is clearly related to the institution of manda-
tory intake and subsequent annual PPD screening of inmates
and staff, as well as universal directly observed therapy for
TB disease and treatment of TB infection and strict isolation
of persons with known or suspected infectious TB. The New
York State policy represents a good model for the control and
management of TB in the correctional setting.6
Table 40.  Active TB disease among inmates, 1997
State/Federal Prison Systems     City/County Jail Systems
(n = 51) (n = 41)
  No. of No. of  No. of No. of
Inmates Under Treatment Systems % Cases Systems % Cases
0 12 24  — 13 32   —
1–10 15 29 52 17 41 51
11–50   5 10   94   4 10 117
51–100   1   2   74   2 51 33
>100   2   4 247   0 — —
Did not report 16 31 —   5   12  —
     Total 51 100 467  41 100 301
Drug-resistant TB cases 35 29
(7%) (10%)
Source:  NIJ/CDC surveys.
Table 41.  TB infection among inmates, 1997
State/Federal Prison Systems     City/County Jail Systems
(n = 51) (n = 41)
  No. of No. of  No. of No. of
Percentage With Positive PPD Systems % Cases Systems % Cases
<5 20 39  6,512   9   22   6,117
5–9.99   3   6 7,200 11   27  8,162
10–20   1   2 1,283   5   12 16,165
>20   0 — —   0   — —
Did not report 27 53 — 16   39 —
     Total 51 100 15,033 41 100 30,539
Source:  NIJ/CDC surveys.
88 1996–1997 Update:  HIV/AIDS, STDs, and TB in Correctional Facilities
In 1996, CDC issued revised guidelines for the prevention
and control of TB in correctional facilities.7  These guide-
lines focus on three critical areas of activity:  (1) screening—
identifying persons with TB infection and TB disease; (2)
containment—preventing transmission of TB and provid-
ing adequate treatment to patients with TB disease and latent
TB infection; and (3) assessment—monitoring and evaluat-
ing screening and containment efforts.  Screening for TB
symptoms is the first line of defense, which CDC recom-
mends be done as soon as possible after intake for inmates
in all types of correctional facilities.  Anyone with symptoms
of TB disease should be immediately isolated, evaluated,
and treated as appropriate.  Inmates in long-term correctional
facilities should be mandatorily screened for TB infection
(using the PPD skin test) at intake and on an annual basis
thereafter.  Those with positive PPDs and those with or at risk
for HIV infection, regardless of the PPD result, should receive
a chest radiograph and medical evaluation.  Inmates who fall
into various risk categories for TB disease listed in the CDC
guidelines should be considered for treatment of tubercu-
lous infection.
The CDC guidelines call for TB symptom screening of
inmates in short-term facilities as soon as possible following
entry.  However, CDC acknowledges that PPD screening
may be infeasible in short-term facilities because most
inmates are released before a PPD can be read.  Larger
facilities serving populations at high risk for TB should
consider minifilm x-ray screening of all incoming inmates
for TB disease.  The cost-effectiveness of minifilm screening
depends on the rates of TB infection in the population being
screened. In short-term facilities serving populations gener-
ally at low risk for TB, further screening beyond initial
symptom screening should depend on an ongoing assess-
ment of the risk level of the population and the potential for
exposure within the facility.
CDC also recommends mandatory PPD screening of correc-
tional employees at hiring and at annual intervals thereafter.
CDC’s recommended strategies for containment include
immediate isolation in negative-pressure rooms of all per-
sons with suspected or confirmed TB disease.  If active TB
is confirmed, isolation should continue until the patient is
receiving effective treatment, improving clinically, and has
three consecutive negative sputum smears collected on
different days.  The recommended initial treatment for TB
disease in most patients is four drugs:  isoniazid (INH),
rifampin (RMP), pyrazinamide (PZA), and either ethambu-
tol (EMB) or streptomycin (SM).
CDC recommends evaluating all PPD-positive individuals
and HIV-seropositive but PPD-negative persons for treat-
ment of tuberculous infection with INH. Individuals with
various risk factors for TB disease should be treated for latent
infection.  Treatment of latent infection should be a 6- to 12-
month course of INH.  Both treatment for TB disease and
treatment of TB infection should be directly observed for all
patients.
Screening
Table 42 summarizes screening policies for TB disease and
TB infection reported to the 1997 NIJ/CDC survey.  This
shows that almost three-fourths of systems are following the
CDC recommendation regarding screening for TB disease.
More than 90 percent of State/Federal systems have manda-
tory PPD screening for inmates at intake and annually
thereafter.  These systems include primarily long-term facili-
ties and thus conform with CDC recommendations.  The
validation study revealed that in 15 State/Federal systems
with policies for mandatory PPD screening of incoming
inmates, 97 percent of facilities reported this policy as well.
Only about half of city/county jail systems, which operate
primarily short-term facilities, require PPD screening of
inmates at intake.  Ten percent of city/county jail systems
reported screening for TB disease by minifilm x ray.
Table 42.  Screening inmates for TB, 1997
  State/Federal    City/County
Prison Systems   Jail Systems
     (n = 51)      (n = 41)
Screening Policy n   % n %
All incoming inmates
    screened for TB
    disease 37 73 30 73
All incoming inmates
    screened for TB
    infection (mandatory) 46 92 21 51
All inmates screened
    at regular intervals
    for TB infection
    (mandatory) 43 91 17 41
Source:  NIJ/CDC survey.
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The vast majority of correctional systems reported screening
employees for TB infection.  Ninety percent of State/Federal
systems and 97 percent of city/county systems reported
mandatory PPD screening of all new employees, and 79
percent of State/Federal systems and 76 percent of city/
county systems reported mandatory screening of staff at
specified intervals during their employment.
Containment
Critical components of a strategy to contain TB are the
isolation of patients with suspected or confirmed TB disease,
proper treatment of TB disease, and treatment of TB infec-
tion.  The vast majority of systems—98 percent of State/
Federal systems and 85 percent of city/county systems—
reported isolating inmates with suspected or confirmed TB
disease in negative pressure rooms.  Eighty-four percent of
State/Federal systems and 74 percent of city/county systems
reported policies for the duration of isolation that conformed
to the CDC guideline of three consecutive negative sputum
smears, although the other details of these policies often
differed from the precise CDC recommendations.
Seventy-one percent of State/Federal systems and 67 per-
cent of city/county systems reported conformity with CDC’s
recommendation of a four-drug initial therapy for TB dis-
ease.  The validation study found that in 13 systems whose
central office policy calls for the recommended four-drug
initial regimen, 76 percent of the 29 facilities reported the
same policy.  Most systems reported a treatment duration of
at least 6 months.  Eighty-three percent of State/Federal
systems and 65 percent of city/county systems reported at
least 6 months of treatment for HIV-negative patients with
TB disease, and 85 percent and 76 percent, respectively,
reported at least 6 months of treatment for HIV-seropositive
patients.
Completion of the course of therapy is important to prevent
relapse, continued transmission, and development of drug
resistance.  Directly observed therapy and postrelease
followup are critical factors in regimen adherence and comple-
tion.  Ninety-eight percent of State/Federal systems and 95
percent of city/county systems reported employing directly
observed therapy for all inmates under treatment for TB
disease.  In 15 systems with this policy, the validation study
revealed agreement from 94 percent of the 35 responding
facilities.  Although it may be difficult to maintain adher-
ence following release, outreach and followup programs in
the community can achieve positive results.  In New York
City, for example, initiation of an expanded outreach pro-
gram that included incentives for patients under treatment
for TB disease who were released from Rikers Island helped
to produce a dramatic increase in appearance rates for
followup appointments in the community, from less than 20
percent to 92 percent.8
Eighty percent of State/Federal systems and 87 percent of
city/county systems reported providing INH treatment to all
PPD-positive inmates less than 35 years of age.  This policy
appears to diverge from the CDC recommendation that
patients in this age group be started on treatment if they are
considered likely to be able to complete 6 months on the
regimen.  Ninety percent of systems reported providing at
least 6 months’ treatment of TB infection to HIV-seronega-
tive patients, the CDC guideline, and a smaller percentage—
71 percent of State/Federal systems and 56 percent of city/
county systems—adhered to the CDC recommendation of
12 months’ treatment for HIV-infected patients.  Directly
observed treatment of TB infection was the reported policy
for all patients in 90 percent of State/Federal systems and 85
percent of city/county systems.
Studies of inmate adherence to treatment of TB infection
have shown mixed results. In a Texas program under which
inmates received education and were asked to sign written
agreements to adhere to treatment appeared to increase
adherence rates.9  A study of 262 persons released from King
County Jail in Seattle while on treatment for TB infection
revealed that 40 percent could not be contacted, another 40
percent had enrolled in a community-based directly ob-
served treatment program, and 20 percent had selected self-
supervised therapy.  Sixty percent of those who selected
directly observed treatment completed the course of treat-
ment, as opposed to 29 percent of those who selected self-
supervised therapy.  In sum, only 30 percent of the starting
sample of releasees completed treatment of TB infection.10
Clearly, more effective strategies for helping patients to
complete treatment are needed.  A San Francisco study also
found low rates of postrelease adherence—only 3 percent of
93 eligible patients appeared at the public health
department’s TB clinic for followup within 1 month of
release.  Nevertheless, the authors concluded that jails
represent important settings for TB screening and recom-
mended more intensive efforts to improve postrelease adher-
ence to the treatment of TB infection, given the potential
effects of nonadherence on the incidence of TB disease.11  A
short-course preventive therapy regimen—2 months on a
combination of rifampin and pyrazinamide—is under study.
A reduction from 6 months to 2 months of therapy, if shown
to be effective, would be likely to improve adherence.12
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Discharge Planning
Appropriate discharge planning for inmates receiving treat-
ment for TB disease or TB infection may improve postrelease
adherence.  Results of the 1997 NIJ/CDC survey reveal that
discharge planning for inmates with TB disease and TB
infection, as for those with HIV/AIDS, almost always in-
volves referrals to the public health department (100 percent
of State/Federal systems and 97 percent of city/county
systems), but much less frequently includes making specific
appointments for releasees with community-based provid-
ers (35 percent of State/Federal systems and 21 percent of
city/county systems).  At the same time, the vast majority of
systems (92 percent of State/Federal systems and 87 percent
of city/county systems) report the names of persons with TB
being released from their facilities to public health depart-
ments along with locator information.  Thus, health depart-
ments may be able to locate and follow up with patients in
the community after their release.
Education
Educational programs may also help improve adherence, as
well as reinforce other aspects of TB-control policies and
procedures.  A survey of TB knowledge among inmates and
staff in Texas State correctional facilities found common
misconceptions about means of transmission, the difference
between TB infection and TB disease, and methods for the
prevention and treatment of TB.  The study concluded that
educational programs sensitive to literacy levels and cul-
tural differences in the target population should be provided
to inmates and staff in the facilities of the Texas Department
of Criminal Justice (TDCJ).13  Consequently, TDCJ insti-
tuted a TB module as part of its regular inmate education
curriculum.  The program includes pre- and posttests of
knowledge and viewing and discussion of a video produced
by TDCJ called “What You Don’t Know About Tuberculosis
Can Kill You.”  A TB study guide prepared by the Windham
School District for TDCJ includes a range of other activities
and suggestions for weaving discussion of TB-related topics
into other school subjects such as language arts, mathemat-
ics, social studies, and health/science.14
Conclusion
The incidence of TB disease has declined in recent years
both in the total U.S. population and among correctional
inmates, but TB incidence rates remain much higher among
inmates than in the total population.  Policies such as those
recommended by CDC in its revised guidelines and imple-
mented by the New York State Department of Correctional
Services can help reduce further the incidence of TB in
correctional settings.  Most State and Federal prison systems
are following key CDC recommendations regarding the
screening of inmates and staff and the isolation and treat-
ment of persons with TB disease and TB infection.  Substan-
tial improvement is needed in city/county jail systems.  In
general, directly observed therapy should be more widely
implemented. Continuing problems with adherence to regi-
mens for the treatment of TB disease and TB infection
following release to the community may be amenable to
improvement by better education, discharge planning,  link-
ages with health departments and community-based provid-
ers, incentives to appear for followup appointments (for
example, food coupons and bus tokens), and shorter courses
of therapy.
Endnotes
1. Centers for Disease Control and Prevention, Reported
Tuberculosis in the United States, 1996, Atlanta (July
1997), table 1: 5.
2. Ibid., table 12, 19; Centers for Disease Control and
Prevention, Reported Tuberculosis in the United States,
1994, Atlanta (July 1995), table 12: 19; Centers for
Disease Control and Prevention, Reported Tuberculosis
in the United States, 1997, Atlanta (July 1998), table 14:
25.
3. Centers for Disease Control and Prevention, Reported
Tuberculosis in the United States, 1997, table 6: 15.
4. Ibid., table 23, 34.
5. K. Steenland, A.J. Levine, K. Sieber, P. Schulte, and D.
Aziz, “Incidence of Tuberculosis Infection Among New
York State Prison Employees,” American Journal of
Public Health 87 (December 1997): 2012–2014.
6. New York State Department of Correctional Services,
Division of Health Services, Health Services Policy
Manual, policy no. 1.18, “Tuberculosis,” May 20, 1996.
7. Centers for Disease Control and Prevention, “Prevention
and Control of Tuberculosis in Correctional Facilities:
Recommendations of the Advisory Council for the Elimi-
91Tuberculosis
nation of Tuberculosis,” Morbidity and Mortality Weekly
Report 45, RR–8 (June 7, 1996): 1–27.
8. T.R. Frieden, P.I. Fujiwara, R.M. Washko, and M.A.
Hamburg, “Tuberculosis in New York City:  Turning the
Tide,” New England Journal of Medicine 333 (1995):
229–233.
9. G.L. Woods et al., “Tuberculosis Education: Develop-
ing Effective Programs for Incarcerated Individuals,”
presentation at the 21st National Conference on Correc-
tional Health Care, San Antonio, TX, November 11,
1997.
10. C.M. Nolan, L. Roll, S.V. Goldberg, and A.M. Elarth,
“Directly Observed Isoniazid Preventive Therapy for
Released Jail Inmates,” American Journal of Respira-
tory Critical Care Medicine 155 (1997): 583–586.
11.  J.P. Tulsky, M.C. White, C. Dawson, T.M. Hoynes, J.
Goldenson, and G. Schechter, “Screening for Tuberculo-
sis in Jail and Clinic Followup After Release,” American
Journal of Public Health 88 (1998): 223–226.
12. M. Lobato, Division of Tuberculosis Elimination, Cen-
ters for Disease Control and Prevention, personal com-
munication, September 29, 1998.
13. G. L. Woods, S. L. Harris, and D. Solomon, “Tuberculosis
Knowledge and Beliefs Among Prison Inmates and Lay
Employees,” Journal of Correctional Health Care 4
(1997): 1–9.
14. Margaret Smith,  Tuberculosis: A Study Guide, Hunts-
ville, TX: Windham School District, 1997.
93Legal and Legislative Issues
Chapter 9
Legal and Legislative Issues
Theodore M. Hammett—Abt Associates Inc.
Key Findings
• The U.S. Supreme Court has ruled that HIV and HIV-related discrimination are covered under the Americans
With Disabilities Act.
• There were few other major legal developments affecting HIV/AIDS in correctional facilities during the period
covered by this Update report, although courts generally continued to uphold correctional systems’ policy
responses to HIV/AIDS.
• Some State legislatures have attempted to expand the requirements for the HIV-antibody testing of inmates
and disclosure of inmates’ HIV status, but these efforts have been generally unsuccessful.
This chapter summarizes legal developments pertinent to
HIV/AIDS, STD, and TB policies in correctional facilities.
Main legal topics include confidentiality of medical infor-
mation, segregation, access to programs and work assign-
ments, alleged exposure to HIV, treatment, early release, and
TB issues.1  Recent legislative activity, which focused on
HIV testing and disclosure of test results, is also summarized.
Confidentiality
As discussed in chapter 5, very few correctional systems have
official policies for disclosing inmates’ HIV status to correc-
tional officers or other correctional officials.  As part of a
settlement in Shumate v. Wilson, the California Department
of Corrections agreed to end practices by which inmates with
HIV were identified to unauthorized persons in two women’s
prisons.2  By and large, however, courts have limited in-
mates’ rights of privacy and confidentiality regarding medi-
cal information such as HIV status.  Indeed, in Anderson v.
Romero, the U.S. Court of Appeals for the Seventh Circuit
ruled that prisoners have no constitutional protection against
the unauthorized disclosure of their medical information,
even if such disclosure is motivated by spite.  An HIV-
infected Illinois prisoner sued a warden and correctional
officer for revealing his HIV status, and the U.S. District
Court held that the inmate might have a legitimate right-of-
privacy case.  However, on appeal, the Circuit Court ruled
that prison officials have wide discretion regarding the
disclosure of medical information about inmates.  In his
opinion, Judge Richard Posner wrote:  “We cannot find any
appellate holding that prisoners have a constitutional right
to the confidentiality of their medical records.”  The court
also held that this inmate’s right to privacy must be subor-
dinate to other inmates’ rights to be free from exposure to
HIV; the protection of other inmates was alleged to have
been the objective of the disclosure.3
Segregation of HIV-Infected
Inmates
Only two State correctional systems, those in Alabama and
Mississippi, segregate asymptomatic HIV-infected inmates.
The Alabama policy of segregation and exclusion of HIV-
infected inmates from programs and activities has been the
target of a lengthy lawsuit, originally filed in 1987 as Harris
v. Thigpen.  In November 1997, a divided three-judge panel
of the U.S. Court of Appeals for the Eleventh Circuit over-
turned the District Court’s 1995 ruling that HIV-infected
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prisoners in Alabama could be excluded from programs on
the basis that HIV transmission is possible in such program
settings.  The case, now captioned Onishea v. Hopper, was
remanded for retrial and the original judge was ordered
removed.  Subsequently, however, in January 1998, the
Eleventh Circuit Court vacated the panel’s ruling and or-
dered that the case be reheard en banc, that is, before the full
Circuit Court.4
At the same time, courts continued their usual pattern of
upholding correctional policies whether they require segre-
gation or integration of HIV-infected inmates.  In Robbins v.
Clarke, the Eighth Circuit Court upheld a ruling by the U.S.
District Court for Nebraska that housing HIV-infected in-
mates in the general prison population does not constitute
“cruel and unusual punishment” of  uninfected inmates.5  In
a more recent Iowa case, Massick v. North Central Correc-
tional Facility, the Eighth Circuit Court upheld the District
Court’s dismissal of an inmate’s claim that prison officials
acted with “deliberate indifference,” the constitutional stan-
dard of cruel and unusual punishment regarding health
issues, by knowingly housing him in a double cell with an
HIV-infected inmate who had open wounds.  The dismissal
was based on acceptance of the defendant’s assertion of
qualified immunity, the superseding of which would have
required the plaintiff to prove that prison officials know-
ingly placed him at substantial risk of serious harm and failed
to abate that risk.  The District Court held that this had not
been established, and the Eighth Circuit Court agreed.6
Implicit in this opinion is the principle that correctional
officials may house HIV-infected and HIV-uninfected in-
mates in the same cells.
Access to Programs
The issue of access to programs is closely related to the issue
of segregation, as in the Alabama case.  Indeed,  the Eleventh
Circuit Court’s decision in Onishea v. Hopper may be
influenced by the U.S. Supreme Court’s important rulings in
Bragdon v. Abbott and Pennsylvania Department of Cor-
rections v. Yeskey. In Bragdon, the Court held that HIV-
related discrimination in the provision of health care ser-
vices is prohibited under the Americans With Disabilities
Act (ADA) unless an alleged transmission risk used to deny
service could be assessed on the basis of objective, scientific
information.7  In the Yeskey case, the Court ruled that the
ADA applies to correctional inmates.  Previously, the Third,
Seventh, Ninth, and Eleventh Circuit Courts had held that
prisoners are covered by the ADA, whereas the Tenth Circuit
Court has issued an ambiguous opinion on the subject, and
the Fourth Circuit Court has ruled against prisoners’ rights
under the ADA.  The Yeskey case did not allege discrimina-
tion against an inmate with HIV disease,  but rather claimed
that a hypertensive inmate was improperly excluded from a
boot camp program.8  Pennsylvania, joined by 36 other
States, argued that a ruling for Yeskey would undermine its
ability to manage prisons efficiently and establish  programs
with restrictive eligibility criteria.  Attorneys for Yeskey
countered that the ADA requires only “reasonable accom-
modation” of disabled persons and that Congress intended
the Act to cover everyone.9   The Supreme Court announced
its decision in June 1998. In his majority, Justice Antonin
Scalia wrote that the ADA “unmistakably includes State
prisons and prisoners within its coverage.”10
Two other Pennsylvania cases addressed correctional sys-
tems’ ability to exclude inmates with HIV from certain work
assignments.  As part of a settlement in Austin et al. v.
Pennsylvania Department of Corrections, a class action
civil rights suit challenging a range of conditions of confine-
ment, the department agreed not to discriminate against
inmates with HIV in making work assignments unless perfor-
mance of the job could involve a direct threat to the health
of others.11  No definition of such direct threat to health was
provided.  However, the Austin settlement was cited by the
same court in rejecting the claims of two Pennsylvania
inmates that the department’s failure to screen food handlers
for HIV antibodies in effect threatened the plaintiffs with
infection.  The court held that under the Austin settlement the
correctional department was not permitted to exclude in-
mates from these work assignments on the basis of HIV
status.12
Alleged Exposure to HIV
There have been several cases in which inmates alleged that
they were infected with HIV through a rape in a correctional
facility.  None has yet resulted in a verdict against a correc-
tional department or its employees.  The most recent, and
perhaps most highly publicized, of these cases was Blucker
v. Washington, in which a former Illinois inmate claimed
that he was repeatedly raped and consequently infected with
HIV, and that prison staff knew that the rapes were occurring
but did nothing to protect him.  The suit named 15 individual
defendants, but not the Illinois Department of Corrections.
Prior to trial, the court dismissed the cases against eight of
the defendants.  In September 1997 a Federal jury refused to
assess damages against five of the remaining defendants but
could not reach verdicts on the other two.  A new trial was
held as to the last two defendants, and in January 1998 a jury
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found no liability on their part.13  The defendants’ main line
of argument was that Blucker’s sexual relations with other
inmates had been consensual.  Blucker’s acquisition of HIV
while incarcerated was not in dispute.
In Arkansas the Court of Appeals for the Eighth Circuit
ordered a new trial in the case of an inmate who claimed to
have been infected with HIV through a prison rape after the
warden failed to protect him from his cellmate. A U.S. District
Court judge had initially found no basis in the inmate’s
allegation that the warden’s failure to change his housing
assignment represented “deliberate indifference.”  The Cir-
cuit Court determined, on the contrary, that the warden had
disregarded direct evidence that the plaintiff was at risk of
being sexually assaulted by his cellmate.14
A Federal District judge dismissed a New York inmate’s suit
against prison officials for failing to protect him from an HIV-
infected inmate who threw feces and semen at him. The court
held that the plaintiff produced no evidence that the prison
officials deliberately denied him protection from his assail-
ant.15  However, the conviction of a Georgia inmate with HIV
for reckless endangerment by attempting to bite a correc-
tional officer was upheld.  The inmate’s attending physician
testified that it was “very strongly possible” that HIV could
be transmitted though a bite.16
Medical Treatment
Several important cases involving the medical treatment of
inmates with HIV/AIDS were recently decided.  In settling
Shumate v. Wilson, the California Department of Correc-
tions agreed to provide inmates at two women’s prisons with
care for HIV/AIDS, cancer, heart disease, and other serious
illnesses that meets or exceeds community standards.  Under
the terms of the settlement, four medical experts are monitor-
ing the provision of care for 16 months.17
In Franklin v. District of Columbia, a Federal District judge
held that the correctional department’s failure to provide
interpreters for Spanish-speaking prisoners in health care
and other situations was unconstitutional.  She specifically
cited the department’s inability to provide adequate HIV
counseling and care, diagnosis and treatment of illness, and
mental health services for Latino inmates.  “It is difficult to
conceive of an example of [a] medical care system that can
be more deliberately indifferent than one in which illnesses
are diagnosed and medication is prescribed based upon the
patient pointing to a region of his or her body and saying the
Spanish word for pain, ‘dolor.’ . . . For medical care to be
adequate, a doctor and patient must be able to understand
each other.”18
In another case the Court of Appeals for the Ninth Circuit
refused to grant a sentence reduction to a Federal inmate with
AIDS who claimed that he needed to receive experimental
medications available only through trials being conducted
in the community.  The court did not rule directly on the
inmate’s right to receive such experimental medications if
he could not tolerate the FDA-approved drugs available in
the prison, but relied on the “sparse” evidence presented by
the plaintiff regarding the seriousness of his medical condi-
tion and the urgency of his need for the medication.19
Early Release
In Jerrell v. State of New York, a U.S. District judge ruled
against an inmate with AIDS who claimed to have been
unconstitutionally denied early release.  Jerrell argued that
the State’s tightening of the eligibility criteria for early
release, thereby excluding him because he was sentenced as
a “persistent, violent felony offender,” represented a statute
not rationally related to a government interest and unduly
burdensome to him as an HIV-infected person.  Jerrell
claimed that he should be eligible for early release because
of his terminal medical condition and his exemplary prison
record.  The court disagreed, holding that the State’s tight-
ening of the eligibility criteria for release was rationally
related to the State’s interest  in protecting its citizens.
Therefore, the court held, Jerrell’s constitutional rights had
not been abridged in the application of these eligibility
criteria to him.20
Tuberculosis Issues
A fairly well-developed line of judicial opinion holds that
correctional systems are empowered to take aggressive
measures, including the mandatory PPD screening of in-
mates, to control tuberculosis in prisons and jails.  Indeed,
courts have held correctional systems liable for failing to
implement such measures, thereby placing inmates at risk of
acquiring TB.21  The most recent major case involving
correctional TB policy is Cunningham v. Coughlin, a New
York action in which inmates exposed to TB sought an end
to double bunking in dormitory settings.  This case is still
pending.22
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Legislative Developments
The area of most common legislative activity regarding HIV/
AIDS in correctional facilities has been, and continues to be,
testing and disclosure policy.  Many States have legislation
mandating HIV testing and disclosure of test results in
certain circumstances, such as being convicted of or charged
with a sex offense or a drug offense, assaulting another
inmate or correctional staff member, or otherwise exposing
another person to blood or body fluids.  The specific provi-
sions of these laws vary widely regarding when and how
testing is to be performed and disclosure of results effectuated.
Recent legislative developments in this area include the
passage of separate laws in Oklahoma requiring the HIV-
antibody testing of persons charged with sex offenses and
inmates who hurl or expel body fluids at officers or other
inmates.23  Colorado Governor Roy Romer vetoed legisla-
tion that would have required the HIV testing of persons
charged with sex crimes involving penetration and forced
public health agencies to divulge whether an HIV-positive
defendant had previously been notified of a positive test
result.  The intent of  the law was to enable prosecutors to
charge individuals who had been given a positive test result
in the past with the felony of committing a sex act with prior
knowledge of being HIV infected.  In his veto message,
Romer argued that using confidential public health surveil-
lance information for this purpose might discourage people
from seeking confidential HIV testing.24
The New York State Assembly took no action on a bill passed
by the Senate that would have made an inmate who throws
feces, urine, blood, or semen on a correctional officer guilty
of a felony.  A California law shortened the time and
streamlined the process by which inmates can appeal an
order to be tested for HIV antibodies following incidents in
which others were exposed to their body fluids.  Legislatures
in California and Arizona voted down proposals requiring
the mandatory HIV screening of inmates.  The governors of
Washington and Rhode Island vetoed bills that would have
given correctional officers access to the names of HIV-
positive inmates.  California Governor Pete Wilson vetoed
a bill that would have permitted the release of terminally ill
inmates expected to die within 6 months and required
correctional officials to consider the costs of such inmates’
continued incarceration in making release decisions.  Fi-
nally, a new Florida law requires all persons convicted of
drug offenses to participate in an HIV awareness program.25
Conclusion
The period under review in this Update has produced few
major developments in case law or legislation regarding
HIV/AIDS or TB in correctional facilities.  Courts generally
have continued to permit correctional systems broad discre-
tion in devising the policies they think necessary and
appropriate and have been loath to interfere with this policy-
making function. Some legislators have sought radical
expansions of existing HIV-testing and disclosure policies
but generally have been unsuccessful in enacting such laws.
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